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Abstract
Harnessing organisms for protein and chemical production is useful to the scientific community and has applications in the fuel, food, and pharmaceutical industries. Biological systems
commonly used for industrial chemical production include yeast and bacteria due to their fast
growth rates and potential for high product yields. However, biologically active proteins, such
as for human therapeutics, usually require production in mammalian and insect systems that are
prohibitively expensive to grow at scale. Recently, photoautotrophic microalgae have emerged as
promising platforms, as some species can be grown quickly and inexpensively at large scales and
have the potential to produce biologically active proteins that mimic those produced in mammalian
systems. Thus, they combine advantages from several traditional biological systems, but require
further genetic and biotechnological development for their full potential to be unlocked.
Ideal biological production systems generally possess a variety of genetic tools to enable foreign gene expression, and genome editing systems to create desired genetic modifications. Here
I present a robust gene editing system, novel genetic tools, and valuable strains for the microalga
Phaeodactylum tricornutum. First, I identify novel endogenous regulatory elements that can drive
expression of foreign genes in P. tricornutum, and design a plasmid-based Cas9 gene editing system for this species. Next, I demonstrate the utility of these tools with the generation of auxotrophic
P. tricornutum strains through the genetic knockout of key enzymes in the uracil and histidine
biosynthesis pathways. I complement the phenotype of the auxotrophs by introducing intact versions of these genes on replicating plasmids, and demonstrate that these genes function as selective
markers for transformation of their respective auxotrophic strain. Finally, I highlight the potential
of these tools by creating a P. tricornutum expression system for the production of SARS-CoV-2
antigens. This will potentially address the need for a cheap, scalable source of serologically-active
antigens for population-wide serological testing to combat the SARS-CoV-2 pandemic, and this
system can be rapidly adapted to tackle future pandemics. I hope that these novel tools and strains
will broaden the potential applications of P. tricornutum for industrial production of high-value
products, and further the study of diatom biology.

Keywords: Phaeodactylum tricornutum, microalgae, genetic tools, Cas9 gene editing, auxotrophs,
synthetic biology, production strains.
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Lay Summary
There is a growing demand for methods to produce food, drugs, and fuels cheaply and in an
environmentally sustainable way. One promising solution is to exploit organisms through genetic
engineering to synthesize these products for us. Yeast, bacteria, and mammalian cell cultures are
commonly used for this purpose but aren’t suitable for all applications, such as large-scale production of pharmaceutical compounds that require special modifications to be functional. Microalgae
are promising alternative platforms for these applications as many microalgal species are photosynthetic, making them inexpensive to grow at large scales, and several species have been deemed
safe to eat. Some microalgae have also shown the potential to perform the special modifications
that are required to produce functional pharmaceuticals. However, many promising microalgae
species lack the proper development and tools required to engineer them for these purposes. Here,
I develop genetic tools and strains of the marine microalga Phaeodactylum tricornutum to enable
industrial-scale production of high-value products in this species.
First I create novel plasmid-based expression tools, and a CRISPR/Cas9 gene-editing system
for P. tricornutum. I then use these tools to generate auxotrophic strains of this species by knocking
out key genes in the P. tricornutum uracil and histidine biosynthesis pathways. I show that the
auxotroph phenotypes can be complemented by plasmid-encoded intact versions of these genes,
providing an antibiotic-free plasmid selection system. Finally, I use these tools and strains to
engineer P. tricornutum to produce the SARS-CoV-2 spike protein to potentially address the need
for a cheap, abundant source of viral proteins required for serological testing. This expression
system can be easily adapted to address future pandemics, or produce human therapeutics. The
tools and strains generated here will enable industrial-scale production of valuable products in P.
tricornutum, and further the study of diatom biology.
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Chapter 1
Introduction
1.1

The biodiversity of algae

Eukaryotic algae are a collection of diverse photosynthetic organisms with members found in
three taxonomic supergroups including plantae, excavates, and SAR (stramenopiles, alveolates,
and rhizaria), as well as the haptophytes and cryptophytes groups, with most lineages within the
plantae and SAR supergroups (Fig. 1.1) (1–3). The plantae supergroup contains algae species that
exclusively arose from primary endosymbiosis events where a photosynthetic cyanobacteria was
engulfed by a heterotrophic eukaryote, followed by most of the cyanobacterial genome being transferred to the host nucleus (4). These endosymbiosis events gave rise to green and red algae, glaucophytes, and higher plants. Algae that are found in the SAR and excavates supergroups arose from
secondary endosymbiosis events involving phagocytosis of a primary red or green algae, where the
nucleus of the engulfed primary algae was largely reduced or lost completely (5). The SAR supergroup includes the lineages stramenopiles, alveolates and rhizaria. The stramenopiles, also called
heterokonts, encompass diatoms and brown algae which are characterized by their golden-brown
or brownish-green colour. These arose through secondary endosymbiosis of a primary red algae
species and include some of the most abundant algal species (5). Algae are generally categorized
as either red (Rhodophyta), green (Chlorophyta), or brown (Phaeophyta), and classified by size
as macroalgae or microalgae. Macroalgae, such as seaweed, are large, multi-cellular organisms
visible with the naked eye, while microalgae are microscopic, unicellular organisms.
Microalgae have adapted to live in a wide range of conditions. They have been found in saltwater, freshwater and terrestrial habitats, in extremes of hot and cold, varying mineral compositions
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Figure 1.1: A possible evolutionary tree of eukaryotic algae. Diagram depicting supergroups in which algae lineages (bolded) are found, and the phylogenetic links that connect them.
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and pH values, very low and very high light, and even industrial wastewater (6). While some microalgae are heterotrophs, most are photoautotrophs capable of synthesizing their own food from
inorganic substances such as CO2 and salts, using light as an energy source (7). A subset of these
are mixotrophic, able to photosynthesize and acquire exogenous organic nutrients (8).
Microalgae are extremely abundant, being found in almost every natural environment, and play
an important role in the global ecosystem (9). They are responsible for more than half of all atmospheric oxygen production and are potent carbon sequestering organisms (10). Additionally,
microalgae are integral members of the global food chain with diatoms being a particularly important group, performing roughly one-fifth of all photosynthesis on earth (11). As a result, diatoms
produce a huge abundance of organic carbon and are the foundation of aquatic ecosystem food
chains worldwide.

1.2

Industrial applications of microalgae

Due to their extensive genetic diversity, microalgae represent an invaluable resource of unique and
potentially useful biomolecules that make them very attractive for bioprospecting. They produce
a wide range of natural products, including lipids, proteins, polysaccharides, pigments, vitamins,
bioactive compounds, and antioxidants (12). Additionally, many microalgae species have high
growth rates even under minimal photosynthetic conditions. These characteristics and others make
them ideal for large scale production of natural products. As a result, they have become the focus
of many industrial efforts to engineer organisms for commercial chemical biosynthesis, driven in
part by the initiatives to use microalgae as a renewable source of biofuels (13, 14). However, it
is believed that economically viable biofuel production from microalgae can only be possible if
coupled with the production of other high-value co-products (15). To date, microalgae have been
used for the biosynthesis of products including biofuels, cosmetics, food, and biopharmaceuticals
(Fig. 1.2) (12, 16–21).

1.2.1

Biofuels

As the global demand for fuel energy increases, fossil fuels are rapidly being depleted and the need
for alternative sources of fuels is becoming a major concern. One promising alternative is biofu-
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Figure 1.2: Industrial applications of microalgae. Microalgae can be cultured to produce biomass for direct consumption, refinement into biofuels, or extraction of valuable bioproducts produced naturally or through genetic modification.
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els, fuels derived from living matter. The first generation of biofuels are fuels created using food
crops such as corn, wheat, sugar cane, and rapeseed (22). These crops generally have high sugar or
starch content and are converted into biofuels such as ethanol and biodiesel through fermentation
processes. Second generation biofuels are those made from feedstocks such as food waste (e.g.
waste vegetable oil), and crops that are not typically food crops, including lignocellulosic agriculture like switchgrass (23). Because they are not intended as food crops, they are usually grown
on marginal land and do not compete with food crops for agricultural space, but generally require
more complicated biofuel conversion processes than first generation feedstocks.
Third generation biofuels are those derived from algae. Microalgae are rapidly gaining interest
as a feedstock for biofuel production because of their potential for high lipid production which
outcompetes even the best first and second generation feedstocks (24). Microalgae have several
advantages over traditional feedstocks, but are limited by a number of factors that prevent them
from becoming the preferred method of biofuel production. Unlike agricultural biofuel feedstocks,
microalgae are capable of year round production, resulting in much higher biofuel yields, and do
not require herbicides or pesticides, reducing environmental pollution (25). Microalgae also need
less water than terrestrial crops despite growing in an aqueous environment, and do not require
cultivation on agricultural land, and thus do not compete for land use with food crops (26). Some
microalgae have rapid growth rates and high lipid content reaching up to nearly 80% of dry-cell
weight, such as in case of Botryococcus braunii (27), further increasing their biofuel production
potential. As an added benefit, microalgae produce organic compounds that can be converted into
valuable co-products. After biofuel extraction, their biomass can be fermented for further biofuel
production, or used as fertilizer or feed for agriculture (24).
Photoautotrophic microalgae require five main inputs for sustained growth; light, water, carbon
dioxide, nitrogen, and phosphorous, which all increase input costs and impact their sustainability.
This can be partially offset by growing the microalgae in wastewater, which can meet some of
their nitrogen and phosphorous needs (27). Their CO2 requirement can be addressed by cultivating
them in photobioreactors that can be set up to feed off of industrial waste CO2 , which has the
added benefit of reducing industrial carbon emissions (27). In addition, it has been shown that
growth under stressful conditions, such as nitrogen deprivation, can greatly increase oil production
in some microalgae species (28). This has the potential to offset nitrogen requirements without

6
impacting biofuel yield.
Despite these approaches, microalgae still require a large amount of water, nitrogen, and phosphorous which can only be partially fulfilled by growth in industrial wastewater and will ultimately
require extensive use of fertilizers. It is predicted that biofuel production from microalgae will
need to be coupled with valuable co-product production to make them economically feasible (23).
In addition, the infrastructure to support large-scale microalgae-based biofuel production is not
fully established, partially due to the fact that there are currently no microalgae species productive
enough to offset the cost of initial setup and continued maintenance and input costs of microalgae
culturing (29). Overcoming these issues will likely require genetic engineering of promising microalgae species to create a balance between high lipid production, fast growth rate, a suitable lipid
profile for biofuel processing, and production of high value co-products.

1.2.2

Cosmetics

Cosmetics are agents used to clean, protect, perfume, and improve or modify the appearance of
skin, hair, nails, or teeth (30). Skin moisturizers, makeup, and toothpaste are common examples
of cosmetics that are composed of a variety of ingredients, many of which can be derived from
natural sources such as pigments and scents from plants, and lubricants like squalene from shark
liver (19). Cosmetic ingredients can also be chemically synthesized if the natural source is scarce
or expensive, or if there is no known natural source of a particular compound. However, for
some traditionally derived cosmetic ingredients, harvesting them from plant and animal sources is
potentially time consuming and can be too inefficient to meet market demands, while the chemical
synthesis approach can be difficult and expensive. In addition, there is an increasing demand
for naturally sourced cosmetic ingredients (30). As a result, cosmetic manufacturers have begun
investigating alternative natural sources of cosmetic compounds, with one of the most promising
being microalgae.
Microalgae are an attractive source of cosmetic compounds as they are generally easier to cultivate than many of the traditional plant sources of cosmetic ingredients. Additionally, certain
species of microalgae either produce useful quantities of desired cosmetic ingredients naturally, or
can be engineered to produce them. In fact, the ingredients of many cosmetics, including cer-

7
tain pigments and dyes, photoprotectants, moisturizers, thickeners, lubricants, and anti-ageing
compounds, are already being sourced from microalgae (19). For example, phycocyanin, phycoerythrin, and allophycocyanin are pigments in the phycobilin family that are unique to algae
and cyanobacteria. These pigments are harvested from species such as Spirulina, Porphyridium,
Rhodella and Galdieria to be used in cosmetics and other applications (31, 32). Porphyra-334,
asterina-330, and palythinol are examples of mycosporin-like amino acids (MAAs) which show
promise as photoprotectant compounds due to their ability to absorb ultraviolet (UV) radiation and
disperse it as heat energy (33). MAAs are produced by a number of organisms including algae and
cyanobacteria, with some MAAs already on the market for use in the anti-photo-ageing cosmetic
Helioguard 365 (34), while others are being investigated for use in sunscreens and UV-protective
biomaterials (33). Polysaccharides from microalgae such as those found in the genera Chlorella
and Porphyridium can act as moisturizing and gelling/thickening agents for cosmetics, much like
the polysaccharides derived from macroalgae (35). Squalene is a compound harvested from shark
livers to be used as a lubricant in cosmetics, skin care products, and hair conditioning agents. Squalene has been shown to be produced at appreciable levels (20% dry-cell weight) in the microalga
Aurantiochytrium mangrovei, providing an alternative, sustainable source for this high-value compound (19). These examples of the many compounds that can be derived from microalgae for use
in cosmetic formulations highlight the potential of microalgae as a source of valuable products.

1.2.3

Food and dietary supplements

Algae are an excellent natural source of carbohydrates, lipids, proteins, and other nutrients. In fact,
algae have been used for nutritional purposes for much of recorded history (36). The Porphyra
seaweeds have been consumed by almost every culture that has had access to them for thousands
of years, and is most commonly recognized as the edible seaweed nori used in sushi preparation
(37). The ancient peoples of Chad and Mexico consumed Spirulina and Aphanizomenon as a food
source (38), and ∼2000 years ago Nostoc was consumed as a means to survive famine in China
(39). The consumption of Nostoc flagelliforme became so popular that it continues to be consumed
by Chinese peoples today.
While macro- and microalgae have been exploited as a food source for much of human history,

8
the purposeful culturing of microalgae in specialized facilities is a relatively modern practice. This
is becoming more popular as biotechnology and food industries show greater interest in microalgae
as a means to cheaply produce valuable nutritional products. The first examples of large-scale
commercial microalgae culturing for food production were with Chlorella in Japan in the 1960s,
Spirulina in Mexico in the 1970s, and Dunaliella salina in Australia in the 1980s (19). Today,
Spirulina and Chlorella are the two most popular microalgae on the market as a human food source
(40). Spirulina is a nutrient-rich species of microalgae for both human and animal consumption,
and is the most abundantly produced microalgae for food supplements. It has a high amino acid
content, is a good source of A and B vitamins, and is a source of linolenic acid, an essential
nutrient for human health (41). Spirulina also produces the phycocyanin commercially known as
”lima blue”, which is harvested for use as a colorant in foods such as soft drinks, candies, and even
dairy products (20, 42). Likewise, Chlorella has been used to make many food products including
soups, noodles, bread, cookies, ice cream, and soy sauce (43).
One of the most popular food products derived from microalgae are polyunsaturated fatty acids
(PUFAs). Animals, including humans, lack the ability to synthesize PUFAs greater than 18 carbons in length and must obtain them from their diet (44). These include the omega-3 fatty acids
eicosapentanoic acid (EPA), docosahexaenoic acid (DHA) and alpha-linolenic acid (ALA). A common dietary source of omega-3 fatty acids for much of the world are fish, which obtain them from
consuming microalgae (45). However, many populations do not have access to a stable supply of
fish, and harvesting omega-3 fatty acids from fish for use as dietary supplements has many issues
and is ultimately unsustainable (46). As some microalgal species (e.g. diatoms) are particularly
rich in these fatty acids, they are regarded as a viable alternative source of dietary PUFAs (20, 47).
Currently, microalgal species like Crypthecodinium cohnii, Schizochytrium, and Ulkenia are being cultivated for their natural accumulation of omega-3 fatty acids (20), while attempts are being
made to increase or alter the PUFA content of species like Arthrospira and Porphyridium for dietary supplements (20, 47). In addition, the diatom Phaeodactylum tricornutum naturally produces
EPA and small amounts of DHA, and some groups have had success modifying this species to increase or alter its omega-3 fatty acid content (48–50). Microalgae have even been added to foods
whole to enrich them with essential fatty acids and other nutrients, such as the addition of Isochrysis galbana biomass to biscuits (51). Microalgae are an excellent source of food and the purposeful
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culturing of microalgae for food and food supplement production is only becoming more popular.
Thus, it is likely that industrially farmed microalgae will become a sustainable food source and
dietary staple for many parts of the world.

1.2.4

Biopharmaceuticals

Among the most promising applications for microalgae is the production of biopharmaceuticals
(BFs) and health related products. Biopharmaceuticals are biological compounds like antibodies, hormones, and vaccines that have applications in the treatment or prevention of disease. The
compounds can be naturally occurring, synthesized chemically, or derived from an engineered organism such as bacteria, yeast, mammalian or insect cells that have been genetically modified to
produce the desired compound (52). For the latter, the choice of host organism depends on the type
and complexity of the biomolecule, and each host comes with unique advantages and disadvantages. For example, protein BFs that require post-translational modifications (PTMs) like N-linked
glycosylation are commonly produced in mammalian culture systems rather than in bacteria, as
bacteria are incapable of performing these modifications. In contrast, simpler drugs like some
peptide hormones can be reliably produced in bacteria much more cheaply than in mammalian
cells (53). Some of the issues faced when producing BFs in mammalian cells include the risk of
contamination with prions and human-infecting viruses (54, 55), and the prohibitive cost to scale
up drug production (56). These issues have prompted a search for novel host organisms suitable
for complex BF production, with many groups turning to microalgae as an attractive alternative
platform (57–60).
The production of biopharmaceuticals in microalgae has a number of distinct advantages over
traditional systems (7, 42, 61). Most microalgae species are photoautotrophs, allowing them to be
cultured relatively inexpensively in specialized photobioreactors or large open ponds. Additionally, many microalgal species also have relatively fast growth rates compared to mammalian culture
systems. These characteristics allow for massive scalability, a major advantage over mammalian
and insect cell culture systems. Eukaryotic microalgae are capable of post-translationally modifying proteins, with a range of possible PTMs available depending on the host microalgal species
(62–66). Many microalgae have GRAS (generally recognized as safe) status (67). Furthermore,
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as microalgae do not require a reduced carbon source in their growth media, they don’t incur the
same risk of bacterial, fungal, or viral contamination as mammalian cell cultures. These qualities
make downstream purification of products simpler and cheaper than other biological platforms.
Some of the earliest examples of biopharmaceutical production from microalgae were using the
model green microalga Chlamydomonas reinhardtii (68). Since then, Chlamydomonas has been
used to produce antibodies, growth factors, hormones, vaccines, and other valuable BFs (69–73).
While Chlamydomonas might be the most studied and have the largest genetic toolkit for transgene expression, other microalgal species have also been investigated for BF production. In 2012,
the model diatom P. tricornutum was successfully engineered to produce and secrete functional
human antibodies against the Hepatitis B Virus surface protein (74). The microalgae Chlorella sp.
and D. salina have been used to produce human growth hormone and Hepatitis B surface antigen,
respectively (75, 76). While not manufactured for human use, another notable example is the production of fish growth hormone in the microlga Nannochloropsis oculata (77). These examples
serve to highlight the potential of microalgae as hosts for the production of functional biopharmaceuticals and provide a glimpse into the future of sustainable large-scale drug production.

1.3

Modification and improvement of algal strains

There are many promising industrial applications for microalgae, and while some species naturally
produce desirable high-value compounds (78), the success of many applications requires the modification of suitable microalgal strains. Techniques ranging from alteration of growth conditions to
complex genome engineering can be used to increase growth rates or tolerance to different growth
conditions, increase yields of natural products, or enable the production of desired proteins and
metabolic products not natively produced by the species of interest (79). In addition to high value
product biosynthesis, these techniques are also generally useful for the study of microalgal biology. Most modification strategies are applicable to a wide variety of microalgal species. Although
the extent and complexity of modification techniques possible for an organism of interest depends
in part on the availability of genetic tools for that species.
The earliest strategies developed for modification of microalgal strains involve altering growth
media composition and growth conditions to increase or alter natural metabolite levels, or using
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random mutagenesis through physical or chemical means followed by selection and screening to
generate a strain with a desired trait. For example, both nitrogen limitation (80–83) and chemical
mutagenesis (84, 85) have been employed to increase or alter the total fatty acid content of the
model diatom P. tricornutum for potential applications in biofuel and cosmetics production. While
these basic techniques can be simple and effective, this study will focus on targeted modification
strategies.
Targeted approaches to microalgal modification involve methods such as targeted mutagenesis, gene knockout, gene overexpression and knockdown, and metabolic pathway engineering to
generate novel microalgal strains. The rapid development of genome sequencing technologies and
resources such as the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (86) have enabled targeted gene knockout and insertion, prediction and modeling of genetic pathways, and the
rational design or redesign of metabolic pathways (87). Currently, genome sequences are available for several industrially-relevant microalgal species including C. reinhardtii, P. tricornutum,
Nannochloropsis gaditana, Chlorella sp., and others (79). Depending on the host species and the
desired high-value product, success may require the application of one or more targeted modification strategies.

1.3.1

Gene expression strategies

One of the goals of modification of microalgal strains is the expression of foreign genes in a chosen
organism. The ability to efficiently overexpress genes of interest in a host species is a powerful tool
that allows for the production of proteins such as selective markers, metabolic enzymes, high-value
peptides, and even targeted nucleases to be used as part of a genome editing strategy. Expression
of foreign genes generally requires promoter and terminator elements that are recognized by the
transcriptional machinery of the host species to drive transgene expression. A common strategy is
to use endogenous promoters derived from genes that are abundantly expressed in the host species,
such as the C. reinhardtii RbcS2 and HSP70A promoters (88–90), or the nitrate-inducible nitrate
reductase promoters for C. reinhardtii and P. tricornutum (91–93). A related strategy, known as
promoter trapping or gene trapping, functions by delivering a reporter gene or genetic selectable
marker as a promoterless DNA construct that is designed to be randomly integrated into the genome
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of the host organism (94). This strategy relies on the DNA construct integrating into a position
downstream of an endogenous promoter that will drive expression of the reporter/marker gene.
Other expression options include using promoters from a closely related species or from a virus
that is known to infect the species of interest, such as the Cylindrotheca fusiformis FcpA promoter
or the Chaetoceros lorenzianus-infecting DNA virus CIP1 promoter, both of which function to
drive gene expression in P. tricornutum (95, 96). Another consideration for achieving efficient
gene expression is codon optimization. In some cases, optimizing codon usage of a transgene to
match the codon usage preference of the host organism can greatly improve protein production
(97, 98).
While gene overexpression is useful for many applications, some modification strategies require the ability to downregulate expression of endogenous genes in the species under study, without creating a genetic knockout. This can be accomplished using RNA interference (RNAi), a
gene silencing tool which has been developed for some organisms, including microalgae species
such as P. tricornutum, C. reinhardtii, and Nannochloropsis oceanica (99–101). Targeted RNAi
knockdown is useful for species that possess functional RNAi machinery and is a way to posttranscriptionally regulate gene expression by using RNA molecules to cause the cleavage and
degradation of a target mRNA transcript. CRISPR interference (CRISPRi) is a more recently
developed method to downregulate gene expression and has been successfully used in microalgae
like C. reinhardtii and Synechococcus (102–104). CRISPRi is a transcriptional regulation system
which uses the catalytically inactive DNA binding protein dCas9 to block transcription of a target
gene (105). As CRISPRi does not require the host species to possess native RNAi machinery, it is
applicable to a wider range of organisms than RNAi.

1.3.2

Transformation and selection methods

Another requirement for microalgal modification is a delivery method to transform microalgae
with a desired DNA construct. A major barrier to the delivery of DNA constructs to microalgae is
the presence of the algal cell wall, which prevents passage of DNA through the cell membrane. As
a result, many delivery methods require the generation of microalgal protoplasts, cell-wall deficient
algal cells that must be generated using specialized proteases or polysaccharide-degrading enzymes
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before transformation can be performed (106–111).
DNA constructs can either be delivered as linear DNA molecules or as circular plasmids. When
transformed into a host organism, linear DNA can be transiently expressed or integrated into the
host chromosome to be maintained and replicated along with the host genome. Circular plasmids
can be replicating or non-replicating, the latter of which will be expressed transiently upon transformation and lost during cell division. Replicating plasmids in eukaryotic microalgae require the
identification of endogenous or exogenous replication signals and centromeres recognized by the
host cellular machinery that are added to a plasmid to create a stably replicating and partitioning
episome. Replicating plasmids have been developed for a number of microalgal species including
C. reinhardtii, P. tricornutum, and Porphyridium purpureum (112–114).
Both linear and circular DNA constructs can be delivered using a variety of transformation
methods, several of which are generally applicable to a wide range of species. One of the simplest methods for gene delivery is by agitating algal protoplasts with glass beads in the presence
of polyethylene glycol (PEG) and a DNA construct (91). Electroporation is another DNA delivery method which uses an electric pulse to open pores in the cell membrane to allow passage of
DNA into the cell (115). Electroporation has been used to successfully transform several microalgae species including P. tricornutum, C. reinhardtii, Dunaliella tertiolecta, Chlorella vulgaris,
Scenedesmus obliquus, Neochloris oleoabundans, and Nannochloropsis sp. (116–123). Biolistic
transformation, also known as micro-particle bombardment, is the most-frequently used transformation method for microalgae (124–129). This method uses DNA-coated gold or tungsten microparticles fired at high speed into the target organism by pressurized gasses (e.g. helium). The
DNA then elutes from the microparticle and either expresses transiently, becomes integrated into
the chromosome, or replicates autonomously as an episome, depending on the construct design.
Biolistic transformation can also be used to deliver purified proteins to the microalgae of interest
in a similar fashion, as was demonstrated in P. tricornutum (130). A common plant transformation method which uses the soil bacterium Agrobacterium tumefaciens to deliver DNA to plant
cells has also been successfully adapted for use in some microalgae species including C. reinhardtii, Haematococcus pluvialis, Schizochytrium sp., and Isochrysis sp. (131–135). Additionally,
a recent transformation method has been developed for the marine diatoms P. tricornutum and Thalassiosira pseudonana which uses conjugation from bacteria such as Escherichia coli to maintain
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stably replicating episomal plasmids in the nucleus of the transformed microalga (113, 136).
One consideration common to nearly all microalgal transformation methods is the need for a
selective marker to select for successful transformants. The most common selectable markers used
for microalgae are antibiotic and herbicide resistance genes. Examples of popular antibiotic resistance markers for microalgae transformation are the zeocin resistance gene ble, and the neomycin
resistance gene nptII (137, 138). Common herbicide resistance markers include the glyphosate
and phytoene resistance genes, GAT and pds (137, 138). Another type of selectable marker that
has seen use in microalgae are those based on metabolic genes. A microalgae that lacks, or is
engineered to be deficient in, a key metabolic enzyme in an essential biosynthetic pathway can be
transformed with the gene encoding that enzyme to complement the deficiency and be selected for
on media lacking that nutrient. Some examples in microalgae are the ARG7 gene, used to transform a C. reinhardtii arginine auxotroph, and NIT1 (nitrate reductase), used to transform a variety
of microalgal NIT1 knockout strains (91, 124, 126, 139, 140).

1.3.3

Gene-editing technologies

The advent of gene-editing technologies, namely targeted nucleases allowing precise gene editing, is one of the most potent enablers of microalgal modification and opens up a wide array
of industrial applications for genetically engineered microalgae. Engineered nucleases that have
been successfully adapted for gene editing in microalgae include zinc-finger nucleases (ZFNs),
transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short
palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) (141–148). ZFNs and TALENs are fusions of the FokI restriction endonuclease with a zinc finger or transcription activatorlike effector DNA-binding platform (149, 150). These DNA-binding platforms are comprised of
repeating protein subunits that rely on protein-DNA contacts for targeting, making them difficult
to construct. In addition, FokI functions as a dimer, requiring a pair of ZFNs or TALENs positioned on either strand of the target site to produce a double-strand break (DSB). In contrast, the
CRISPR/Cas9 system is an RNA-guided DNA endonuclease that functions as a monomer to produce DSBs (151). Targeting is determined by RNA-DNA hybridization, where an expressed single
guide RNA (sgRNA) complexes with the Cas9 protein and directs it to cleave DNA at the site of
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DNA-binding which must be immediately upstream of short DNA sequence called a protospacer
adjacent motif (PAM) for cleavage. Retargeting Cas9 simply requires expressing a sgRNA that
hybridizes specifically to the target site of interest. In addition, multiple sgRNAs can be expressed
simultaneously, allowing multiple editing events at different locations in the genome (152).
Metabolic engineering of a microalgal strain is often required to improve the production levels
of the desired protein or chemical compound, and gene-editing tools are a simple and effective
way to achieve this. Engineered nucleases like ZFNs, TALENs, and CRISPR/Cas9 can be used to
stimulate a range of genetic modifications including gene disruption, deletion, insertion, and replacement (153). To achieve this, engineered nucleases are delivered to algal cells, either encoded
on DNA constructs (154), or as assembled proteins (130). Once in the nucleus, these reagents
can cleave DNA at a targeted site, generating a DSB that is repaired using the hosts endogenous
DSB-repair machinery, which can be exploited for genome engineering purposes (Fig. 1.3). The
most commonly exploited DSB-repair mechanism is the error-prone non-homologous end joining
(NHEJ) repair pathway, which functions to ligate together blunt DNA ends. During this repair
process, end-processing enzymes may add or remove bases from the free DNA ends, resulting in
the deletion or insertion of short sequences of DNA (INDELs) at the cleavage site. This can be
exploited to generate gene knockouts by introducing frameshift mutations, or by deleting residues
critical for structure or function of a protein of interest. It can also be used to create knock-ins by
using NHEJ to ligate a linear DNA construct into the DSB site.
Homologous recombination (HR) is another DSB-repair pathway that can be exploited for
genome editing purposes. The HR repair mechanism uses a DNA sequence homologous to the
region of the DSB to repair the break in an error-free manner. This function can be exploited
to delete, insert or replace a chosen DNA sequence. This is achieved by co-transforming the
engineered nuclease with a DNA construct, flanked by sequences of DNA homologous to the site of
the DSB. The flanking DNA targets the DNA construct to be recombined into the site of the DSB,
and can be designed to disrupt or replace the target DNA if desired. Unfortunately, this method
has proven to be difficult as some microalgal species display very low frequencies of homologous
recombination (155–158). Efficient homologous recombination has only been observed in a small
number of algal species, including P. tricornutum, Cyanidioschyzon merolae and Nannochloropsis
sp. (123, 155, 159). However, progress is being made towards improving the rates of HR in
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Figure 1.3: Genome modification strategies using engineered nucleases. A Zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), or Cas9 nuclease can be used to generate a targeted DNA doublestrand break (DSB). INDELs can be produced when the DSB is repaired by error-prone non-homologous end joining
(NHEJ). Repair by homologous recombination (HR) can remove or replace a sequence of DNA to produce knock-outs.
Knock-in events can be produced by either NHEJ or HR repair when donor DNA (yellow) is provided.

certain microalgae using strategies like knockdown of NHEJ-pathway proteins to bias repair events
towards HR (160).

1.4

Phaeodactylum tricornutum is an attractive species for synthetic biology applications

The model marine diatom P. tricornutum is a photoautotrophic eukaryotic microalga. It is the
second diatom species to have its genome fully sequenced and is one of the most well-studied
diatoms to date. It has been observed to exhibit three morphotypes: oval, fusiform, and triradiate
(Fig. 1.4), with fusiform being the predominant form (161). It has a genome size of ∼27.4 Mb
with over 10,000 predicted genes (162). Like other closely-related diatoms, P. tricornutum has the
rare ability to metabolize silicates, which it incorporates into its silicified cell wall. Unlike most
other diatom species, it is able to be grown in media lacking silicon (161).
Synthetic biology is the design or redesign of organisms or biological systems for new pur-
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Figure 1.4: The three morphologies of Phaeodactylum tricornutum. P. tricornutum has been observed in three
morphotypes: oval, fusiform, and triradiate.

poses (163). P. tricornutum has a number of characteristics that make it attractive as a platform
for synthetic biology applications including the industrial production of value-added products. As
a photoautotrophic organism, P. tricornutum is simple and inexpensive to grow, even at industrial
scales, and has a relatively fast growth rate. It is a marine microalga and can be grown in filtered
seawater. Thus, it does not require a fresh water supply for cultivation. P. tricornutum can accumulate high levels of fatty acids (164), making it of particular interest for biofuel production.
It is also an abundant source of the PUFA EPA, though not at a level to be commercially viable
without modification to improve yields (48). It has been demonstrated that P. tricornutum can perform protein post-translational modifications that result in functional proteins that resemble those
made in mammalian cell systems (58, 165). Specifically, P. tricornutum possesses a glycosylation
pathway that is very similar to the pathway found in human cells (62), including an important Fucosyltransferase (FuT) required to produce fucosylated N-Glycans (63). This is signficant as this
enzyme is not present in other popular bioproduction species such as Saccharomycaes cerevisae.
While P. tricornutum lacks two enzymes, present in humans, that are involved in the synthesis of
core N-linked glycosylation events (ALG10 and MOGS), the N-glycan product of this pathway
matches that produced in human cells (62).
In addition to the innate characteristics, P. tricornutum also has a currently limited but useful
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foundation of genetic tools and resources that enable strain engineering. There are a number of
promoter elements characterized for this species, including the FcpA and FcpB promoters, as well
as the inducible nitrate reductase promoter (92, 93, 128, 166). It has well-established transformation methods, including electroporation and microparticle bombardment, as well as a number of
reporter genes and selectable markers (93, 97, 116, 128, 167–169). A novel transformation method
has been developed for P. tricornutum which uses conjugation with E. coli to establish stably replicating nuclear episomes, allowing stable gene expression without relying on genomic integration
(113). The full genome sequence (162) and expressed sequence tag (EST) database (170, 171)
enables the use of genome editing and manipulation tools such as TALENs, CRISPR/Cas9, and
RNAi (100, 130, 144, 155, 172, 173). For these reasons P. tricornutum has been the platform of
choice for various high-value product biosynthesis efforts such as the production of PUFAs, monoand triterpenoids, and human antibodies (49, 58, 165, 174–178).
While it is the most well-studied diatom, it suffers from a lack of genetic tools that prevent it
from becoming an ideal platform for synthetic biology applications. The few promoters available
for transgene expression are inadequate for the design and construction of complex metabolic pathways. The need to use expensive antibiotics to maintain selection of transformants significantly
hinders its use as an industrial-scale production platform. While gene-editing technologies have
been adapted for use in P. tricornutum, delivery relies on biolistic transformation of expression
constructs that often integrate randomly into the genome (144, 155), making it difficult to remove
the engineered nuclease and causing unknown negative effects on genomic stability. Thus, there is
a need to develop more sophisticated gene editing strategies for this organism, and to generate a
wider range of genetic tools to allow for more complex metabolic engineering in P. tricornutum.

1.5

Scope of the thesis: Genetic tools to enable synthetic biology applications in P. tricornutum

This thesis focusses on the study and manipulation of P. tricornutum with the goal to generate novel
genetic tools and strains, and to characterize P. tricornutum biology to aid in the development of
this species for synthetic biology applications. The model diatom P. tricornutum has the potential
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to be a powerful platform for production of high-value compounds such as food products and
functional biopharmaceuticals due to its attractive natural characteristics and a solid foundation
of genetic tools and laboratory methods available for this species. At the outset of my doctoral
work, I hypothesized that P. tricornutum could be genetically modified to produce such high-value
compounds. However, for this to be accomplished, P. tricornutum required further genetic and
biotechnological development. Using the recently developed conjugation-based transformation
method, I was able to rapidly generate and characterize a variety of genetic tools for modification of
this organism, and subsequently engineer novel strains of P. tricornutum for industrial applications
and the study of diatom biology.

My first goal was to expand the P. tricornutum genetic toolbox to enable the design and construction of more complex synthetic pathways that could be used to produce industrially-relevant
products. As described in chapter two, I characterized a number of endogenous promoters, terminators, and introns that allow for the expression of exogenous genes in P. tricornutum. Using
these tools I was able to construct a replicating plasmid-based CRISPR/Cas9 gene editing tool that
I validated by generating a genetic knockout of the P. tricornutum urease gene. These tools were
further used to construct a proof-of-principle vanillin biosynthesis pathway that I demonstrated
could be maintained in P. tricornutum over several generations. In chapter 3, I created auxotrophic
strains of P. tricornutum by using the plasmid-based CRISPR/Cas9 tool (Chapter 2) to knock out
essential genes in the histidine and uracil metabolic pathways, and demonstrated that the auxotrophic phenotypes could be complemented with plasmid-encoded copies of the intact genes. I
also provided evidence of large deletions and loss-of-heterozygosity stimulated by CRISPR/Cas9
editing using Nanopore long-read sequencing. In chapter 4, I successfully engineered a strain of
P. tricornutum that produces the SARS-CoV-2 spike antigen. This strain was developed with the
goal of addressing the need for population-wide serological testing. By developing these tools, I
hope to transform P. tricornutum into a powerful platform for synthetic biology applications and
further the study of diatom biology.
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Chapter 2
An expanded plasmid-based genetic toolbox
enables Cas9 genome editing and stable
maintenance of synthetic pathways in
Phaeodactylum tricornutum
The work presented in this chapter is reprinted (adapted) with permission (Appendix A) from:
S. S. Slattery, A. Diamond, H. Wang, J. A. Therrien, J. T. Lant, T. Jazey, K. Lee, Z. Klassen, I.
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Enables Cas9 Genome Editing and Stable Maintenance of Synthetic Pathways in Phaeodactylum
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2.1

Introduction

Diatoms are a diverse and widespread group of eukaryotic microalgae that play an important role
in many aquatic ecosystems through their capacity to fix atmospheric CO2 (1). Diatoms produce
more than 20% of global oxygen and possess a rare ability to metabolize silicates, which they
incorporate into their cell walls (2, 3). These characteristics make diatoms attractive organisms for
biotechnological purposes, with potential applications in the food, cosmetics, and pharmaceutical
industries. Diatoms are also an abundant source of long chain fatty acids (4–6) and are particularly
relevant to the biofuel industry. The sequencing of the P. tricornutum and T. pseudonana genomes
in 2008 and 2004, respectively (7, 8), and the development of selectable markers and endogenous
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regulatory sequences for foreign gene expression has further enabled biotechnological applications
(9, 10).
A major barrier to biotechnological applications in diatoms is the low efficiency of DNA transformation (11, 12). A commonly used method for transformation of P. tricornutum is microparticle
bombardment using DNA-coated microparticles, termed biolistic transformation (12, 13). However, the efficiency of biolistic transformation of P. tricornutum is variable, making it unsuitable for
applications such as high-throughput screening of plasmid-based libraries. Moreover, selecting biolistic transformants relies on random genomic integration of an antibiotic resistance marker, with
possible variable expression levels and potentially undesirable phenotypic effects for downstream
applications (14). Targeted genomic integration of transformed DNA is possible by flanking the
DNA insert with sequences homologous to the desired site of integration. Genomic integration
occurs at very low frequency unless a double-strand break was made at the integration site using a
targeted endonuclease (15).
Recently, a novel transformation method was established using conjugation from E. coli to
maintain stably replicating plasmids in the nucleus of P. tricornutum (16–19). Utilizing this new
transformation method, it is possible to express heterologous genes in P. tricornutum without the
need for genomic integration. However, only a few transcriptional promoter elements and selectable markers have been identified and characterized (20–25), limiting the genetic tools available
for the study of diatom biology and assembly of complex synthetic pathways. Here, we identified
additional endogenous promoters, terminators and introns from P. tricornutum that regulated expression of plasmid-based selectable markers. We use these tools to develop a simple and robust
plasmid-based Cas9 editing system, demonstrating efficient editing of the urease gene and subsequent curing of the Cas9 plasmid from edited strains. We also show that P. tricornutum can stably
replicate two plasmids simultaneously, and constructed and replicated over a four-month period a
plasmid encoding eight genes involved in vanillin biosynthesis.
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2.2
2.2.1

Materials and Methods
Microbial strains and growth conditions

S. cerevisiae VL6-48 (ATCC MYA-3666: MATα his3-∆200 trp1-∆1 ura3-52 lys2 ade2-1 met14
cir0 ) was grown in YPD medium or complete minimal medium lacking histidine (Teknova) supplemented with 60 mg l-1 adenine sulfate. Complete minimal media used for spheroplast transformation contained 1 M sorbitol. E. coli (Epi300, Epicentre) was grown in Luria Broth (LB)
supplemented with appropriate antibiotics (chloramphenicol (25 mg l-1 ) or kanamycin (50 mg l-1 )
or ampicillin (50 mg l-1 ) or gentamicin (20 mg l-1 )). P. tricornutum (Culture Collection of Algae
and Protozoa CCAP 1055/1) was grown in L1 medium without silica at 18◦ C under cool white
fluorescent lights (75 µE m-2 s-1 ) and a photoperiod of 16 h light:8 h dark.
P. tricornutum liquid L1 media consisted of 1 l aquil salts, 2 ml nitrate phosphate (NP) stock,
1 ml L1 trace metals stock, 0.5 ml f/2 vitamin solution, and was filter sterilized through a 0.2-µm
filter. For agar plates, equal parts sterilized liquid L1 medium and autoclaved 2% agar were combined and poured into petri dishes. To make aquil salts, two separate solutions of 2× anhydrous
and hydrous salts were mixed. Anhydrous salts consisted of (in 500 ml H2 O) 24.5 g NaCl, 4.09
g Na2 SO4 , 0.7 g KCl, 0.2 g NaHCO3 , 0.1 g KBr, 0.03 g H3 BO3 (or 3 ml of 10 mg ml-1 stock),
0.003 g NaF (or 300 µl of 10 mg ml-1 stock). Hydrous salts consisted of 11.1 g MgCl2 ·6H2 O
and 1.54 g CaCl2 resuspended in 500 ml H2 O. The NP stock was made in 100 ml H2 O and consisted of 37.5 g NaNO3 and 2.5 g NaH2 PO4 ·H2 O. The L1 trace metal stock solution was made
by mixing FeCl3 ·6H2 O 3.15 g, Na2 EDTA·2H2 O 4.36 g, CuSO4 ·5H2 O (9.8 g l-1 dH2 O) 0.25 ml,
Na2 MoO4 ·2H2 O (6.3 g l-1 dH2 O) 3.0 ml, ZnSO4 ·7H2 O (22.0 g l-1 dH2 O) 1.0 ml, CoCl2 ·6H2 O
(10.0 g l-1 dH2 O) 1.0 ml, MnCl2 ·4H2 O (180.0 g l-1 dH2 O) 1.0 ml, H2 SeO3 (1.3 g l-1 dH2 O) 1.0
ml, NiSO4 ·6H2 O (2.7 g l-1 dH2 O) 1.0 ml, Na3 VO4 (1.84 g l-1 dH2 O) 1.0 ml, K2 CrO4 (1.94 g l-1
dH2 O) 1.0 ml in 1L H2 O. The F/2 vitamin stock solution was made by mixing 200 mg powder l-1
thiamine-HCl, 10 ml l-1 of a 0.1 g l-1 biotin stock, and 1 ml l-1 of a cyanocobalamin 1 g l-1 stock.
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2.2.2

Transfer of DNA to P. tricornutum via conjugation from E. coli

Conjugation protocols were adapted from Karas and colleagues (16). Briefly, liquid cultures
(250 µl) of P. tricornutum were adjusted to density of 1.0 × 108 cells ml-1 using counts from a
hemocytometer, plated on 1/2 × L1 1% agar plates and grown for four days. L1 media (1 ml) was
added to the plate and cells were scraped and the concentration adjusted to 5.0 × 108 cells ml-1 .
E. coli cultures (50 ml) were grown at 37◦ C to A600 of 0.8–1.0, centrifuged for 10 mins at 3,000
× g and resuspended in 500 µl of SOC media. Conjugation was initiated by mixing 200 µl of P.
tricornutum and 200 µl of E. coli cells. The cell mixture was plated on 1/2 × L1 5% LB 1% agar
plates, incubated for 90 mins at 30◦ C in the dark, and then moved to 18◦ C in the light and grown
for 2 days. After 2 days, 1.5 ml of L1 media was added to the plates, the cells scraped, and 300 µl
(20%) plated on 1/2 × L1 1% agar plates supplemented with Zeocin™ 50 mg l-1 or nourseothricin
200 mg l-1 . Colonies appeared after 10–14 days incubation at 18◦ C with light.

2.2.3

Plasmid DNA isolation

Plasmid DNA was isolated from E. coli using the BioBasic miniprep kit. Plasmid DNA was isolated from all other species using a modified alkaline lysis protocol. For DNA isolation from
S. cerevisiae, cells were pelleted at 3,000 × g for 5 mins and resuspended in 250 µl resuspension
buffer, which contained 240 µl P1 (Qiagen), 0.25 µl of 14 M β-mercaptoethanol, and 10 µl zymolyase solution (200 mg zymolyase 20 T (USB), 9 ml H2 O, 1 ml 1 M Tris pH7.5, 10 ml 50%
glycerol) and incubated at 37◦ C for 60 mins. For DNA isolation from P. tricornutum, cultures
(10–20 ml) were harvested during exponential growth phase, pelleted at 4,000 × g for 5 mins, and
resuspended in 250 µl resuspension buffer consisting of 235 µl P1 (Qiagen), 5 µl hemicellulose
100 mg ml-1 , 5 µl of lysozyme 25 mg ml-1 , and 5 µl zymolyase solution and incubated at 37◦ C for
30 mins. Next, 250 µl of lysis buffer P2 (Qiagen) was added, followed by 250 µl of neutralization
buffer P3 (Qiagen) and centrifugation at 16,000 × g for 10 mins. The supernatant was transferred
to a clean tube, 750 µl isopropanol was added, and the samples centrifuged at 16,000 × g for 10
mins. A 70% EtOH wash was performed, centrifuged at 16,000 × g for 5 mins, and pellets briefly
dried, resuspended in 50–100 µl of TE buffer, and incubated at 37◦ C for 30–60 mins to dissolve.
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2.2.4

Plasmid construction

Plasmids (Supplementary Table B.6) were constructed using a modified yeast assembly (26, 27).
Plasmids pPtGE10–17 were made from pPtPuc3 (16) by replacing the FcpF promoter with PCR
fragments consisting of 500 bp upstream of the start codon of the P. tricornutum EF1α, 40SRPS8,
H4-1B, γ-Tubulin, RBCMT, FcpB, FcpC, or FcpD genes. Plasmids pPtGE18–25 were made from
pPtGE10–17 by replacing the FcpA terminator with PCR fragments consisting of 500 bp downstream of the stop codon of the gene corresponding to each promoter described above. Plasmids
pPtGE26–29 were made by assembling the nat or cat ORF between the H4-1B or FcpD promoter
and FcpA terminator and inserting them immediately downstream of the CEN6-ARSH4-HIS3 element in pPtPuc3. Plasmid pPtGE30 was created from p0521s by replacing the FcpF promoter
(driving Sh ble) by the FcpD promoter. In addition, a ClaI restriction site was added immediately
upstream of the FcpD promoter, and the sequence of the I-SceI site downstream of the URA3 element was corrected. Plasmid pPtGE31 was made by replacing the Sh ble ORF in pPtGE30 with
a nat ORF. Plasmid pPtGE32 was made by replacing the Sh ble ORF in pPtGE30 by a Sh ble
ORF linked to a nat ORF by a T2A self-cleaving peptide linker. Plasmid pPtGE33 was made by
replacing the URA3 element in pPtGE30 by a cassette containing the FcpD promoter and terminator driving GFP linked to mCherry by a T2A self-cleaving peptide linker. Plasmid pPtGE34 was
made by assembling the oriT, Sh ble, and CEN6-ARSH4-HIS3 elements from pPtGE19 into pKS
diaCas9 sgRNA (Addgene #74923) (28) upstream of the FcpB promoter. The Sh ble gene driven
by the 40SRPS8 promoter and terminator from pPtGE19 was chosen because these elements do
not contain BsaI sites that would interfere with sgRNA cloning. Plasmid pPtGE35 was made by
cloning the first 510 bp (170 aa) of the I-TevI homing endonuclease and a GGSGGS linker immediately upstream of Cas9 in pPtGE34. To facilitate this, the NLS and HA-tag were moved from the
N-terminus of Cas9 to the C-terminus. I-TevI variants K135R+N140S, V117F+S134G, or S134G
were used depending on the sequence requirements upstream of the sgRNA target site. Using
golden gate assembly (29), sgRNAs targeting different regions of the P. tricornutum urease gene
were cloned into the BsaI sites positioned between the P. tricornutum U6 promoter and terminator
in pPtGE34 and pPtGE35. Plasmid constructs were confirmed by Sanger sequencing at the London
Regional Genomics Facility. The plasmid (p0521s-V) encoding components of a vanillin biosyn-
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thesis pathway was made by assembling genes linked in pairs by 2A self-cleaving peptides, flanked
by P. tricornutum promoters and terminators, between the I-CeuI and I-SceI sites in p0521s (16).
The pairs are as follows: phenylalanine ammonia lyase (PAL) and trans-cinnamate 4-hydroxylase
(C4H) with the H41B promoter and terminator, tyrosine ammonia lyase (TAL) and p-coumarate
3-hydroxylase (C3H) with the 40SRPS8 promoter and terminator, hydroxycinnamoyl transferase
(HCT) and 4-hydroxycinnamoyl-CoA ligase (4CL) with the EF1α promoter and terminator, and
caffeic acid 3-O-methyltransferase (COMT) and vanillin synthase (VAN) with the FcpD promoter
and terminator. The plasmid was assembled with a URA3 yeast marker positioned between the
40SRPS8 terminator and the EF1α promoter to assist in selection of correctly assembled plasmids.
Two clones of p0521s-V were completely sequenced as described below.

2.2.5

Western blot

P. tricornutum cultures (5 ml) were harvested during exponential growth phase and pelleted at
4,000 × g for 5 mins. The cell pellet was resuspended in 300 µl of sodium dodecyl sulphate
(SDS) sample loading buffer (60 mM Tris-HCl, pH 6.8, 2% SDS [w/v], 0.01% bromophenol blue
[w/v], 1% β-mercaptoethanol [v/v]) and boiled for 5 mins. Samples (10 µl) were resolved on
12% polyacrylamide gels and electroblotted to a polyvinylidene difluoride (PVDF) membrane.
Membranes were blocked in 5% milk for 1 hr, then incubated in 5% milk at 4◦ C overnight with
primary antibody (1:500 dilution mouse anti-GFP, Sigma) followed by 1 hr incubation with a
1:5000 dilution of secondary antibody (goat anti-mouse-HRP, Jackson ImmunoResearch). Blots
were developed using Clarity ECL Western Blotting Substrate (BioRad).

2.2.6

RNA isolation and cDNA synthesis

To isolate total RNA from P. tricornutum, cultures (10 ml) were harvested during exponential
growth phase, pelleted at 4,000 × g for 5 mins, supernatant was removed, and pellets were flash
frozen in liquid nitrogen. Frozen pellets were ground in liquid nitrogen and total RNA was extracted using an RNeasy Plant Mini Kit (Qiagen). RNA samples were treated with 3U of TURBO
DNase (Invitrogen), supplemented with 15U of HhaI (NEB), in 50 µl reactions for 45 mins at
37◦ C, then Ethylenediaminetetraacetic acid (EDTA) was added to a final concentration of 15 mM
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and samples were heat inactivated at 75◦ C for 15 mins. Reverse transcription of 2 µg of total
RNA from all samples was performed with High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Reactions where the reverse transcriptase was not added were included for all
samples to be used as genomic and plasmid DNA controls during the quantitative real-time PCR
(RT-qPCR) analyses. The cDNA samples were diluted to 30 ng µl-1 with TE buffer and stored at
-20◦ C.

2.2.7

Quantitative PCR experiments

Quantitative PCR analysis was performed using a ViiA 7 Real-Time PCR System (Applied Biosystems) with SYBR Select Master Mix (Applied Biosystems). To perform copy number qPCR experiments, total DNA was extracted from P. tricornutum cells containing plasmids p0521s and
pPtGE31. Standard curves were performed for Sh ble and nat using serial dilutions of purified
p0521s or pPtGE31 plasmid, respectively. Copy number qPCR reactions consisted of master mix
diluted to 1×, purified plasmid serial dilutions or P. tricornutum plasmid extracts diluted 1:10000,
and 400 nM primers in a 10 µl total volume. Forward and reverse primers used are listed in Supplementary Table B.5. The reactions were cycled under the following conditions: 50◦ C for 2 mins,
95◦ C for 2 mins, 40 cycles of 95◦ C for 15 s, 60◦ C for 15 s, then 72◦ C for 1 min during which data
were collected. Ct values were calculated by QuantStudio™ Real-Time PCR software, plotted as
a function of number of template molecules and fit to a logarithmic trend line. Curves were linear
over at least four orders of magnitude. Plasmid samples extracted from two P. tricornutum strains
maintaining both plasmids were tested, each with at least three technical replicates. Ct values resulting from experimental samples were used to calculate the number of molecules of template
molecule in the qPCR reaction. To perform relative gene expression qPCR experiments, total
RNA was extracted from P. tricornutum cells containing pPtPuc3, pPtGE11, pPtGE12, pPtGE13,
pPtGE16, pPtGE19, pPtGE20, pPtGE21, or pPtGE14 and converted to cDNA. Relative gene expression qPCR reactions consisted of master mix diluted to 1×, 30 ng cDNA generated from P. tricornutum total RNA, and 400 nM primers in 10 µl total volume. Forward and reverse primers used
are listed in Supplementary Table B.5. The reactions were cycled under the following conditions:
50◦ C for 2 mins, 95◦ C for 2 mins, 40 cycles of 95◦ C for 15 s, 60◦ C for 15 s, then 72◦ C for 1 min
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during which data were collected. Three biological replicates were analyzed with at least three
technical replicates for each. The P. tricornutum Actin16 gene was used as an endogenous control
and Sh ble under control of the FcpF promoter and FcpA terminator was used as a reference gene
for relative quantitation. Ct values were calculated by QuantStudio™ Real-Time PCR software
and the relative expression of Sh ble for each sample was calculated using double delta Ct analysis.

2.2.8

Generation of urease knockouts using Cas9 and TevCas9

Plasmids pPtGE34 or pPtGE35, containing no guide RNA or sgRNA#1, sgRNA#2, sgRNA#3, or
sgRNA#4 for the P. tricornutum urease gene, were conjugated from E. coli to P. tricornutum and
exconjugants were selected on Zeocin™-containing media. Ten colonies from each conjugation
were resuspended in TE buffer and flash frozen at -80◦ C followed by heating at 95◦ C to lyse
cells and extract genomic DNA. The genomic target site of each sgRNA in P. tricornutum was
amplified by PCR and the products were analyzed by T7EI assay as follows; PCR products were
denatured at 95◦ C for 5 mins, slowly cooled to 50◦ C, and flash frozen at -20◦ C for 2 mins. PCR
products (250 ng) were incubated with 2U of T7EI (NEB) in 1× NEBuffer 2 for 15 mins at 37◦ C
and analyzed by agarose gel electrophoresis. Colonies that showed editing by T7EI assay were
grown in liquid culture supplemented with Zeocin™ for 2 weeks and serial dilutions were plated
on selective media to isolate sub-clones. Sub-clones were then screened for homozygous urease
knockout phenotypes by replica streaking on L1 media containing 2.1 mM urea or 4.2 mM nitrate.
Streaks were grown for 5 days before visual identification of phenotypes. Sub-clones that were
identified as urease knockouts were resuspended in TE buffer and flash frozen at -80◦ C followed
by heating at 95◦ C to lyse cells and extract genomic DNA, then sgRNA target sites were PCR
amplified. Sanger sequencing of PCR products was performed at the London Regional Genomics
Facility to identify the type and length of indels generated. Stable bi-allelic urease knockout mutant
lines were then grown in nonselective L1 media for 1 week to cure them of plasmids before plating
to obtain single colonies. Resulting colonies were replica streaked onto nonselective and Zeocin™containing media to identify colonies which had successfully been cured of the plasmid.
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2.2.9

Whole plasmid sequencing and genotyping

Plasmids encoding the vanillin synthesis pathway were propagated for 1 or 4 months, and DNA
isolated from P. tricornutum as described and transformed into E. coli for cloning. Plasmids were
extracted from E. coli, linearized by digestion with I-CeuI, electrophoresed on a 0.8% agarose gel,
stained with ethidium bromide, and analyzed on an AlphaImager™ 3400 (Alpha Innotech). Plasmids were also used as template for multiplex PCR designed to amplify the Sh ble and nat ORFs
using primers DE3214, DE3215, DE3216, and DE3217. Plasmids were completely sequenced by
Nicole Stange Thomann and the team at CCIB DNA Core (Massachusetts General Hospital, via
Science Exchange). To display sequence coverage and SNPs, each FASTQ file was aligned to the
plasmid reference sequence using BOWTIE2 on the Galaxy server (https://cpt.tamu.edu/galaxypub/), and the bam files converted to sam format using SAMTools. A plasmid Editor (ApE) and
BLAST Ring Image Generator (BRIG) (30) were used to draw the plasmid map and display sequence coverage.

2.3
2.3.1

Results
Endogenous P. tricornutum promoters drive exogenous gene expression

To characterize additional P. tricornutum endogenous promoters and terminators for expression of
exogenous genes, we identified putative promoter and terminator regions from the P. tricornutum
genome sequence that are predicted to be highly expressed based on their function (Supplementary Table B.1. Supplementary Table B.7). The promoters with their corresponding native terminators, or with the previously described FcpA terminator (31, 32), were cloned up- and downstream of the Sh ble coding region, respectively (Figure 2.1A). The resultant plasmids (named
pPtGE10 through pPtGE25) were conjugated to P. tricornutum from E. coli and the efficiency of
promoter/terminator pairings was determined by the number of P. tricornutum colonies that formed
on Zeocin™-containing media after 14-days incubation (Figure 2.1B). As a positive control, we
used the previously described FcpF promoter and FcpA terminator that were cloned up- and downstream of the Sh ble gene, respectively (31–34). Similar assays have been used to test genetic
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elements in microalgae (20, 32). We found that all promoter/terminator pairs produced colonies
but the γ-tubulin and FcpC promoters with their native terminators yielded an 11- and 7.4-fold
increase in Zeocin™-resistant colonies than when the promoters were paired with the FcpA terminator (Figure 2.1B,C). Other combinations of promoter/terminator pairs exhibited smaller changes
in the appearance of Zeocin™-resistant colonies (Figure 2.1B,C). To extend the results of the plating assays, we used quantitative reverse transcription PCR (RT-qPCR) to measure the expression
levels of 4 promoters (40SRPS8, H4-1B, γ-tubulin, and FcpC), finding that the differences in expression levels when each promoter was paired with its native or FcpA terminator correlated with
the results of the plating assays (Figure 2.1D).

2.3.2

P. tricornutum introns allow expression of foreign genes in P. tricornutum and not in E. coli

In addition to promoter and terminator elements, we also tested the function of P. tricornutum nuclear (spliceosomal) introns embedded within exogenous genes (Supplementary Table B.7). We
first cloned an intron from the FBAC2 gene at position 1072 of the MegaTev genome-editing nuclease (35), and showed by RT-PCR that the intron was correctly spliced in P. tricornutum (Figure
2.2a). We next inserted the FBAC2 intron, and introns from the TUFA and RPS4 genes, into the
MscI (position 1) or SexAI (position 2) restriction sites in the Zeocin™ resistance gene Sh ble on
plasmid p0521s (Figure 2.3a). The MscI and SexAI sites of the ble gene have previously been used
to test the effects of endogenous introns on gene expression in the microalga C. reinhardtii (36).
Plating of P. tricornutum exconjugants harboring each of these plasmids on Zeocin™-containing
media reproducibly yielded similar colony numbers to an intronless Sh ble control, whereas a Sh
ble construct with the RPS4-1 intron lacking the predicted splice donor and acceptor sites did not
grow on Zeocin™-containing plates (Figure 2.3b). We also demonstrated that the intron-containing
constructs prevented growth of E. coli on Zeocin™-containing plates, presumably because the introns cannot be spliced from the Sh ble transcript (Figure 2.2b).
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Figure 2.1: Effect of P. tricornutum promoters and terminators on the efficiency of the Sh ble marker. (A)
Diagram of promoter-terminator assay constructs. (B) P. tricornutum transformants selected on L1 agar media supplemented with Zeocin™. (C) Bar graph of P. tricornutum colony formation for each of the promoter/terminator pairs.
Values listed above each data set indicate the fold difference in Zeocin™-resistant colonies obtained from promoters
paired with their native terminator compared to the FcpA terminator. Dark gray and light gray bars indicate promoters
paired with the FcpA terminator or their native terminator, respectively. The FcpF promoter with FcpA terminator
driving Sh ble was used as a positive control (+). Wild-type P. tricornutum was used as a negative control (-). Error
bars represent standard error of the mean for at least three replicates. (D) Boxplot of relative expression of Sh ble determined by RT-qPCR. Expression was normalized to Sh ble driven by the FcpF promoter and FcpA terminator. Solid
bars represent the median values. The lower and upper boundaries of the boxes represent the first and third quartiles,
respectively. The whiskers represent the highest and lowest values.
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Figure 2.2: Effect of P. tricornutum introns on foreign gene expression. (A) RT-PCR detection of the P. tricornutum
FBAC2-1 intron splicing from the MegaTev endonuclease ORF. The Sh ble construct was not interrupted by an intron.
M, 100 bp ladder. (B) Introns in either MscI (top) or SexAI (bottom) position of the Sh ble ORF prevented E. coli
growth on media supplemented with zeocin. Colonies of strains not resistant to zeocin that form on zeocin plates at
the 100 and 101 dilutions are due to spontaneous resistance.
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Figure 2.3: Effect of P. tricornutum introns on colony formation. (A) Diagram of intron assay constructs. FBAC21, fructose-1,6-bisphosphate aldolase intron 1; TUFA-1, elongation factor Tu intron 1; RPS4-1, ribosomal protein S4
intron 1; RPS4-1 mut, intron lacking predicted splice donor and acceptor sites; (-), mock conjugation negative control.
(B) Bar graph of P. tricornutum colony counts for each construct on zeocin-containing plates. Values represent the
average colonies obtained from conjugation with each plasmid. Error bars show standard error of the mean for at least
three replicates.
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2.3.3

The Sh ble and nat antibiotic resistance markers allow selection of
replicating plasmids in P. tricornutum

When designing plasmid-based systems for expression in eukaryotic systems, a selectable marker
(typically an antibiotic resistance gene) is necessary to isolate transformed cells. Several antibiotic resistance genes, including but not limited to those for nourseothricin and chloramphenicol,
have been used as selectable markers when integrated into the nuclear genome of P. tricornutum (9, 11, 37, 38), but have not yet been shown to function in replicating plasmids. We therefore cloned the Sh ble gene (conferring resistance to Zeocin™) with either the nat or cat genes
(conferring resistance to nourseothricin and chloramphenicol (39, 40)) onto a replicating plasmid
(Figure 2.4A). The nat and cat resistance genes were cloned downstream of the H4-1B or FcpD
promoter, and paired with the corresponding native terminator, as shown in Figure 2.4A. Plasmids
were conjugated to P. tricornutum and selected on Zeocin™-containing plates. Individual colonies
harboring the different plasmids were grown in liquid media and dilutions were spotted onto agar
plates supplemented with different concentrations of Zeocin™, nourseothricin or chloramphenicol. As shown in Figure 2.4B, all plasmids promoted growth on Zeocin™-containing plates regardless of the promoter used and the concentration of antibiotic in the media. We observed that
the cat marker was much less effective at promoting chloramphenicol resistance than previously
reported(11), which could be due to specific genomic location integration or integration of multiple
copies of the cat gene (12, 14), or the possibility that we used different promoter/terminator pairs
to drive expression of the cat gene than in previous studies (11). Regardless, including multiple
copies of the cat gene or enhancing expression with stronger promoter/terminator pairings may be
required for stringent resistance in plasmid-based systems. Interestingly, we observed that chloramphenicol, nourseothricin, and Zeocin™ selection was more effective when the amount of aquil
salts used in media preparation was reduced to one quarter (half that in typical 1/2 × L1 plates)
when re-plating 10% of scraped cells onto selective media (Figure 2.4B and Figure 2.5). This
effect has been previously observed where a decrease in the concentration of seawater from 100%
to 50% in plates increased the sensitivity of P. tricornutum to Zeocin™ and phleomycin (32). We
also demonstrated antibiotic resistance on appropriate plates when the nat and Sh ble genes were
separated by the sequence for an in-frame 2A peptide linker that would self-cleave upon translation
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(41), liberating mature nat and Sh ble polypeptides (Figure 2.6a). Function of the self-cleaving 2A
peptide was also demonstrated using a GFP-2A-mCherry reporter system (Figure 2.6b and c).

Figure 2.4: Effect of plasmid-based selectable markers on antibiotic resistance in P. tricornutum. (A) Diagram
of selective marker constructs. (B) Representative images of P. tricornutum exconjugants plated on L1 media supplemented with Zeocin™ (zeo), nourseothricin (NTC), or chloramphenicol (cm). Antibiotic concentrations listed below
each panel are in µg mL-1 . Antibiotic concentrations with asterisks (*) indicate plates made with 1/4 × aquil salts
concentration (half that of typical 1/2 × L1 plates).

To further compare the effectiveness of the Zeocin™ and nourseothricin resistance genes as
selective markers for conjugation to P. tricornutum, we cloned the Sh ble or nat coding region
between the FcpD promoter and FcpA terminator and separately assembled them into p0521s to
generate pPtGE30 and pPtGE31, respectively. Plasmids pPtGE30 or pPtGE31 were moved into P.
tricornutum via conjugation with E. coli, and exconjugants were isolated on media supplemented
with Zeocin™ or nourseothricin, respectively (Figure 2.7a). P. tricornutum colonies selected on
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Figure 2.5: Effect of varying antibiotic and salt concentration on the Sh ble marker in P. tricornutum. P. tricornutum conjugated with marker plasmids were first selected on appropriate antibiotic, single colonies were isolated,
grown in selective liquid media, and adjusted to the same concentration before spotting onto L1 media containing different concentrations of Zeocin™ (Zeo). Antibiotic concentrations listed below each panel are in µg ml-1 . Antibiotic
concentrations with asterisks (*) indicate plates made with 1/4 aquil salts concentration (half that of typical 1/2 × L1
plates).
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Figure 2.6: The T2A self-cleaving peptide linker promotes co-expression of proteins in P. tricornutum. (A) The
Sh ble ORF between the FcpD promoter and FcpA terminator in pPtGE30 was replaced by a Sh ble ORF linked to a nat
ORF by a T2A self-cleaving peptide linker to generate plasmid pPtGE32. P. tricornutum transformed with pPtGE32
survives on media containing Zeocin™ and nourseothricin. (B) The URA3 element in pPtGE30 was replaced by GFP
linked to mCherry by a T2A self-cleaving peptide linker, driven by the FcpD promoter and terminator, to generate
plasmid pPtGE33. GFP and mCherry fluorescence was detected in P. tricornutum transformed with pPtGE33. (C)
Western blot of GFP extracted from P. tricornutum strains containing pPtGE33. M, protein ladder; WT, wild-type P.
tricornutum whole cell extract; 1 and 2, whole cell extracts of two P. tricornutum clones containing pPtGE33; G1, 3
ng of purified eGFP; G2, 30 ng of purified eGFP.
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nourseothricin were visible after 7 days, two days earlier than Zeocin™-resistant colonies, possibly because nourseothricin is more efficient at killing off the untransformed P. tricornutum after
conjugation (Figure 2.7b). These results indicate that the nourseothricin resistance gene, nat, is an
effective plasmid-based marker for selection of P. tricornutum exconjugants.

Figure 2.7: Comparison of Sh ble and nat as selectable markers for P. tricornutum conjugation. (A) Bar plot
shows number of P. tricornutum colonies obtained over 15 days from conjugations with pPtGE30 (ZeoR) or pPtGE31
(NTCR) plasmids. Error bars show standard error of the mean for six replicates. (B) Plates containing 100 µg ml-1
nourseothricin (NTC) and are more effective at selecting against wild-type P. tricornutum than plates containing 50 µg
ml-1 Zeocin™ (Zeo). Wild-type P. tricornutum was plated on nonselective media (L1) as a control.
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2.3.4

Simultaneous maintenance of multiple plasmids in P. tricornutum

Stable replication of multiple plasmids in the same organism is useful for probing basic biological processes such as protein-protein and protein-DNA interactions (42–44), or for use as reporter
readouts of gene expression (45). Multiple plasmids also offers advantages in the design, construction, and testing of synthetic pathways (46–48). To investigate whether P. tricornutum can
stably maintain two plasmids (each using identical centromere sequences), we conjugated p0521s
encoding the Sh ble gene from E. coli to P. tricornutum, followed by conjugation of pPtGE31 encoding the nat marker to P. tricornutum containing p0521s (Supplementary Figure B.1). As shown
in Figure 2.8A, P. tricornutum cells harboring both plasmids survived on media containing either
Zeocin™ or nourseothricin, and on media with both antibiotics. To demonstrate that both p0521s
and pPtGE31 were present in exconjugants, plasmid DNA isolated from individual P. tricornutum
colonies selected on plates containing nourseothricin and Zeocin™ was independently transformed
into E. coli. Here, the plasmid DNA is expected to be a mixture of p0521s and pPtGE31. Because
the efficiency of co-transformation is low, and p0521s and pPtGE31 possess the same bacterial origin of replication, individual E. coli transformants would contain either p0521s and pPtGE31, but
not both. Plasmids isolated from 20 E. coli transformants showed no obvious signs of rearrangements as judged by diagnostic restriction digest (Figure 2.8B). To determine the identity of each
plasmid, we used a multiplex PCR strategy with primers specific for the nat and Sh ble genes, and
found that p0521s (Sh ble) was approximately 3-fold more abundant than pPtGE31 (nat) (Figure
2.8C, Supplementary Table B.2). We also used qPCR to assess plasmid copy number from total
DNA extracts of two P. tricornutum clones, each containing p0521s and pPtGE31, and found that
the copy number of p0521s to pPtGE31 was approximately 3:1 in both clones (Figure 2.9), agreeing with the multiplex PCR results in Figure 2.8C. This ratio of p0521s to pPtGE31 is higher than
the 1:1 ratio expected if there is no replication bias of the plasmid in P. tricornutum or E. coli, but
nonetheless demonstrates that P. tricornutum can be sequentially conjugated with E. coli to stably
replicate two independent plasmids expressing different antibiotic resistance genes.
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Figure 2.8: Stable maintenance of two plasmids in P. tricornutum imparts dual antibiotic resistance. (A) P.
tricornutum possessing both p0521s (ZeoR) and pPtGE31 (NTCR) survive on media containing Zeocin™ (Zeo) and
nourseothricin (NTC) antibiotics. (B) Agarose gel of plasmids recovered from one P. tricornutum two-plasmid exconjugant and linearized by digestion with I-CeuI. M, 1 kb ladder. (C) Agarose gel of multiplex PCR products showing
the identity of 20 plasmids recovered from one P. tricornutum two-plasmid exconjugant. M, 100 bp ladder.

Figure 2.9: Copy number of two plasmids in P. tricornutum DNA extracts determined by qPCR. Plasmids were
extracted from two P. tricornutum clones containing p0521s and pPtGE31, diluted 1:10000, and used as template for
qPCR reactions. (A) Copy number of Shble and Nat for clone 1. (B) Copy number of ShBle and Nat for clone 2.
ShBle, the Sh ble gene on p0521s; Nat, the nat gene on pPtGE31. Error bars show standard error of the mean for three
replicates.
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2.3.5

CRISPR/Cas9 gene editing in P. tricornutum using a stably replicating
plasmid-based system

Encouraged by our results and previous demonstration of stable replication of plasmids expressing
exogenous genes in P. tricornutum (16), we developed a simple and robust conjugative plasmidbased protocol for genome editing using the Cas9 protein derived from the Streptococcus pyogenes
type II CRISPR system (49), and a TevCas9 dual nuclease variant (50) (Figure 2.10A). As proofof-principle, we designed 4 different single guideRNAs (sgRNAs) against the P. tricornutum urease gene. Each sgRNA, designed to take into account the 5’-CNNNG-3’ cleavage motif targeting
requirements of the TevCas9 dual nuclease (50), could be used for gene editing with Cas9 or TevCas9. After conjugative delivery and selection of exconjugants, editing efficiency was determined
by T7 endonuclease I (T7EI) mismatch cleavage assays on fragments of the urease gene directly
amplified from P. tricornutum colonies by PCR. We observed a 10–60% editing rate depending
on the sgRNA and nuclease used (Figure 2.10B). To determine if the P. tricornutum colonies positive by the T7EI assay were monoallelic or mosaics, sub-clones were isolated and analyzed in
two ways. First, dilutions of each sub-clone were plated on agar-containing plates with nitrate or
urea as a nitrogen source, with the expectation that clones with a knockout of the urease gene (or
homozygous knockout) would be unable to grow on plates with urea as the sole nitrogen source
(Figure 2.10C). This screen identified 15 sub-clones with a urea-deficient growth phenotype. Second, the urease gene of the 15 sub-clones identified by this phenotypic screen were analyzed by
sequencing of PCR products. In 12 of 15 sub-clones analyzed, a single genotype was evident from
the sequencing reads (Figure 2.10D), with different length deletions observed as would be expected
by mutagenic non-homologous end-joining repair. Interestingly, 3 sub-clones each possessed two
different genotypes, suggesting different repair events at each copy of the urease gene. In 9 of
18 sequences, Cas9 or TevCas9 editing created a -2 frameshift that would result in a truncated or
non-functional urease protein, 6 of 18 sequences revealed a -1 frameshift, 2 of 18 revealed in frame
deletions that disrupted urease function, and a single sequence revealed a +1 frameshift. Performing long-range PCR of the full urease ORF of the knockouts, followed by sequencing of the PCR
products, revealed that 7 of the 12 strains that were originally thought to contain homozygous
mutations actually possessed large deletions in the second copy of the urease gene which could
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not be detected using our previous screening method (Figure 2.11). The high proportion of strains
with large deletions as a result of NHEJ repair of Cas9 cleavage events suggests that this may be a
common DSB repair outcome in P. tricornutum.

Figure 2.10: Editing of the P. tricornutum urease gene by Cas9 and TevCas9. (A) Diagram of pPtGE34 and
pPtGE35. (B) Table of experimental workflow and number of urease knockouts generated by Cas9 or TevCas9 with
each sgRNA. Exconjugants were screened by T7EI assay to identify editing at the urease sgRNA target site. Colonies
that showed editing were diluted in L1 media and plated to obtain subclones. Five or ten subclones from each were
subsequently screened for urease knockout phenotypes by streaking onto media containing nitrate or urea. (C) Representative images of P. tricornutum urease knockout strains plated on L1 media supplemented with nitrate or urea.
Biallelic urease knockouts are unable to survive on plates containing urea as the sole nitrogen source. (D) Sequences
of urease sgRNA target sites in P. tricornutum urease knockout strains. Red text indicates the sgRNA target sequence,
blue text indicates the Tev target sequence, bold text indicates the PAM motif, underlined text indicates insertions, and
dashes (-) indicate deletions. Asterisks (*) next to strain names indicate subclones that contain two different genotypes,
suggesting different repair events at each copy of the urease gene.

Previous groups showed Cas9-mediated editing of diatoms using biolistic bombardment with
non-replicating plasmids expressing Cas9 (28, 51). One drawback of this methodology is that the
plasmids are stably integrated into the genome, with (as of yet) no mechanism to prevent long-term
Cas9 expression. To demonstrate that we could cure the Cas9 or TevCas9 expressing plasmids from
urease-edited P. tricornutum, we grew sub-clones under non-selective conditions (media lacking
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Figure 2.11: Large deletions in the P. tricornutum urease gene revealed by sequencing. Graphical map of the
position and extent of indels for each of the urease knockouts relative to the wild-type urease gene (shown at top).
Red rectangles indicate nucleotide deletions, green triangles indicate nucleotide insertions, and white rectangles with
dashed lines represent introns.
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Zeocin™) for 9 generations, and streaked colonies onto plates containing or lacking Zeocin™. As
shown in Figure 2.12, 3 of 18 sub-clones displayed phenotypes consistent with Zeocin™ sensitivity. To provide further evidence for plasmid loss, multiplex PCR was successful for a genomic
target (actin), but not a plasmid-based target (Sh ble) for colonies that showed Zeocin™ sensitivity
(Figure 2.12b).

Figure 2.12: Isolation of urease knockout clones cured of the pPtGE34 plasmid. (A) Representative image of
plasmid-cured P. tricornutum urease knockout strains. P. tricornutum containing stable bi-allelic knockouts of the
urease gene confirmed by sequencing and phenotypic analysis were grown in nonselective media for 1 week before
plating to obtain single colonies. Colonies were replica streaked onto Zeocin™ (L1 + Zeocin) and nonselective (L1)
plates to identify clones that were cured of the pPtGE34 plasmid (colonies 2, 4, and 5). (B) Multiplex PCR to detect
Sh ble and actin in urease knockout colonies. Urease knockout colonies identified as Zeocin™ sensitive were lysed in
TE and used as template in a multiplex PCR to screen for the presence of the pPtGE34 plasmid. A colony resistant
to Zeocin™ (colony 3) and wild-type P. tricornutum were used as controls. M, 100 bp ladder; 4, colony 4 from panel
(a); 5, colony 5 from panel (a); 3, colony 3 from panel (a); WT, wild-type P. tricornutum; (-), no template control.
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2.3.6

Stable replication of a plasmid-based vanillin biosynthesis pathway in
P. tricornutum

To highlight the synthetic biology potential of our plasmid-based tools, we next tested whether
P. tricornutum can maintain a putative synthetic metabolic pathway on a replicating plasmid over
an extended growth period. We assembled components of a vanillin biosynthetic pathway (52) in
the p0521s plasmid (creating p0521s-V) (Figure 2.13A). The pathway consists of eight genes derived from Zea mays (corn), Arabidopsis thaliana (mouse-ear cress), and Vanilla planifolia (vanilla
orchid) under control of P. tricornutum promoters and terminators. The pathway is designed to metabolize phenylalanine and tyrosine, through a series of intermediates, into ferulic acid (53). The
eight genes were organized into four pairs that mimics proposed steps in the vanillin biosynthesis
pathway (52). Each gene pair was cloned in-frame with an intervening 2A self-cleaving peptide
(41) to coordinately express each protein.
As a precursor to detailed analyses of mRNA expression, protein stability, and metabolic intermediates, we first examined long-term stability and replication fidelity of the plasmids in P. tricornutum, as faithful long-term maintenance would be necessary for robust synthetic output. The
pathway was assembled in yeast and moved to E. coli where they were screened for correctly
assembled clones. From 54 clones screened, 15 correct clones were identified as assayed by multiplex PCR screen. Six of these were analytically digested which identified a total of four correct
clones. These four individual clones (called V1, V2, V3, V4) were conjugated from E. coli into
P. tricornutum, then two exconjugants from each transformation were selected and grown in liquid culture. Next, plasmids were recovered in E. coli after ∼1 and 4 months (40 and 120 days)
of serial culture passage in P. tricornutum, representing approximately 50 and 160 P. tricornutum
generations, respectively (Supplementary Table B.3). Multiplex PCR of plasmids recovered from
P. tricornutum cultures after ∼1 and 4 months showed that all 8 metabolic genes were present
(Figure 2.13C), and the recovered plasmids showed no major rearrangements by diagnostic restriction digest (Figure 2.13D). To more accurately assess replication fidelity in P. tricornutum, we
completely sequenced two plasmid clones after yeast assembly and initial cloning in E. coli (V1.0
and V3.0), and after ∼1 month (V1.1 and V3.1) and 4 months (V1.4 and V3.4) of propagation in
P. tricornutum (Figure 2.13E). We identified several point mutations that differ between the ini-
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tial sequences of clones V1.0 and V3.0 and that possibly occurred during yeast assembly (Figure
2.13E). Additionally, we found several point mutations that appeared in each clone after ∼1 month
of passage in P. tricornutum, but no further mutations had accumulated by the 4-month endpoint
(Figure 2.13E, Supplementary Table B.4). This finding suggests that mutations in V1.1 and V3.1
occurred during or shortly after conjugation, but no new mutations accumulated once the plasmids were stably replicating in P. tricornutum. The majority of mutations were in the non-coding
regions of the plasmid, including the plasmid backbone and promoter and terminator elements.
However, some point mutations were identified in coding regions of the genes encoding enzymes
of the biosynthetic pathway. Notably, a 1-bp insertion at nucleotide position 812 was identified in
the 4-hydroxycinnamoyl-CoA ligase (4CL) coding region in the 1- and 4-month time points of V3
(V3.1 and V3.4). This 1-bp insertion results in a +1 reading frame shift creating a premature stop
codon at position 855 of the coding region (numbered according to the wild-type sequence) that
results in a truncated protein missing the last 281 amino acid residues.
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Figure 2.13: Stable maintenance of a plasmid-based biosynthetic pathway in P. tricornutum. (A) Diagram of
the putative vanillin biosynthetic pathway (not to scale). Yellow arrows represent multiplex PCR primer pair locations. PAL, phenylalanine ammonia lyase; C4H, trans-cinnamate 4-hydroxylase; TAL, tyrosine ammonia lyase; C3H,
p-coumarate 3-hydroxylase; HCT, hydroxycinnamoyl transferase; 4CL, 4-hydroxycinnamoyl-CoA ligase; COMT, caffeic acid 3-O-methyltransferase; VAN, vanillin synthase. 2A, P2A self-cleaving peptide. Promoters are indicated by
right-facing green arrows, and terminators by red hexagons. (B) Diagram of p0521s-V. Rv; EcoRV sites. (C) Agarose
gel electrophoresis of multiplex PCR showing presence of metabolic genes in vanillin biosynthesis plasmids recovered
from P. tricornutum. V1, p0521s-V clone 1; and V3, p0521s-V clone 3. MPX 1–6, multiplex PCR products generated
by the corresponding primer pairs shown in panel (a). M, 100 bp ladder (D) Agarose gel electrophoresis of vanillin
biosynthesis plasmids recovered from P. tricornutum and digested with EcoRV. M, 1 kb ladder. (E) Plasmid maps
depicting sequencing coverage and positions of SNPs. Constructs were fully sequenced after initial assembly (V1.0
and V3.0) and after ∼1 month (V1.1 and V3.1) and ∼4 months (V1.4 and V3.4) of serial passage in P. tricornutum.
The inner ring is the reference plasmid map, and outer rings indicate the plasmid sequence for each time point. Red
triangles indicate positions of mutation relative to the reference sequence. Sequencing coverage for each construct is
shown in gray, with blue shading indicating regions where sequencing reads exceed a set maximum: V1.0 = 1000
reads; V1.1 = 400 reads; V1.4 = 1200 reads; V3.0 = 900 reads; V3.1 = 900 reads; V3.4 = 1100 reads. *172 bp
insertion was identified in a region of repetitive sequence in V1.0 but was not present in later time points and is likely
a sequencing contig assembly error. **2 bp deletion was identified in V1.0 and V1.4 but was not present in V1.1
(sequence coverage at these positions in V1.1 is 0).
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2.4

Discussion

The model diatom P. tricornutum is an attractive species for synthetic biology applications, but
requires further development to be suitable for industrial production applications. Toward this,
we have developed novel genetic tools and an efficient gene editing system for P. tricornutum
that will enable more complex genetic engineering of this species. The novel regulatory elements
described here are important for three reasons. First, we have expanded the repertoire of promoter
and terminator elements that function to express an exogenous gene in P. tricornutum. Second,
our data imply that pairing promoters with different combinations of terminators could be used to
modulate expression of individual genes, as might be required in a synthetic metabolic pathway.
Third, the strategy of using a eukaryotic spliceosomal intron to limit or prevent expression in E. coli
would be useful when cloning P. tricornutum genes or during construction of synthetic pathways
where very low levels of expression could result in toxicity or plasmid instability in E. coli. In
addition, we have shown that Zeocin™ and nourseothricin can be used for selection of plasmid
based systems, and suggest a cost-saving measure in that less antibiotic can be used for selection
of P. tricornutum exconjugants than what is currently used for selection of integrated copies of the
nat gene (15).
Examples of Cas9 gene editing in P. tricornutum previously relied on genomic integration
of the expression construct (28, 54, 55). This results in prolonged exposure to the nuclease and
potentially increases the risk of off-target effects. We have demonstrated simple and robust editing
of the P. tricornutum genome using a conjugative plasmid system that can be cured after editing to
avoid complications related to long-term Cas9 expression.
Using several genetic regulatory elements described in this study, we created a plasmid-based
multi-gene biosynthetic pathway for expression in P. tricornutum. Tracking plasmid stability over
160 generations revealed evidence that suggests mutations occurred during initial conjugation,
but no new mutations were accumulated during plasmid propagation. These results highlight the
importance of validating plasmid constructs by whole-plasmid sequencing after transformation
before assaying for biosynthetic activity. Furthermore, our data show that while mutations can
occur during or shortly after conjugation, plasmids encoding large biosynthetic pathways can be
stably replicated in P. tricornutum over extended periods.
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In summary, we have described the development and testing of several plasmid-based tools for
expression and regulation of genes in P. tricornutum. The addition of a multi-plasmid system with
new genetic elements will facilitate heterologous gene expression, study of protein-protein interactions, reporter readouts of gene expression, and stable maintenance of plasmid-based synthetic
metabolic pathways in this species. When combined with the simple and robust plasmid-based
Cas9 genome-editing systems described here, we anticipate that our tools will open the door for
construction of designer P. tricornutum knockout strains for synthetic biology applications, and for
the study of the basic biology of this important species.
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Chapter 3
Plasmid-based complementation of large
deletions in Phaeodactylum tricornutum
biosynthetic genes generated by Cas9
editing
The work presented in this chapter is reprinted (adapted) with permission (Appendix A) from:
S. S. Slattery, H. Wang, D. J. Giguere, C. Kocsis, B. L. Urquhart, B. J. Karas, D. R. Edgell. (2020)
Plasmid-Based Complementation of Large Deletions in Phaeodactylum tricornutum Biosynthetic
Genes Generated by Cas9 Editing. Scientific Reports 10 (1), 1–12.
Copyright (2020) Springer Nature

3.1

Introduction

Photoautotrophic microalgae and cyanobacteria are emerging as alternative platforms for synthetic
biology applications (1, 2). One microalgae species of interest is the diploid marine diatom P.
tricornutum. A variety of plasmid-based genetic tools have been developed for P. tricornutum
that facilitate basic molecular manipulations and expression of complex synthetic pathways (3–
6). We, and others, have developed plasmid-based and DNA-free CRISPR (clustered regularly
interspaced palindromic repeats) reagents for targeted chromosome editing in P. tricornutum and
related diatoms using the Cas9 protein (CRISPR-associated protein 9) (6–11). P. tricornutum
is diploid, meaning that Cas9-edited cells must be carefully screened to determine if knockouts
are monoallelic or biallelic and exhibit loss of heterozygosity. These plasmid-based tools and
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synthetic pathways are currently maintained by available antibiotic-based selections, including
Zeocin™, phleomycin, nourseothricin, and blasticidin-S and their resistance genes, Sh ble, nat,
and bsr (12–15). Antibiotic-based selections can be prohibitively expensive for maintaining largescale cultures and are problematic for applications such as the biosynthesis of products intended
for human consumption (16–18).
A viable alternative to antibiotics is the use of auxotrophic selective markers which require
a strain engineered to have a loss of function mutation in a key enzyme of an essential biosynthetic pathway. Examples of commonly used auxotrophic strains in industrial and academic labs
include uracil, histidine, and tryptophan auxotrophs (19–21). Two approaches have been taken
to generate P. tricornutum auxotrophs. First, uracil-requiring mutants were generated by random
mutagenesis that resulted in the identification of the bi-functional uridine monophosphate synthase (PtUMPS) gene predicted to catalyze the conversion of orotate into uridine monophosphate
(UMP) (22). Biolistic transformation and chromosomal integration of the PtUMPS gene rescued
the uracil-requiring phenotype. Second, Cas9 was used to knockout the PtUMPS gene to create
uracil auxotrophs and the PtAPT gene encoding a predicted adenine phosphoribosyl transferase to
create adenine auxotrophs (7). However, direct selection of these auxotrophs via transformation
with the corresponding complementation marker has not been explored and the generation of additional auxotrophic strains would facilitate development of new plasmid-based complementation
markers.
Here, we used a plasmid-based editing strategy to generate knockouts in the uracil, histidine,
and tryptophan biosynthesis pathways of P. tricornutum and show for the first time that plasmidbased copies of the intact PtUMPS and PtPRA-PH/CH genes can complement the uracil- and
histidine-requiring phenotypes, respectively. Individual auxotrophic strains are characterized by
loss of heterozygosity at the edited alleles, and Nanopore sequencing of the edited population
reveals large, heterogeneous deletions up to ∼ 2.7 kb. The uracil and histidine auxotrophs and
their respective complementation markers are a potential alternative to antibiotic-based selection
of plasmids in P. tricornutum. Our results also suggest a simple methodology to cure plasmids
from uracil auxotrophs to enable strain and genome engineering.
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3.2
3.2.1

Methods
Microbial strains and growth conditions

S. cerevisiae VL6-48 (ATCC MYA-3666: MATα his3-δ200 trp1-δ1 ura3-52 lys2 ade2-1 met14 ◦ )
was grown as described in section 1.2.1. E. coli (Epi300, Epicenter) was grown as described in
section 1.2.1. P. tricornutum (Culture Collection of Algae and Protozoa CCAP 1055/1) was grown
in L1 medium without silica, with or without uracil (50 mg l-1 ) or histidine (200 mg l-1 ) or 5-FOA
(100 mg l-1 ), supplemented with appropriate antibiotics Zeocin™ (50 mg l-1 ) or nourseothricin
(100 mg l-1 ), at 18◦ C under cool white fluorescent lights (75 µE m-2 s-1 ) and a photoperiod of 16 h
light:8 h dark. L1 media supplemented with nourseothricin contained half the normal amount of
aquil salts. P. tricornutum auxotroph genotypes are as follows. Mutations in PtUMPS are described in reference to the chromosome 6 sequence (GenBank: CM000609.1), and mutations for
PtPRA-PH/CH are in reference to the chromosome 3 sequence (GenBank: CP001142.1). Mutations described for each gene are listed for allele 1 followed by allele 2, and numbered beginning
from the first nucleotide of the start codon for simplicity. Genotypes of auxotroph strains generated
in this study are listed in Supplementary Table C.4.

3.2.2

Transfer of DNA to P. tricornutum via conjugation from E. coli

Conjugations were performed as described in section 1.2.2. Exconjugants were selected on 1/2 ×
L1 1% agar plates supplemented with Zeocin™ 50 mg l-1 or nourseothricin 100 mg l-1 . Colonies
appeared after 7–14 days incubation at 18◦ C with light.

3.2.3

Plasmid design and construction

All plasmids (Supplementary Table C.5) were constructed using a modified yeast assembly protocol (23, 24). Plasmids pPtUMPSA1 and pPtUMPSA2 were made from pPtGE31 (6) by replacing
the URA3 element with a PCR fragment consisting of PtUMPS allele 1 or 2 with ∼1 kb up- and
downstream of the PtUMPS ORF, amplified from P. tricornutum genomic DNA (oligonucleotides
are listed in Supplementary Table C.6). Plasmids pPtUMPScA1 and pPtUMPScA2 were made
from pPtUMPSA1 and pPtUMPSA2 by replacing the PtUMPS ORF with a PCR fragment con-
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sisting of PtUMPS allele 1 or 2 amplified from P. tricornutum cDNA. Plasmid pPtUMPS40S was
made from pPtGE31 by replacing the URA3 element with a cassette consisting of PCR fragments
of the 40SRPS8 promoter and terminator (6) flanking a PCR fragment of the PtUMPS allele 1 ORF
amplified from P. tricornutum genomic DNA. Plasmid pPtPRAPHCH was made from pPtGE31 (6)
by replacing the URA3 element with a PCR fragment consisting of PtPRA-PH/CH with ∼1 kb upand downstream of the PtPRA-PH/CH ORF, amplified from P. tricornutum genomic DNA. Using
Golden Gate assembly (25), sgRNAs targeting different regions of the PtUMPS and PtPRA-PH/CH
genes were cloned into the BsaI sites positioned between the P. tricornutum U6 promoter and terminator in pPtGE34 and pPtGE35. Plasmid constructs were confirmed by Sanger sequencing at
the London Regional Genomics Facility.

3.2.4

Generation of PtUMPS and PtPRA-PH/CH knockouts using Cas9 and
TevCas9

Plasmids pPtGE34 or pPtGE35, containing no guide RNA or sgRNA.UMPS.1944,
sgRNA.UMPS.1646, sgRNA.UMPS.157, sgRNA.UMPS.311 for the PtUMPS gene, or
sgRNA.PRAPHCH.929 or sgRNA.PRAPHCH.120 for the PtPRA-PH/CH gene, were conjugated
from E. coli to P. tricornutum and exconjugants were selected on Zeocin™-containing media, supplemented with uracil or histidine as appropriate (26). Ten colonies from each conjugation were
resuspended in TE buffer and flash frozen at -80◦ C followed by heating at 95◦ C to lyse cells and
extract genomic DNA. The genomic target site of each sgRNA in P. tricornutum was amplified
by PCR and the products were analyzed by T7EI assay as follows; PCR products were denatured
at 95◦ C for 5 mins, slowly cooled to 50◦ C, and flash frozen at -20◦ C for 2 mins. PCR products
(250 ng) were incubated with 2U of T7EI (NEB) in 1× NEBuffer 2 for 15 mins at 37◦ C and analyzed by agarose gel electrophoresis. Colonies that showed editing by T7EI assay were grown
in liquid culture supplemented with Zeocin™ and uracil or histidine as appropriate for 2 weeks
and serial dilutions were plated on selective media with uracil or histidine to isolate sub-clones.
Sub-clones were then screened for homozygous PtUMPS or PtPRA-PH/CH knockout phenotypes
by replica streaking on minimal L1 media and L1 media supplemented with uracil or histidine as
appropriate. Streaks were grown for 5 days before visual identification of phenotypes. Sub-clones
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that were identified as phenotypic knockouts were resuspended in TE buffer and flash frozen at
-80◦ C followed by heating at 95◦ C to lyse cells and extract genomic DNA, then sgRNA target sites
were PCR amplified. Sanger sequencing of PCR products was performed at the London Regional
Genomics Facility to identify the type and length of indels generated. Stable bi-allelic PtUMPS
or PtPRA-PH/CH knockout mutant lines were then grown in nonselective L1 media supplemented
with uracil or histidine for 1 week to cure them of plasmids before plating to obtain single colonies.
Resulting colonies were replica streaked onto nonselective and Zeocin™-containing media supplemented with uracil or histidine to identify colonies which had successfully been cured of the
plasmid.

3.2.5

Spot plating P. tricornutum

Cultures of P. tricornutum were adjusted to 1 × 106 cells ml-1 and serially diluted 2× three times.
For uracil auxotrophs, 10 µL of each adjusted culture and dilutions were spot plated onto minimal
L1 media and L1 media supplemented with uracil (50 mg l-1 ), 5-FOA (100 mg l-1 ), or both. For
histidine auxotrophs, 10 µL of each adjusted culture and dilutions were spot plated onto minimal
L1 media and L1 media supplemented with histidine (200 mg l-1 ). Plates were incubated at 18◦ C
under cool white fluorescent lights (75 µE m-2 s-1 ) and a photoperiod of 16 h light:8 h dark for
7–10 days.

3.2.6

Measuring P. tricornutum growth rates

Growth was measured in a Multiskan Go microplate spectrophotometer. Cultures of each strain
(WT, ∆UMPS1, ∆UMPS1 + pPtUMPS40S, ∆UMPS1 + pPtUMPSA1, ∆UMPS1 + pPtUMPSA2,
∆UMPS1 + pPtUMPScA1, ∆UMPS1 + pPtUMPScA2, ∆UMPS2 + pPtUMPSA1, ∆UMPS2 +
pPtUMPSA2, ∆UMPS2 + pPtUMPScA1, ∆UMPS2 + pPtUMPScA2) were adjusted to 5 × 105
cells ml-1 in L1 media with and without supplemented uracil (50 mg l-1 ), 5-FOA (100 mg l-1 ),
or both. Two hundred microliters of each adjusted culture was added to three wells (technical
replicates) of a 96-well microplate. The 96-well microplates were incubated at 18◦ C under cool
white fluorescent lights (75 µE m-2 s-1 ) and a photoperiod of 16 h light:8 h dark for 10 days, and
absorbance at 670 nm (A670 ) was measured every 24 hrs. The 96-well microplates were shaken
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briefly to resuspend any settled cells prior to absorbance measurements. Note that the A670 was not
adjusted for path length and light scattering from the microplate lid and is therefore not directly
comparable to optical density readings measured in a standard cuvette.

3.2.7

P. tricornutum metabolite extraction

Cultures of P. tricornutum (wild-type, ∆UMPS1, and ∆UMPS2) were grown with and without
uracil supplementation and harvested during exponential phase as follows (Note: The ∆UMPS1
and ∆UMPS2 cultures were first grown with uracil supplementation, then switched to minimal L1
media for 1 week prior to harvesting). Cultures (∼1 × 109 cells) were pelleted by centrifugation at
4000 × g for 10 mins and washed by resuspending in fresh L1 media. Cells were pelleted again,
resuspended in a small volume (∼5 ml) of L1 media, and transferred to a clean 10 ml syringe
(without needle) with the exit plugged by parafilm. The syringe was placed, tip-down, into a clean
50 ml falcon tube and the cells were pelleted as above. The supernatant was removed and the
pellet was slowly ejected from the syringe into a pre-chilled mortar containing liquid nitrogen.
The frozen cells were ground to a fine powder and then transferred to a clean pre-weighed 1.5 ml
Eppendorf tube, suspended half way in liquid nitrogen. Being careful to keep samples frozen,
50 mg of frozen ground powder was weighed out into a new clean 1.5 ml Eppendorf tube, precooled in liquid nitrogen, and 250 µL of cold extraction buffer with internal standard (IS) (80%
methanol in MilliQ water, 125 µM

15

N2 -uracil) was added. The IS was added to the samples to

compensate for losses that might occur during preparation of the samples and loss of sensitivity
attributable to quenching of the signal by coeluting compounds. Samples were then homogenized
by vigorous vortexing for 30 s in 10 s intervals, between which samples are kept on ice for ∼30 s.
Homogenized samples were then spun down at 4◦ C for 10 mins at 20,000 × g. The supernatant
was transferred to a new clean 1.5 ml Eppendorf tube and spun down at 20,000 × g for 5 mins at
4◦ C. The supernatant was again transferred to a new clean 1.5 ml Eppendorf tube and kept at 4◦ C
overnight prior to LC-MS analysis.
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3.2.8

Chromatographic separation and mass spectrometry

Metabolites were separated at 45◦ C on a Waters Acquity HSS T3 column [2.1 × 100 mm, 1.8 µm]
in a Waters ACQUITY UPLC I-Class system (Waters, Milford, MA). Solvent A consisted of water
and solvent B consisted of methanol, both containing 0.1% formic acid. Elution was performed
by use of a linear gradient, at a flow rate of 0.3 ml min-1 , as follows: 0–2 mins, 100% solvent A
to 90% solvent B; 2.01 mins, 100% solvent A to recondition the column. A Waters Xevo G2-S
quadrupole time of flight mass spectrometer was operated in negative electrospray ionization (ESI)
in resolution mode. The capillary voltage was set to 1.0 kV, the source temperature was 150◦ C,
desolvation temperature was 600◦ C, the cone gas was 50 l hr-1 and the desolvation gas was 1000
l hr-1 . Leucine enkephalin was infused as the lock mass with a scan time of 0.3 s every 10 s, and
three scans were averaged. Linearity and detection limits for each compound were established
by injection of calibration mixtures with different concentrations (0, 1, 2, 4, 8, 16, 31.25, 62.5,
125, 250, and 500 µmol l-1 ). Stable-isotope-labeled uracil (15 N2 -uracil) was used as the IS. The
concentration of each analyte was determined by use of the slope and intercept of the calibration
curve that was obtained from a least-squares regression for the analyte/IS peak-area ratio vs the
concentration of the analyte in the calibration mixture.

3.2.9

P. tricornutum DNA extraction and targeted long-read sequencing

Plasmids pPtGE34 or pPtGE35, containing sgRNAs targeting the PtUMPS, PtUrease, or PtI3GPSPRAI gene were conjugated from E. coli to P. tricornutum and exconjugants were selected on
Zeocin™-containing media, supplemented with uracil or tryptophan (100 mg l-1 ) as appropriate.
For each transformation, colonies (∼1000) were scraped and pooled in liquid L1 media and genomic DNA was extracted using a modified akaline lysis protocol as follows: Cells were pelleted
at 4000 × g for 5 mins, and resuspended in 250 µL resuspension buffer consisting of 235 µL P1
(Qiagen), 5 µL hemicellulose 100 mg ml-1 , 5 µL of lysozyme 25 mg ml-1 , and 5 µL zymolyase
solution (200 mg zymolyase 20 T (USB), 9 ml H2 O, 1 ml 1 M Tris pH 7.5, 10 ml 50% glycerol)
and incubated at 37 ◦ C for 30 mins. Next, 250 µL of lysis buffer P2 (Qiagen) was added, followed
by 250 µL of neutralization buffer P3 (Qiagen) and centrifugation at 16000 × g for 10 mins. The
supernatant was transferred to a clean tube, 750 µL isopropanol was added, and the samples cen-
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trifuged at 16000 × g for 10 mins. A 70% EtOH wash was performed, centrifuged at 16000 × g for
5 mins, and pellets briefly dried, resuspended in 50–100 µL of TE buffer, and incubated at 37◦ C
for 30–60 mins.
The sgRNA target site regions were PCR amplified from sgRNA transformant genomic DNA
samples, as well as a wild-type sample, with PrimeStar GXL polymerase (Takara) using primers
positioned ∼3 kb up- and downstream of the target site (Supplementary Table C.6). PCR products
were purified and DNA libraries were prepared, barcoded, and pooled using an Oxford Nanopore
Ligation Sequencing Kit (SQK LSK109) and Native Barcoding Expansion 1–12 (EXP-NBD104)
kit according to manufacturers protocol with the following modification: all reactions were scaled
down to half the recommended volume and the end prep incubation times were extended to 15 mins
at 20◦ C and 15 mins at 65◦ C. The pooled library was then loaded on to a MinION R9.4.1 flowcell
and sequenced.

3.2.10

Targeted long-read sequencing analysis

After sequencing on an R9.4.1 flowcell, base calling was performed using GPU Guppy with the
high accuracy configuration file version 3.4.4 (https://community.nanoporetech.com). Reads in
each barcode were filtered using NanoFilt (27) for a minimum average read quality score of 10 and
a minimum read length of 2000, mapped using minimap2 (28) and filtered for reads that map to
within 100 bases of each end of the reference sequence (the unedited 6 kb PCR product sequence)
to remove short fragments. The filtered reads were mapped using minimap2 (parameters: -ax mapont) and outputted in sam format, then converted to bam, sorted, and indexed using samtools (29).
The per-base coverage depth for each barcode was calculated using Mosdepth (30). All plots were
created in R using the ggplot2 package (31).

3.3
3.3.1

Results
Identification of Cas9 targets in biosynthetic pathway genes

We examined the KEGG predictions (32, 33) based on the genome sequence of P. tricornutum
to identify genes in the uracil and histidine biosynthetic pathways for Cas9 editing. We focused
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on these two pathways as uracil and histidine auxotrophy, and counter-selection strategies are
commonly used in other model organisms. This approach identified the previously described bifunctional PtUMPS gene that is predicted to catalyze two steps in the uracil pathway — conversion
of orotate to orotidine monophosphate (OMP), and conversion of OMP to UMP (Fig. 3.1 and Fig.
3.2A) (22). Proteins that are orthologs of characterized enzymes involved in histidine biosynthesis
were also identified (Fig. 3.3 and Fig. 3.4A ). The PHATR 3140 gene, hereafter called PtPRAPH/CH, encodes a predicted bifunctional protein that shares sequence similarity with the bacterial
protein HisIE, and its Arabidopsis counterpart HISN2 (34, 35). These proteins possess two functional domains that are homologous to the phosphoribosyl-ATP pyrophosphohydrolase (PRA-PH)
and phosphoribosyl-AMP cyclohydrolase (PRA-CH) enzymes, respectively. PRA-PH and PRACH, alone or as a bifunctional protein, are predicted to catalyze two successive steps that occur
early in the histidine biosynthesis pathway (Fig. 3.3 and Fig. 3.4A). The PtIGPS gene encoding
imidazole glycerol phosphate synthase (a HIS3 homolog) was found to be a duplicated gene in the
P. tricornutum genome assembly and thus not prioritized as a Cas9 target.
We also identified the PtI3GPS-PRAI gene as a potential target as it encodes a predicted bifunctional enzyme that is a fusion of indole-3-glycerol-phosphate synthase (I3GPS) and phosphoribosylanthranilate isomerase (PRAI), and would catalyze two successive steps in the tryptophan
biosynthesis pathway (Fig. 3.5).
To confirm the genomic target sites, we PCR-amplified and sequenced the PtUMPS and
PtPRA-PH/CH genes of the P. tricornutum CCAP 1055/1 strain used in our laboratory. Two
distinct alleles for both the PtUMPS and PtPRA-PH/CH genes were identified. Seven singlenucleotide polymorphisms (SNPs) in the PtUMPS alleles result in amino acid substitutions that
differentiate the two alleles from each other and from the published P. tricornutum genome (Supplementary Table C.1). All substitutions are located in non-conserved regions of the PtUMPS protein (Fig. 3.6). Similarly, an A to G mutation at base position 1205 in allele 2 of the PtPRA-PH/CH
gene was identified (Supplementary Table C.2). This transversion converts a highly conserved glutamate to a glycine in the catalytic site of the PRA-PH domain. The impact of these substitutions
on PtUMPS and PtPRA-PH/CH function is unknown.
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Figure 3.1: The predicted P. tricornutum uracil biosynthesis pathway. The diagram depicts the biosynthesis pathway for conversion of carbonic acid to uracil and uridine triphosphate, with the PtUMPS enzyme highlighted in blue.
The competitive inhibitor, 5-Fluoroorotic acid (5-FOA), is also shown in a hashed box at the position where it enters
the pathway. No enzymes sharing significant sequence similarity with uridine nucleosidase or uridine phosphorylase
(highlighted in red) were identified in P. tricornutum by NCBI and EnsemblProtists BLAST queries. Abbreviated
names for molecules and enzymes are indicated in parentheses, and the predicted corresponding P. tricornutum gene
names are indicated in square brackets.
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Figure 3.2: CRISPR-generated knockouts in the predicted P. tricornutum uracil biosynthesis pathway. (A) A
portion of the predicted P. tricornutum biosynthesis pathway for conversion of carbonic acid to uracil and uridine
triphosphate, with the PtUMPS enzyme highlighted in blue. The competitive inhibitor, 5-fluoroorotic acid (5-FOA), is
shown in a dashed box at the position where it enters the pathway. Abbreviated names for molecules and enzymes are
indicated in parentheses, and the predicted corresponding P. tricornutum gene names are indicated in square brackets.
(B) Example image of T7EI editing assay to screen exconjugants for potential editing events in the PtUMPS gene.
Substrate indicates PtUMPS gene fragments amplified by the PCR, while T7 product indicates exconjugants with
evidence of Cas9 editing. WT, wild-type P. tricornutum genomic DNA used in the T7EI editing assay. M, 100
bp ladder with sizes indicated in basepairs (bp). (C) Example of phenotypic screening of one PtUMPS knockout
strain (∆UMPS2) plated on L1 alone or L1 supplemented with uracil at the indicated dilution of initial concentration.
(D) Example of screening for loss of the zeocin-resistant Cas9 editing plasmid in a ∆UMPS2 knockout strain by
plating on L1 supplemented with uracil or L1 supplemented with uracil and Zeocin™. (E) Sanger sequencing traces
of characterized PtUMPS knockouts with the position (below trace) and type of insertion or deletion (above trace)
indicated for each allele of the three strains. (F) Graphical map of the position and extent of indels for each of the three
PtUMPS knockouts relative to the wild-type UMPS gene (shown at top). Red rectangles indicate nucleotide deletions,
green triangles indicate nucleotide insertions, the yellow and blue rectangles on the WT gene indicate the position of
the PtUMPS active sites (orotate phosphoribosyl transferase and orotidine-5’-phosphate decarboxylase), and the white
rectangles with dashed lines represent introns.
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Figure 3.3: The predicted P. tricornutum histidine biosynthesis pathway. The diagram depicts the biosynthesis
pathway for conversion of ribose-5-phosphate to L-histidine, with the PtPRA-PH/CH enzyme highlighted in blue. No
enzymes sharing significant homology with HPP (highlighted in red) were identified in P. tricornutum by NCBI and
EnsemblProtists BLAST queries. Abbreviated names for each enzyme are indicated in parentheses, and the predicted
corresponding P. tricornutum gene names are indicated in square brackets.

79

Figure 3.4: CRISPR-generated knockouts in the predicted P. tricornutum histidine biosynthesis pathway. (A)
A portion of the predicted biosynthesis pathway for conversion of ribose-5-phosphate to L-histidine, with the bifunctional PtPRA-PH/CH enzyme highlighted in blue. Abbreviated names for each enzyme are indicated in parentheses, and the predicted corresponding P. tricornutum gene names are indicated in square brackets. (B) Example
image of T7EI editing assay to screen exconjugants for potential editing events in the PtPRA-PH/CH gene. Substrate
indicates PtPRA-PH/CH gene fragments amplified by the PCR, while T7 product indicates exconjugants with evidence of Cas9 editing. WT, wild-type P. tricornutum genomic DNA used in the T7EI editing assay. M, 1 kb ladder
with sizes indicated in basepairs (bp). (C) Example of phenotypic screening of one PtPRA-PH/CH knockout strain
(∆PtPRAPHCH1) transformed with or without the complementing PRA-PH/CH plasmid (pPtPRAPHCH) on L1 solid
media alone or L1 supplemented with histidine at the indicated dilution of initial concentration. WT, wild-type P.
tricornutum strain. (D) Sanger sequencing traces of characterized PtPRA-PH/CH knockouts with the position (below
trace) and type of insertion or deletion (above trace) indicated for each allele. (E) Graphical map of the position and
extent of indels for PtPRA-PH/CH knockout relative to the wild-type PtPRA-PH/CH gene (shown at top). Red rectangles indicate nucleotide deletions, while the yellow and blue rectangles on the WT gene indicated the position of the
PRA-PH and PRA-CH active sites.
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Figure 3.5: The predicted P. tricornutum tryptophan biosynthesis pathway. The diagram depicts the biosynthesis
pathway for conversion of shikimate to L-tryptophan, with the PtI3GPS-PRAI enzyme highlighted in blue. Abbreviated names for molecules and enzymes are indicated in parentheses, and the predicted corresponding P. tricornutum
gene names are indicated in square brackets.
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Figure 3.6: Predicted PtUMPS structure indicating the positions of the ODC (dark grey) and OPRT (light
grey) domains. Regions containing conserved active site residues for the ODC and OPRT domains are indicated in
yellow and blue, respectively. Residue substitutions that differentiate the two alleles are labeled and highlighted in
green (allele 1) and magenta (allele 2). Folding prediction was modeled using the PHYRE2 Protein Fold Recognition
Server.
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3.3.2

Cas9 and TevCas9 editing of auxotrophic genes is characterized by
loss of heterozygosity

To generate knockouts in uracil and histidine biosynthetic genes, we designed and individually
cloned Cas9 and TevCas9 single guide RNAs (sgRNAs) against different sites in the PtUMPS,
PtPRA-PH/CH, and PtI3GPS-PRAI genes (Table 3.1 and Fig. 3.7, Fig. 3.8, Fig. 3.9). The
TevCas9 nuclease is a dual nuclease that generates a 33–38 base pair deletion between the I-TevI
(Tev) and Cas9 cut sites (36). The targeting requirements for a TevCas9 nuclease are an I-TevI
50 -CNNNG-30 cleavage motif positioned ∼15–18 base pairs upstream of the 50 end of the sgRNA
binding site. The Cas9 or TevCas9 editing plasmids were moved into P. tricornutum by bacterial
conjugation and exconjugants selected on Zeocin™-containing media.
Table 3.1: Summary of sgRNAs used for Cas9 and TevCas9 editing.
Target
UMPS

Platform

Guide RNA

Cas9

sgRNA.UMPS.1944
sgRNA.UMPS.1646
sgRNA.UMPS.157
sgRNA.UMPS.311
sgRNA.UMPS.1944
sgRNA.UMPS.1646
sgRNA.UMPS.157
sgRNA.PRAPHCH.929
sgRNA.PRAPHCH.120
sgRNA.PRAPHCH.1000
sgRNA.PRAPHCH.929
sgRNA.PRAPHCH.120
sgRNA.IGPSPRAI.244
sgRNA.IGPSPRAI.244

TevCas9

PRA-PH/CH

Cas9

TevCas9
I3GPS-PRAI

Cas9
TevCas9

Exconjugants edited / total
screened (T7E1)
0/10
0/10
0/10
4/10
0/10
4/10
0/10
2/6
0/6
1/6
3/6
0/6
0/10
3/10

Number of subclones with
auxotroph phenotype / screened
N/A
N/A
N/A
1/35
N/A
2/35
N/A
1/28
N/A
0/28
0/28
N/A
N/A
1/35

We first assessed editing by screening P. tricornutum exconjugants by T7 endonuclease I (T7EI)
mismatch cleavage assays on PCR products amplified from each target gene (Fig. 3.2B and 3.4B,
and Table 3.1). This assay identified 6 sgRNAs with detectable editing rates based on screening of exconjugants. Colonies that showed editing were diluted, plated to obtain subclones, and
subsequently screened for the corresponding auxotrophic phenotype on solid media with and without auxotrophic supplement (uracil or histidine) (Fig. 3.2C and 3.4C). To cure the Cas9-editing
plasmids, knockout strains were grown without Zeocin™ selection for 1 week, and dilutions were
plated to obtain single colonies. Colonies were streaked onto L1 plates with and without Zeocin™
to screen for plasmid loss. A representative image demonstrating Zeocin™ sensitivity due to Cas9editing plasmid loss is shown in Fig. 3.2D. For knockout of the PtUMPS gene, we further charac-
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Figure 3.7: The PtUMPS coding sequence and gRNA target sites. The coding regions for the ODC (yellow) and
OPRT (blue) catalytic residues, and TevCas9 target sites (light blue) are highlighted. Residues that differ between the
two alleles are indicated by red boxes.
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Figure 3.8: The PtPRA-PH/CH coding sequence and gRNA target sites. The coding regions for the PRA-PH
(blue) and PRA-CH (yellow) catalytic residues, and TevCas9 target sites (light blue) are highlighted. Residues that
differ between the two alleles are indicated by red boxes.
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Figure 3.9: The PtI3GPS-PRAI coding sequence and gRNA target sites. The coding regions for the I3GPS (blue)
and PRAI (yellow) catalytic residues are highlighted. Residues that differ between the two alleles are indicated by red
boxes.
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terized 3 subclones with a uracil-requiring phenotype to determine if the knockouts were monoallelic or biallelic. Because the two PtUMPS alleles of P. tricornutum possessed SNPs relative to
each other, we were able to map allele-specific editing events (Fig. 3.2E and 3.2F). Two of the
strains, ∆UMPS1 and ∆UMPS2, were biallelic and exhibited loss of heterozygosity with one allele
possessing a small deletion (< 20 bps) and the other allele possessing a large deletion (> 610 bp).
The third characterized subclone, ∆UMPS3, was monoallelic and possessed a homozygous 1-bp
insertion. For the PtPRA-PH/CH knockouts that generated a histidine-requiring phenotype (Fig.
3.4B and 3.4C), targeted sequencing of one subclone revealed a biallelic genotype with an 11-bp
deletion in one allele and a 6-bp deletion in the second allele (Fig. 3.4D and 3.4E).
The types of deletions observed in the uracil- and histidine-auxotrophs are consistent with
heterogeneous editing events resulting in loss of heterozygosity (37–39). To extend these observations, we used Nanopore sequencing to better assess the spectrum of large deletions that are
often overlooked in Cas9-editing studies. In addition to the two sgRNAs that showed robust editing on the PtUMPS gene, we examined deletion events in exconjugants with sgRNAs targeted to
the PtUREASE gene (6) and the PtI3GPS-PRAI gene. For each experiment, ∼1000 exconjugants
were pooled and a ∼6 kb PCR product generated for each of the target genes with the predicted
Cas9 or TevCas9 target sites in the middle of the amplicon. We focused our attention on deletions
> 50 bp as these deletions are typically under-reported in targeted amplicon sequencing. We noted
a drop in Nanopore read coverage centered around the predicted sgRNA target sites for products
amplified from Cas9 and TevCas9 editing experiments (black dots) as compared to read coverage
for control experiments (orange dots), consistent with editing at those sites (Fig. 3.10, left panels).
Mapping the deletion start and end points revealed that most deletions were centered on the Cas9
or TevCas9 target site (Fig. 3.10, right panels), with deletions extending up to 2700 bp (Fig. 3.10,
centre panel). The mean deletion length for editing events examined by Nanopore sequencing and
> 50 bp was 1735±719 bp for Cas9 and 2006±633 bp for TevCas9.
Collectively, this data shows that Cas9 or TevCas9 editing of biosynthetic genes can readily
generate P. tricornutum auxotrophs that can be identified by phenotypic or genetic screens. Moreover, our data agree with a growing body of evidence revealing that Cas9 editing (and TevCas9
editing here) generates large deletions that would typically be missed unless screening strategies
are explicitly designed to look for loss of heterozygosity.

87

A Cas9 TRP1

0.6

Deletion length

0.8

Density

Normalized
read coverage

1.0
0.002

0.001

0.4
0.2

0.000
−2000

0

2000

0

1000

Position

2500
2000
1500
1000

2000

−1000

1

Deletion length

1000

Position

B TevCas9 TRP1

0.50
0.25
0.00

Deletion length

0.003

0.75

Density

Normalized
read coverage

1.00

0.002
0.001
0.000

−2000

1

2000

−1000

1000

2000

1000

0
0

1000

2000

−2000 −1000

1

1000

2000

+1000

Position

Deletion length

Position

C Cas9 gRNA1 UMPS
2500

0.8
0.7

Deletion length

0.9

Density

Normalized
read coverage

1.0
0.002

0.001

0.6
0.5

2000
1500
1000
500

0.000
−1000

1000
1

+1000
2000
+2000

500

1000

Position

1500

2000

2500

1000

2000

Deletion length

+1000

Position

D TevCas9 gRNA1 UMPS

0.8
0.7
0.6

Deletion length

0.003

0.9

Density

Normalized
read coverage

1.0

0.002
0.001

2000

1000

0.000
−1000

1000
1

2000

+1000
+2000

1000

Position

2000

1000

2000

Deletion length

+1000

Position

E Cas9 gRNA4 UMPS

0.9
0.8
0.7

Deletion length

Density

Normalized
read coverage

1.0
0.002

0.001

0.000
−2000
−1000

1

2000
1000

2000
1500
1000
500
0

0

500

1000

1500

2000

2500

−1000

1

1000

2000

+1000

Position

Deletion length

Position

0.005

0.9

0.004

0.8
0.7
0.6

3000

Deletion length

1.0

Density

Normalized
read coverage

F Cas9 UREASE

0.003
0.002
0.001

0.5

0.000
−1000

1000
1

+3000
2000
+4000

2000
1000
0

0

Position

Figure 3.10: Caption continued on following page.

500

1000

1500

2000

Deletion length

2500

1

1000

Position

2000

+3000

88
Figure 3.10: Large deletions in edited P. tricornutum metabolic genes captured by Nanopore amplicon sequencing. For each panel A–E, the name of the target gene as well as the editing enzyme are indicated. The leftmost plot
shows normalized read coverage averaged over a 5-bp window for the edited sample (black dots) and the wild-type
sample (orange dots) relative to the position in PCR amplicon. Numbering on the x-axis is relative to the ATG start
codon for each gene, with sequence upstream indicated by a minus (-) symbol and sequence downstream indicated
by a plus (+) symbol. The green vertical line indicates the Cas9 or TevCas9 cleavage site, while the shaded rectangle
indicates the ORF. The middle plot is a density plot of deletions > 50 bp. The rightmost plot shows the length and
position of deletions > 50 bp relative to their position in the PCR amplicon, with numbering of the x-axis as in the
leftmost panel. Each horizontal line indicates a mapped deletion event. Deletions are ordered from longest to smallest.
The green line indicates the Cas9 or TevCas9 cleavage site.

3.3.3

Phenotypic and metabolomic characterization of the PtUMPS knockouts

Two uracil-requiring auxotrophs (∆UMPS1 and ∆UMPS2) were selected for further characterization by first spot plating onto L1 media with and without uracil and 5-FOA (Fig. 3.11A). The
PtUMPS knockout strains were only able to survive in the presence of uracil supplementation.
Additionally, the knockouts survived on 5-FOA concentrations that fully inhibited the growth of
wild-type P. tricornutum (Fig. 3.11A). This is consistent with phenotypes previously observed for
P. tricornutum UMPS knockouts (7, 22). There was a slight growth advantage of ∆UMPS1 over
∆UMPS2 on media supplemented with both 5-FOA and uracil, but not on media containing uracil
alone. To compare if the observed phenotypes were consistent across solid and liquid media, we
monitored the growth of these strains over 10 days in liquid media (Fig. 3.11B) and found that the
growth rates were consistent with those observed on solid media, with one notable difference (Fig.
3.12, Fig. 3.13, and Supplementary Table C.3). The growth advantage of ∆UMPS1 over ∆UMPS2
observed on solid media supplemented with both 5-FOA and uracil was not replicated in liquid
media as the generation times for ∆UMPS1 and ∆UMPS2 were very similar (∼24 and ∼22 hrs,
respectively).
To investigate the impact of PtUMPS knockouts on uracil metabolism, we performed targeted
metabolomics on the UMPS substrate orotate using LC-MS in wild-type and knockouts strains
(Fig. 3.11C). We focused on characterizing the orotate intermediate in the uracil pathway (Fig.
3.4A and 3.11C) predicting that there should be an increase of orotate in knockout strains relative
to wild type. We were unable to detect orotate in the ∆UMPS1 strain in the absence of uracil
supplementation (-uracil), or in the ∆UMPS2 strain in either the -uracil or +uracil condition. A
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Figure 3.11: Phenotypic and metabolomic characterization of PtUMPS knockouts. (A) Spot plating assays of
wild type (WT), ∆UMPS1 and ∆UMPS2 strains on L1 solid media alone, L1 supplemented with uracil, L1 supplemented with 5-FOA, or L1 supplemented with both uracil and 5-FOA. Indicated dilutions are relative to the initial
concentration. (B) Liquid growth curves of wild type (WT), ∆UMPS1 and ∆UMPS2 strains in L1 liquid media alone,
or supplemented with uracil or 5-FOA or both. Data points are the mean of three independent replicates, with error
bars representing the standard error of the mean. (C) Orotate concentrations were measured by LC-MS from cultures
grown with and without uracil supplementation. Bars represent mean values and error bars represent standard deviation for three biological replicates. Individual data points are represented as colored dots. Statistical confidence level
was calculated by one-sided t test. p < 0.001 is indicated by an asterisk. (D) Bar graph showing percent plasmid
retention in the ∆UMPS1 and ∆UMPS2 strains harbouring various PtUMPS constructs after 14 days of outgrowth.
Bars represent the mean ratio of colonies on selective L1 + nourseothricin versus non-selective L1 plates from three
independent replicates, with error bars representing the standard error of the mean.
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Figure 3.12: Assaying ∆UMPS1 knockout and complemented growth rates in L1 media supplemented with
uracil, 5-FOA, or both. A biallelic PtUMPS mutant (∆UMPS1) is unable to grow in L1 media without uracil supplementation. Reintroducing the gene on a stably replicating plasmid restores the WT phenotype in L1 media. (A)
Growth rates in L1 media. (B) Growth rates in L1 media supplemented with uracil. (C) Growth rates in L1 media
supplemented with 5-FOA. (D) Growth rates in L1 media supplemented with uracil and 5-FOA. WT, Wild-type P.
tricornutum; ∆UMPS1, PtUMPS knockout strain 1; ∆UMPS1-A1, ∆UMPS1 possessing pPtUMPSA1; ∆UMPS1-A2,
∆UMPS1 possessing pPtUMPSA2; ∆UMPS1-cA1, ∆UMPS1 possessing pPtUMPScA1; ∆UMPS1-cA2, ∆UMPS1
possessing pPtUMPScA2. Points represent mean values and error bars represent standard deviation for three replicates.
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Figure 3.13: Assaying ∆UMPS2 knockout and complemented growth rates in L1 media supplemented with
uracil, 5-FOA, or both. A biallelic PtUMPS mutant (∆UMPS2) is unable to grow in L1 media without uracil supplementation. Reintroducing the gene on a stably replicating plasmid restores the WT phenotype in L1 media. (A)
Growth rates in L1 media. (B) Growth rates in L1 media supplemented with uracil. (C) Growth rates in L1 media
supplemented with 5-FOA. (D) Growth rates in L1 media supplemented with uracil and 5-FOA. WT, Wild-type P.
tricornutum; ∆UMPS2, PtUMPS knockout strain 1; ∆UMPS2-A1, ∆UMPS2 possessing pPtUMPSA1; ∆UMPS2-A2,
∆UMPS2 possessing pPtUMPSA2; ∆UMPS2-cA1, ∆UMPS2 possessing pPtUMPScA1; ∆UMPS2-cA2, ∆UMPS2
possessing pPtUMPScA2. Points represent mean values and error bars represent standard deviation for three replicates.
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∼6-fold increase of cellular orotate levels was observed in the wild-type strain when L1 media was
supplemented with uracil (+uracil) as compared to minimal L1 media (-uracil) (Fig. 3.11C). Interestingly, when the ∆UMPS1 strain was grown with uracil supplementation we detected orotate at
levels similar to those observed in the wild-type strain grown with uracil. This result suggests that
allele 1 in the ∆UMPS1 knockout strain (with an 18-bp in-frame deletion) retains UMPS activity
that behaves similarly to the wild-type strain. In contrast, the ∆UMPS2 strain has two out-offrame deletions that likely abolish ODC and OPRT activity. We speculate that undetectable levels
of orotate in the ∆UMPS2 strain may be because it is diverted to another biosynthetic pathway.

3.3.4

Plasmid complementation of the uracil and histidine auxotrophs

Plasmid-based complementation of P. tricornutum auxotrophs would validate that the Cas9-editing
event was the cause of the auxotrophic phenotype, as well as providing alternatives to antibioticbased selection methods to maintain episomal vectors. We first examined complementation of the
uracil-requiring phenotype by cloning both gDNA and cDNA versions of each PtUMPS allele with
the native promoter and terminator into the nourseothricin-resistant pPtGE31 expression plasmid
(6). These plasmids were designated pPtUMPSA1, pPtUMPSA2, pPtUMPScA1, and pPtUMPScA2 (Supplementary Table C.3) and moved into the ∆UMPS1 and ∆UMPS2 strains via conjugation. Exconjugants were spot-plated onto solid L1 media with and without uracil and 5-FOA
supplementation (Fig. 3.11A). All complemented strains grew on minimal L1 media, while the
uncomplemented knockouts did not, confirming expression of the UMPS gene from the pPtGE31
plasmid. No strain grew on 5-FOA alone. Unexpectedly, some of the complemented strains survived on plates supplemented with both 5-FOA and uracil. For example, when ∆UMPS2 was
transformed with either of the allele 1 complementation plasmids (pPtUMPSA1 and pPtUMPScA1), clear resistance to 5-FOA in the presence of uracil was observed. The phenotypes observed
on solid media were consistent with those observed when the strains were grown in liquid media
with similar media supplementation (Fig. 3.12 and Fig. 3.13).
The growth phenotype of the ∆UMPS1 and ∆UMPS2 strains in media supplemented with uracil
and 5-FOA could be explained by counter-selection against the plasmid carrying an intact PtUMPS
gene that would metabolize 5-FOA to a toxic intermediate. We thus tested for plasmid loss in the
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complemented strains by plating the ∆UMPS1 and ∆UMPS2 strains carrying different expression
plasmids on solid L1 with and without nourseothricin after 14 days of growth. As shown in Fig.
3.11D, plasmid retention, as measured by the ratio of colonies on L1 plus nourseothricin versus
L1 plates, was severely reduced in all strains, ranging from ∼1% to ∼33%. This observation could
explain why colonies readily appeared on L1 media supplemented with 5-FOA and uracil and
suggest that curing of plasmids carrying the PtUMPS gene from PtUMPS knockout strains is a
simple matter of growth on the appropriate media.
Similarly, we were able to complement the histidine-requiring phenotype by cloning a wildtype copy of the PtPRA-PH/CH gene into an expression vector, and transforming the plasmid
into the ∆PRAPHCH1 strain by conjugation. The ∆PRAPHCH1 strain with the complementing
plasmid grew on both solid L1 media with and without histidine supplementation, whereas the
∆PRAPHCH1 strain without the complementing plasmid only grew on L1 media with histidine
supplementation (Fig. 3.4C).

3.4

Discussion

The available tools for genetic manipulation of P. tricornutum and other diatoms have grown substantially in recent years, including the adaptation of TALEN and Cas9 genome-editing nucleases
for targeted knockouts as well as plasmid-based and DNA-free methods to deliver the nucleases
to cells (6–9, 11, 40, 41). Applications of genome-editing nucleases in P. tricornutum at this point
have mostly been to generate gene knockouts, with a few examples of reporter construct knockins. Generation of gene knockouts by Cas9 or other editing enzymes relies on non-homologous
end-joining repair pathways (42), homologs of which are predicted to occur in the P. tricornutum
genome (32, 33). A recent study used antisense RNA to knockdown a predicted DNA ligase IV
homolog (ligIV) in P. tricornutum resulting in an increased rate of homologous recombination of a
reporter construct (43). What is not yet known for P. tricornutum is the balance between NHEJ and
homology directed repair (HDR) pathways that process endonuclease-introduced double-strand
breaks (see for example (44)). Examination of Cas9 or TALEN-edited sites in P. tricornutum revealed small nucleotide insertions or deletions localized near the editing site that are consistent
with NHEJ repair events. It is becoming increasingly apparent that repair of Cas9-edited sites
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result in heterogenous alleles often characterized by both small and large deletions (for example,
Fig. 3.2D)(6, 8, 45). Repair events leading to large indels are often missed by experimental strategies that examine repair outcomes localized around the editing site. In contrast, large deletions
visible by long-read sequencing methodologies and our Nanopore data indicate that Cas9 and TevCas9 editing events result in deletions up to ∼2.7 kb in length. Cas9 editing with a single sgRNA
in P. tricornutum could achieve the same goal as the paired Cas9 nickase strategy to specifically
introduce large deletions (46), and may be complementary with recently developed methods to
multiplex sgRNAs on Cas9-editing plasmids for P. tricornutum (10). Regardless, a better understanding of DNA repair pathways that operate on Cas9-introduced double-strand breaks will better
inform strategies to bias repair events depending on the experimental goal.
The creation of auxotrophic strains of P. tricornutum with plasmid based rather than chromosomally integrated complementation markers is critical for a number of reasons. Auxotrophic strains
expand the available selection schemes beyond traditional antibiotic markers and provide a facile
method for strain cataloging and validation. Antibiotic-free selection is also an advantage when
P. tricornutum is used for production of human therapeutics. In the case of uracil auxotrophs,
complementing plasmids can be cured (or counter selected) by simple inclusion of 5-FOA and
uracil in the growth media. We have previously shown that plasmids are lost from P. tricornutum by passaging cultures over multiple days in the absence of antibiotic selection required for
maintenance of the plasmid (5). However, the counter selection method by 5-FOA and uracil supplementation is more rapid and requires screening significantly fewer colonies to confirm plasmid
loss. The ability to rapidly cure plasmids will be of tremendous value to prevent prolonged expression of Cas9 and possible toxicity issues during strain engineering, to cure incompatible plasmids,
or to cure reporter or expression plasmids under distinct growth conditions. We also envision that
rapid curing of plasmids would allow recycling of a limited number of selection markers for serial
transformations needed for strain construction or genomic engineering.
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Chapter 4
A plasmid-based system for expression and
secretion of the SARS-CoV-2 spike protein
in the model diatom Phaeodactylum
tricornutum
4.1

Introduction

The spread of the SARS-CoV-2 virus (Severe acute respiratory syndrome coronavirus 2) is currently causing a global pandemic with major impacts on healthcare systems and economies. Rapid,
accurate testing is required to help fight the spread and reduce the burden associated with this pandemic. There are two main methods of testing: nucleic acid tests that allow for the detection of
active infections, and serological assays that screen blood samples for the presence of antibodies
against the virus. While serological assays are not suitable for detecting active infections, they
can determine who has been previously exposed to the virus and are now potentially immune or
resistant to reinfection. This type of testing is critical, especially for front line healthcare workers,
as it identifies individuals who are at low risk from the virus and may be safe to return to work. A
recent study has provided evidence that reinfection does not occur in primates who have developed
antibodies against the virus (1). Individuals who have been identified to possess antibodies against
the virus are also candidates for serum/plasma donation to develop antiviral therapies. Thus, large
scale serological testing will be a major advantage in the fight against the SARS-CoV-2 virus.
One of the main barriers to development of serological assays has been the availability of a
cheap, reliable source of serologically-reactive SARS-CoV-2 proteins. Serological assays require
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purified viral antigens that are used to react with and thereby indicate the presence of antibodies
against the virus in blood samples. One of the most promising viral antigens is the SARS-CoV-2
spike protein (2, 3). Coronavirus spike proteins, and in particular their receptor-binding domain
(RBD), have been show to be highly immunogenic and antibodies against the spike protein and
its RBD domain are commonly found in individuals who have survived infections with previous
coronaviruses (4). They are therefore a good candidate for use in serological assays against this
most recent coronavirus. Production of viral antigens is currently achieved in engineered mammalian and insect culture due to their ability to properly post-translationally modify the antigens,
namely N-linked glycosylation. Glycosylation of the spike protein has been shown to be a requirement for proper antigen recognition by neutralizing antibodies (5). Production of viral antigens
in these systems is viable for small-scale production, but is prohibitively expensive for large-scale
production, especially at the levels that would be required for population-wide serological testing.
These systems also require specialized equipment and complicated supply chains, biosafety certifications, and can have low protein yields. Thus, there is a need for a production system that is
cheap, scalable, and has the ability to produce serologically-reactive viral antigens.
The model diatom P. tricornutum has the potential to be an efficient, cost-effective biological
platform for large-scale viral antigen production. P. tricornutum is a photoautotrophic marine microalga with a fast growth rate which can be grown relatively cheaply even at industrial-scales. It
has a variety of genetic tools for genome modification and overexpression of transgenic proteins
available (6, 7). P. tricornutum possesses a glycosylation pathway that is similar to that of humans and is therefore likely to properly glycosylate expressed viral antigens (8, 9). Additionally,
production of biologically active, glycosylated proteins has been demonstrated in P. tricornutum
engineered to express the hepatitis B virus surface antigen and human antibodies against the antigen (10, 11). Secretion of viral antigens from P. tricornutum would mimic mammalian expression
systems and facilitate downstream purification. This strategy is promising as secretion of transgenic proteins using endogenous and exogenous signal peptides has been previously demonstrated
in P. tricornutum (11, 12). In addition, P. tricornutum secretes very few proteins, potentially simplifying downstream purification of secreted viral antigens. Here, we report the use of a plasmidbased system to overexpress and secrete the SARS-CoV-2 spike protein and RBD domain in P. tricornutum. This system will aid in the production of viral antigens to facilitate population-wide
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serological testing to combat the current SARS-CoV-2 pandemic, and can be rapidly repurposed
to tackle future pandemics.

4.2
4.2.1

Materials and Methods
Microbial strains and growth conditions

S. cerevisiae VL6-48 (ATCC MYA-3666: MATα his3-δ200 trp1-δ1 ura3-52 lys2 ade2-1 met14 ◦ )
was grown as described in section 1.2.1. Escherichia coli (Epi300, Epicenter) was grown as described in section 1.2.1. P. tricornutum (Culture Collection of Algae and Protozoa CCAP 1055/1)
was grown in L1 medium without silica, with or without histidine (200 mg l-1 ), supplemented
with appropriate antibiotics ZeocinTM (50 mg l-1 ) or nourseothricin (100 mg l-1 ), at 18◦ C under
cool white fluorescent lights (75 µE m-2 s-1 ) and a photoperiod of 16 h light:8 h dark. L1 media
supplemented with nourseothricin contained half the normal amount of aquil salts.

4.2.2

Plasmid design and construction

All plasmids (Supplementary Table D.1) were constructed using a modified yeast assembly protocol (13, 14). We cloned versions of the SARS-CoV-2 spike protein gene into the E. coli /
P. tricornutum pDMI-2 shuttle plasmid, also called pPtGE31 (6). Primers are listed in Supplementary Table D.2. We obtained SARS-CoV-2 expression plasmids from the Krammer lab in NY
city. These served as templates for PCR amplification of the human codon-optimized spike and
receptor-binding domain coding regions for cloning into P. tricornutum expression plasmids. We
also ordered synthetic constructs corresponding to the full-length spike protein gene and RBD
from IDT-DNA that were codon-optimized for P. tricornutum. The nine initial constructs are listed
in Supplementary Table D.1 and schematics can be seen in Figure 4.1. The constructs differed
in the following ways: codon-optimization for human or P. tricornutum, full-length or RBD of
the spike protein, version 1 or version 2 of the P. tricornutum HASP1 promoter (originating from
two homologous P. tricornutum chromosomes). We also cloned a version of the full-length construct with two proline stabilizing mutations and a mutation of the furin cleavage site, in addition
to a stabilizing trimerization motif. The constructs were made with a promoter from the P. tri-
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cornutum 40SRPS8 (40S ribosomal protein S8) gene or from the HASP1 gene (highly abundant
secreted protein 1). All constructs contained the 40SRPS8 terminator. All constructs also included
a HIS4 (PtPRA-PH/CH) expression cassette from the pPtPRAPHCH plasmid (7) for selection and
maintenance in a P. tricornutum histidine auxotroph strain. Plasmids encoding the P. tricornutum
codon-optimized versions had the HASP1 promoter and the HASP1 secretory signal peptide, while
plasmids encoding the human codon-optimized versions used the 40SRPS8 promoter and the native
spike protein secretory signal. The plasmid constructs were assembled in yeast by co-transforming
linear DNA fragments of the pDMI-2 plasmid backbone, the HIS4 expression cassette, the HASP1
or 40SRPS8 promoter, and the spike or RBD protein gene. Resultant yeast colonies were pooled,
DNA extracted, and transformed into E. coli. Single E. coli colonies were grown and plasmid
DNA isolated using standard plasmid mini-prep kits. Correct assembly was confirmed by restriction enzyme digests, by whole-plasmid sequencing using a Minion sequencer from Nanopore, and
by sequencing of the spike protein expression cassette at the London Regional Genomics Centre.

4.2.3

Transfer of DNA to P. tricornutum via conjugation from E. coli

Conjugations were performed as previously described (6, 15). Briefly, liquid cultures (250 µl) of
P. tricornutum were adjusted to a density of 1.0 × 108 cells ml-1 using counts from a hemocytometer, plated on 1/2 × L1 1% agar plates with or without histidine (200 mg l-1 ), and grown for four
days. L1 media (1.5 ml) was added to the plate and cells were scraped and the concentration was
adjusted to 5.0 × 108 cells ml-1 . E. coli cultures (50 ml) were grown at 37◦ C to A600 of 0.8–1.0,
centrifuged for 10 mins at 3,000 × g and resuspended in 500 µl of SOC media. Conjugation was
initiated by mixing 200 µl of P. tricornutum and 200 µl of E. coli cells. The cell mixture was plated
on 1/2 × L1 5% LB 1% agar plates, incubated for 90 mins at 30◦ C in the dark, and then moved to
18◦ C in the light and grown for 2 days. After 2 days, L1 media (1.5 ml) was added to the plates,
the cells scraped, and 300 µl (20%) plated on 1/2 × L1 1% agar plates supplemented with ZeocinTM
50 mg l-1 or nourseothricin 100 mg l-1 . Colonies appeared after 7–14 days incubation at 18◦ C with
light.
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4.2.4

Measuring P. tricornutum growth rates

Growth was measured in a Multiskan Go microplate spectrophotometer. Wild-type P. tricornutum was adjusted to 5 × 105 cells ml-1 in L1 media with and without the following additives or
conditions. L1 plus 0.05 M, 0.1 M, or 0.2 M glycerol; L1 plus 5%, 10%, 25%, or 50% (v/v)
final concentration Luria Broth (LB); L1 plus 5%, 10%, 25%, or 50% (v/v) final concentration
Soper optimal broth with catabolite repression (SOC); L1 supplemented with tryptone (1 g l-1 );
L1 supplemented with yeast extract (0.5 g l-1 ); L1 supplemented with yeast extract and tryptone;
L1 prepared with 10x diluted nitrate phosphate stock buffer. Two hundred microliters of each
adjusted culture was added to three wells (technical replicates) of a 96-well microplate. The 96well microplates were incubated at 18◦ C under cool white fluorescent lights (75 µE m-2 s-1 ) and
a photoperiod of 16 h light:8 h dark for 10 days, and absorbance at 670 nm (A670 ) was measured
every 24 hrs. The 96-well microplates were shaken briefly to resuspend any settled cells prior to
absorbance measurements. Note that the A670 was not adjusted for path length and light scattering from the microplate lid and is therefore not directly comparable to optical density readings
measured in a standard cuvette.

4.2.5

Plasmid stability assay

P. tricornutum harbouring different spike protein expression constructs were grown for ∼28 days
in liquid media. Total DNA was isolated and 1–5 µl was used to electroporate 40 µl of E. coli.
Electroporations were recovered for 60 mins in SOC media at 37◦ C and then plated on LB plates
supplemented with chloramphenicol (25 mg l-1 ) and grown overnight at 37◦ C. For each electroporation, a minimum of 6 colonies were picked and grown overnight in 5 ml liquid LB with chloramphenicol (25 mg l-1 ), plasmid DNA was isolated using a BioBasic miniprep kit, and digested with
appropriate diagnostic restriction enzymes. Plasmids were scored as correct if the digest pattern
matched the predicted pattern.
For direct PCR assays, dilutions of RBD protein expression cultures were plated onto L1 with
nourseothricin (100 mg l-1 ) and screened for the presence of the RBD gene using a Thermo Scientific Phire Plant Direct PCR Master Mix according to manufacturers instructions. PCR screens used
a forward primer located in the HASP1 promoter (DE5241) for P. tricornutum codon-optimized
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constructs, or in the 40SRPS8 promoter (DE4130) for human codon-optimized constructs. Reverse
primers were positioned inside the RBD domain coding regions (DE5323, DE5326). Screening
primers are listed in Supplementary Table D.2.

4.2.6

RNAseq analysis

Total RNA was extracted from 50 ml cultures with an OD670 of ∼0.6–0.7 by first crushing the
algal cells in liquid nitrogen as follows. Cultures were centrifuged at 3000 × g for 10 mins at
4◦ C. The pellet was resuspended in 1 ml TE and added dropwise to a mortar (pre-cooled at 80◦ C) filled with liquid nitrogen. The frozen droplets were ground into a fine powder with a
mortar and pestle, being careful to keep the cells from thawing by adding more liquid nitrogen
when necessary. The frozen ground powder was transferred to a new clean 1.5 ml microfuge
tube and stored at -80◦ C. RNA was extracted from 50–100 mg of frozen ground powder with the
Monarch Total RNA Miniprep Kit (T2010S). The RNA was stored in TE pH 8.0 at -80◦ C until
use. RNA was then sequenced with a 1 × 150 NextSeq 550 mid-output run after rRNA depletion
with the Ribo-off Plant rRNA depletion kit. Reads were filtered using Trimmomatic v0.36 with
the following settings: AVGQUAL:30 CROP:150 MINLEN:140. Reads counts were generated
after mapping to the P. tricornutum genome and appropriate plasmid, and counts were generated
using htseq-count (16). TPM (Transcripts Per Kilobase Million) values were calculated for the
Actin16 (XP 002183295.1), HIS4, NrsR, and RBD genes in each sample. Wild type reads were
independently mapped against the pDMI-2 PtRBD c14, pDMI-2 PtRBD c17, and pDMI-2 HsRBD
plasmids and subsequent TPM calculations were performed (all plasmids mapped against gave
identical values).

4.2.7

Protein extraction and purification

P. tricornutum cultures (50 ml) were harvested during exponential growth phase and pelleted at
3,000 × g for 10 mins. Cell pellets were resuspended in 5 ml lysis buffer (50 mM Tris-HCl pH
7.4, 0.5 M NaCl, 1 mM PMSF, 1 mM DTT) and sonicated for 5 mins to lyse. Sonicated cells
were centrifuged at 10,000 × g for 10 mins at 4◦ C to pellet cell debris and supernatants were
collected in a new tube and stored on ice before purification using a 1 ml GE Healthcare HisTrap
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HP Ni-NTA column as follows. Columns were first washed with 10 column volumes of ddH2O,
then equilibrated with 10 column volumes of binding/wash buffer (50 mM Tris-HCl pH 7.4, 0.5 M
NaCl, 1 mM DTT). Supernatants from lysed cultures were run over equilibrated columns at a flow
rate of 1 ml min-1 and flowthrough was collected. Columns were washed with 10 ml binding/wash
buffer and wash was collected. His-tagged proteins were eluted with 5 ml elution buffer (50 mM
Tris-HCl pH 7.4, 0.5 M NaCl, 0.5 M imidazole, 1 mM DTT), collecting 0.5 ml fractions. Samples
(20 µl) of lysis supernatant, flowthrough, wash, and elutions were mixed with 10 µl of SDS sample
loading buffer (187.5 mM Tris-HCl (pH 6.8), 6% (w/v) SDS, 30% [v/v] glycerol, 150 mM DTT,
0.03% (w/v) bromophenol blue, 2% [v/v] β-mercaptoethanol) and boiled for 5 mins. Samples
(10 µl) were resolved on standard SDS-polyacrylamide gels (15%). Bands were visualized with
Coommassie Brilliant Blue and destained with a solution of 40% methanol, 10% acetic acid.

4.2.8

Western blots

Samples (20 µl) of lysis supernatant and Ni-NTA elution (above) were mixed with 10 µl of SDS
sample loading buffer and boiled for 5 mins. Samples (10 µl) were resolved on standard SDSpolyacrylamide gels (15%) and electroblotted to a polyvinylidene difluoride (PVDF) membrane
using a Trans-Blot Turbo Transfer System (BioRad, Hercules, CA, USA). Membranes were incubated for 1 hour in blocking solution (3% bovine serum albumin (BSA), 0.1% Tween 20, 1× TBS)
before adding primary antibody at a 1:1000 final dilution (2019-nCoV Spike/RBD, Sino Biological, 40592-T62). Membranes were incubated overnight at 4◦ C, washed for 3 × 10 mins in washing
solution (1% BSA, 0.1% Tween 20, 1× TBS), then incubated with anti-rabbit (Sigma, GENA9340)
horse radish peroxidase-linked secondary antibody for 2 hr at 1:2000 final dilution. Membranes
were then washed in 1× TBS with 0.1% Tween 20 for 3 × 10 mins, followed by one wash for
10 mins in 1× TBS. Blots were developed using Clarity ECL Western Blotting Substrate (BioRad)
following the manufacturer’s instructions and imaged with a ChemiDoc XRS+ System (Bio-Rad).

4.2.9

Mass spectrometry

Wild-type P. tricornutum and cultures (200 ml) harboring different SARS-CoV-2 overexpression
plasmids were grown to a density of ∼1 × 107 cells ml-1 . Cultures were centrifuged at 3000 × g
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for 10 mins to pellet. Supernatants were collected and filtered through 0.2 µm vacuum filters to
remove cells. Protease inhibitor cocktail (Sigma) was added to the supernatants to 1× concentration
and supernatants were concentrated using Thermo Scientific PierceTM Protein Concentrators (PES)
with a 10 kDa molecular weight cutoff at 4◦ C to a final volume of ∼0.3 ml. Protein concentrations
were measured using a Bradford assay and ∼30 µg of protein was loaded onto a 12% SDS-PAGE
gel. Bands were visualized with Coommassie Brilliant Blue and destained with a solution of 40%
methanol, 10% acetic acid. Bands were excised and placed in 1.5 ml microfuge tubes with 500 µl
of 1% acetic acid. Mass spectrometry analysis and peptide identification by ms/ms was performed
at the SPARC BioCentre, Sick Kids Hospital, University of Toronto. Peptide data was downloaded
from the SPARC BioCentre server and analyzed by the Scaffold software package using a FASTA
file of the P. tricornutum and SARS-CoV-2 proteomes. The protein threshold was set at 90% and
the peptide threshold at a 1% false discovery rate.

4.3
4.3.1

Results
Design of SARS-CoV-2 antigen expression constructs

We designed nine plasmids overexpressing different versions of the SARS-CoV-2 spike/RBD protein gene, testing different promoter/terminator pairs and secretion signals (Fig. 4.1, Supplementary Table D.1). All constructs were designed to secrete the expressed proteins into the media,
and contained nourseothricin resistance and P. tricornutum HIS4 (PtPRA-PH/CH) markers for selection in wild-type and histidine auxotroph (7) P. tricornutum strains, respectively. We designed
P. tricornutum codon-optimized and human codon-optimized versions of the full length SARSCoV-2 spike gene, full length with K986P and V987P substitutions, and soluble RBD domain
for expression in our system. The human codon-optimized genes were subcloned from plasmids
obtained from the Krammer laboratory (17). The P. tricornutum codon-optimized versions were
driven by the HASP1 promoter and included an N-terminal HASP1 secretion signal peptide (12).
The human codon-optimized versions were driven by the 40SRPS8 promoter and included the native N-terminal spike protein secretion signal peptide. All constructs contained a C-terminal 6xHis
tag to facilitate purification. Sequencing of the P. tricornutum codon-optimized constructs identi-
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fied two unique sequences of the HASP1 promoter. The HASP1 promoter was PCR amplified from
wild-type P. tricornutum genomic DNA for cloning into the expression constructs. As P. tricornutum is diploid, the two sequences identified correspond to different HASP1 promoter sequences
present on two homologous chromosomes. We chose to examining both versions of the HASP1
promoter for each of the P. tricornutum codon-optimized constructs in the event that there were
expression differences between them. Expression plasmids were transformed into wild-type and
histidine auxotroph P. tricornutum strains via conjugation (15). Resulting transformants for each
construct were pooled and grown in liquid L1 media with nourseothricin antibiotic selection for
wild-type transformants, and L1 media without supplementation for histidine auxotroph transformants. All downstream analyses, unless otherwise stated, were performed on cultures of pooled
wild-type exconjugants.

4.3.2

Optimization of P. tricornutum growth conditions

We tested a number of media supplements to maximize P. tricornutum growth rates for rapid
screening of SARS-CoV-2 spike protein expression. P. tricornutum growth in 96-well microtitre
plates was measured at A670 nM over 17 days. As shown in Figure 4.2, addition of glycerol,
tryptone, yeast extract, or a combination of tryptone and yeast extract to the media had the largest
impacts on growth rate. These cultures also reached a higher density after 17 days than those grown
with L1 media alone. We subsequently used L1 liquid media supplemented with 0.1 M glycerol
for all growth experiments. We also tested the impact of glycerol on conjugation frequency of
plasmids from E. coli to P. tricornutum. Bacterial conjugation is a simple and rapid method to
move plasmids from common laboratory E. coli strains to P. tricornutum. The protocol involves
growing P. tricornutum on L1 plates without antibiotic selection for 4 days before conjugation
with E. coli. When 0.1 M glycerol was included in the initial L1 plates, conjugation frequency,
as judged by the number of exconjugant P. tricornutum colonies on antibiotic containing plates,
increased by 2.5 fold (Fig. 4.3A). Including glycerol in the selective antibiotic plates did not
impact conjugation frequency but colonies were smaller than those on selective plates without
glycerol (Fig. 4.3B). These data suggest that inclusion of glycerol in initial plates results in a
higher conjugation frequency.
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Figure 4.1: Schematic of plasmid vectors (A) and expression constructs (B) for overexpression of P. tricornutum (Pt) and human (Hs) codon-optimized SARS-CoV-2 spike protein and receptor-binding domain (RBD).
CEN6-ARSH4-HIS3, yeast element for replication and selection; CmR, chloramphenicol resistance gene; FcpD promoter, FcpA terminator, regulatory elements from the P. tricornutum Fucoxanthin-chlorophyll a-c binding protein D
and A genes, NrsR, nourseothricin resistance gene; HIS4, HIS4 (PtPRA-PH/CH) gene and regulatory elements from
P. tricornutum; HASP1 promoter, regulatory element from the P. tricornutum HASP1 gene; 40SRPS8 promoter and
terminator, regulatory elements from the P. tricornutum 40SRPS8 gene; oriT, origin of conjugative DNA transfer.
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Figure 4.2: Growth rates of wild-type P. tricornutum in L1 media supplemented with different additives.
0.05M.GLYC, L1 plus 0.05 M glycerol; 0.1M.GLYC, L1 plus 0.1 M glycerol; 0.2M.GLYC, L1 plus 0.2 M glycerol; L1 - no additive; LB5, LB10, LB25, LB50, L1 plus 5%, 10%, 25% or 50% (vv) final concentration Luria Broth;
SOC5, SOC10, SOC25, SOC50, L1 plus 5%, 10%, 25%, or 50% (vv) final concentration Super optimal broth with
catabolite repression; TRYP, L1 supplemented with tryptone (1 g l-1 ); YE, L1 supplemented with yeast extract (0.5
g l-1 ); YE.TRYP, L1 supplemented with yeast extract and tryptone; LOW.NP, L1 prepared with 10x diluted nitrate
phosphate stock buffer.
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Figure 4.3: Impact of glycerol on conjugation frequency. (A) Bar plot of number of P. tricornutum exconjugants
with 0.1 M glycerol added to L1 plates at various steps of the conjugation protocol. Data are mean of three experimental replicates with standard error of the mean. (B) Representative pictures of L1 plates from conjugations with
glycerol added at the indicated steps.
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4.3.3

Stability of overexpression plasmids in P. tricornutum

Stability of the overexpression plasmids in P. tricornutum was measured after 28 days growth by
isolating total DNA from each P. tricornutum culture followed by transformation into E. coli. We
examined plasmid DNA from at least 6 E. coli colonies for each transformation by diagnostic
restriction digest (Table 4.1). Of the rearranged plasmids identified, there appeared no consistent
stability pattern between the different spike protein expression plasmids, suggesting that rearrangements likely occurred during conjugation from E. coli to P. tricornutum, as previously observed
(6), and did not occur in response to selective pressure to remove the expression construct. The exception was the P. tricornutum strain harbouring the pDMI-2 HsSpike plasmid (Fig. 4.1), where no
correct clones were observed in 16 total colonies screened. It is important to note that all plasmids
retained both the chloramphenicol and nourseothricin resistance genes required for maintenance
in E. coli and wild-type P. tricornutum, respectively.
Table 4.1: Summary of correct spike expression clones by diagnostic restriction digests. RBD, receptor-binding
domain; Hs, human codon-optimized gene construct, Pt, P. tricornutum codon-optimized gene construct; c, refers to
clone number.

Plasmid
pDMI-2 PtRBD c14 (HASP1 v1)
pDMI-2 PtRBD c17 (HASP1 v2)
pDMI-2 PtSpike c1 (HASP1 v1)
pDMI-2 PtSpike c2 (HASP1 v2)
pDMI-2 PtSpike2P c1 (HASP1 v1)
pDMI-2 PtSpike2P c2 (HASP1 v2)
pDMI-2 HsRBD
pDMI-2 HsSpike
pDMI-2 HsSpike2P

Correct / Total Analyzed
2/7
2/6
4/6
3/9
2/7
6/7
2/8
0/16
5/8

Following this result, we opted to screen and isolate individual P. tricornutum clones harbouring correct expression plasmids. To do this we plated dilutions of all wild-type and histidine
auxotroph expression cultures onto L1 media supplemented with nourseothricin to obtain single
colonies. We began by screening for the presence of the RBD genes by direct PCR of colonies from
all RBD expressing strains (Fig. 4.4). For the histidine auxotroph strains, all colonies screened
for the human and P. tricornutum codon-optimized RBD genes were positive. For the wild-type
strains, all colonies screened for the P. tricornutum codon-optimized RBD gene were positive,
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but only 2 out of 6 colonies screened for the human codon-optimized RBD gene were positive.
These results demonstrate that complementation of a histidine auxotroph with a plasmid-based
HIS4 (PtPRA-PH/CH) gene is a viable method to stably maintain the RBD expression plasmid in
P. tricornutum in the absence of antibiotic selection. Colonies that were positive by PCR screen
were picked and grown in liquid media for further analysis. However, we have not been able to
perform analyses on these clones at this time.

Figure 4.4: PCR-based screen of P. tricornutum expression strain colonies. Representative images of a PCRbased screen for the RBD gene in single colonies of wild-type (A) and histidine auxotroph (B) P. tricornutum strains
harbouring RBD expression plasmids. -, no template control; +, PtRBD and HsRBD expression plasmid controls; c14,
plasmid clone 14 encoding HASP1 promoter sequence 1; c17, plasmid clone 17 encoding HASP1 promoter sequence
2.

4.3.4

Analysis of full-length spike protein expression and secretion by mass
spectrometry

To examine expression and secretion of full-length spike or RBD proteins, P. tricornutum harbouring expression plasmids were grown in 200 ml volumes, and culture supernatants were collected
by pelleting cell mass by centrifugation. An aliquot of the cell mass was also taken for further
analysis. The supernatants were used for (i) concentration with a spin concentrator with a 10 kDa
molecular weight cutoff, (ii) direct application to a metal-ion affinity column for purification by the
C-terminal 6xHis tag, or (iii) analysis without further concentration or purification. We found that
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option (iii), analysis without further concentration or purification, yielded insufficient material for
visualization by SDS-PAGE or Western blot analysis. All future analyses were done using concentrated or purified samples. Concentration of cell supernatants from 200 ml cultures typically gave
∼1–2 mg ml-1 of total protein. Approximately 30 ng of total protein was resolved on SDS-PAGE
gels and visualized by Coomassie blue staining. Example gels are shown in Figure 4.5A. Of particular note are bands that are visible in supernatants from full-length spike overexpressing strains
that are absent from wild-type control supernatants. Western blotting of these supernatants using a
commercially available anti-spike antibody gave inconclusive results. We then excised the bands
from these gels and used mass spectrometry to identify peptides present after in-gel digestion with
trypsin. Unique peptides that map to the SARS-CoV-2 spike protein were identified in samples
from all spike expression strains except the Pt Spike c1 strain (Table 4.2). No peptides that map
to the SARS-CoV-2 spike protein were identified in any wild-type samples. As shown in Figure
4.5B and C, peptide hits map to regions across the SARS-CoV-2 spike protein for some samples,
and are localized to specific regions of the protein for others. It should be noted that the excised
bands that contained peptides derived from the SARS-CoV-2 spike protein were all smaller than
the predicted size of the full-length spike protein (∼140 kDa). These results suggest that while it
appears the the full-length spike protein is being expressed and secreted into the media, it is likely
being degraded.

4.3.5

Analysis of spike RBD domain expression by RNASeq and Western
blot

Based on protein yields reported for mammalian and insect expression systems (17), we reasoned
that the RBD domain would be more highly expressed in P. tricornutum than the full-length spike
protein, and be less susceptible to proteolysis. We first analyzed expression of the RBD domain by
RNASeq in cultures harbouring both P. tricornutum and human codon-optimized RBD expression
constructs. Reads were mapped against the P. tricornutum genome and appropriate plasmids, and
TPM (Transcripts Per Kilobase Million) values were calculated for the HIS4, NrsR, and RBD
genes encoded on the plasmid, as well as the endogenous Actin16 gene. As shown in Table 4.3,
TPM values for the RBD gene were several fold higher than those of the endogenous Actin16 gene
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Figure 4.5: Identification of SARS-CoV-2 spike proteins in supernatants of P. tricornutum expression strains.
(A) SDS-PAGE gels of concentrated supernatants from wild type (WT) and 5 strains expressing full-length spike
protein. Arrows indicate bands that were excised and sent for mass spectrometry analyses. M, markers; Lane 1,
P. tricornutum codon-optimized full-length spike, clone1; Lane 2, P. tricornutum codon-optimized full-length spike,
clone2; Lane3, P. tricornutum codon-optimized full-length spike with K986P and V987P mutations, clone1; Lane4,
P. tricornutum codon-optimized full-length spike with K986P and V987P mutations, clone2; Lane 5, human codonoptimized full-length spike protein. (B and C) Screenshots of Scaffold software analysis of mass spectrometry data
showing peptides from samples 5-4 (B) and 8-3 (C) that map to the SARS-CoV-2 spike protein sequence. Sample IDs
are those shown in panel (A) above.
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Table 4.2: List of peptide hits to the SARS-CoV-2 spike protein identified in samples by mass spectrometry. NA,
not applicable (no peptide hits); Hs, human codon-optimized gene construct, Pt, P. tricornutum codon-optimized gene
construct; c, refers to clone number. Sample names are those shown in Figure 4.5A. The protein threshold was set at
90% and the peptide threshold at a 1% false discovery rate.

Strain
Wild Type

Pt Spike c1
Pt Spike c2

Pt Spike2P c1

Pt Spike2P c2

Hs Spike

Sample
Name
W1
W2
W3
W4
W5
3-1
3-2
4-1
4-2
4-3
5-1
5-2
5-3
5-4
6-1
6-2
6-3
8-1
8-2
8-3
8-4

Unique Peptide
Hits
0
0
0
0
0
0
0
0
2
4
0
0
3
4
0
3
6
7
9
11
11

Protein Identification
Probability
NA
NA
NA
NA
NA
NA
NA
NA
100%
100%
NA
NA
100%
100%
NA
100%
100%
100%
100%
100%
100%

Percent Sequence
Coverage
NA
NA
NA
NA
NA
NA
NA
NA
1.49%
2.83%
NA
NA
2.20%
2.83%
NA
2.20%
4.10%
5.73%
7.46%
8.33%
7.62%
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Table 4.3: Expression of the RBD gene from plasmids measured by RNAseq analysis. Reads were mapped to the
P. tricornutum genome and appropriate RBD expression plasmid and TPM (Transcripts Per Kilobase Million) values
were calculated for the Actin16, HIS4, NrsR, and RBD genes. Wild type reads mapped to each plasmid independently
gave identical TPM values for the HIS4, NrsR, and RBD genes. WT, wild type; RBD, receptor-binding domain;
Actin16, P. tricornutum Actin16 gene; HIS4, P. tricornutum HIS4 (PtPRA-PH/CH) gene; NrsR, nourseothricin resistance gene; Hs, human codon-optimized gene construct, Pt, P. tricornutum codon-optimized gene construct; c, refers
to clone number.

Strain
WT

Gene
RBD
HIS4
NrsR
Actin16
Pt RBD c14 RBD
HIS4
NrsR
Actin16
Pt RBD c17 RBD
HIS4
NrsR
Actin16
Hs RBD
RBD
HIS4
NrsR
Actin16

TPM
0
1.1
0
4.88
60.5
9.92
119
13.2
79.6
10.8
44.2
6.68
30.8
4.93
39.8
10.0
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and plasmid-encoded HIS4 genes in all RBD expression strains. No expression of the RBD was
detected in wild-type cells. As the HIS4 gene is an endogenous gene in the P. tricornutum genome
in addition to being encoded on expression plasmids, the reads observed for the HIS4 gene in wild
type are expected.
We then proceeded to analyze RBD expression by Western blotting with an anti-RBD antibody
on whole cell extracts. As shown in Figure 4.6, the RBD could be detected in whole cell extracts
and in the elution from a nickel-based affinity column purification. No RBD protein was detected
in wild-type cells. This result demonstrates expression of the RBD protein from P. tricornutum
strains harbouring the RBD expression plasmid, and enrichment of the 6xHis tagged RBD domain
from whole cell extracts can be achieved by nickel-affinity chromatography.

Figure 4.6: Identification of SARS-CoV-2 spike RBD domain in P. tricornutum expression strains. (Left) Western
blot of whole cell extracts (WCE) before (L) enrichment over a nickel-affinity column (E) for a strain harbouring the
P. tricornutum codon-optimized RBD clone 14 plasmid (Pt RBD c14) and for wild-type cells not harbouring any
plasmid (WT). The (+) lane indicates 5 ng of commercially purified RBD. (Right) Coomassie stained replica of the
gel that was used for Western blotting.

4.4

Discussion

Biological systems like yeast and bacteria are useful protein overexpression systems, but are not
suitable for expression of biopharmaceutical and medical reagent proteins that require proper post-
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translational modifications to be biologically active (18). Mammalian expression systems can address this but are prohibitively expensive to scale and therefore not appropriate for large-scale protein production. Photoautotrophic microalgae, like the model diatom P. tricornutum, can produce
post-translationally modified proteins and be grown at scale rapidly and inexpensively. Thus, they
have the potential to be a more cost-effective biological platform for industrial-scale production
of medically relevant protein reagents. We demonstrate here that the SARS-CoV-2 spike proteins
can be expressed and secreted by P. tricornutum, and show that P. tricornutum-produced SARSCoV-2 spike receptor-binding domain (RBD) proteins are recognized by commercially available
antibodies designed against a mammalian-produced RBD protein. These results suggest the P. tricornutum-produced RBD proteins are likely to be serologically-reactive in commercial test kits.
This expression system used strong constitutive promoters to drive expression of the spike and
RBD domain proteins at laboratory scales (less than 200 ml). However, sustained overexpression
of these proteins at industrial scales may have unforeseen negative effects on culture viability and
protein yield. An inducible expression system, using promoters such as the nitrate-inducible nitrate
reductase promoter (19–21) may be a more stable alternative and should be explored.
Maintenance of the spike protein expression plasmids in P. tricornutum relies on use of an
antibiotic (typically zeocin or nourseothricin). While antibiotic selection is feasible in small-scale
laboratory cultures, the cost of antibiotics in larger scale cultures will be prohibitive for industrialscale production of the spike protein. To overcome this problem, we transformed all spike protein
expression plasmids into a histidine auxotroph strain of P. tricornutum (7). To facilitate this, all
spike expression plasmids included the P. tricornutum HIS4 marker for selection and maintenance
of plasmids in L1 media without the addition of antibiotics. A PCR-based screen revealed that
the RBD gene was intact on the expression plasmids in all RBD expression colonies screened,
confirming that the HIS4 gene is a viable method to stably maintain the RBD expression plasmids
in a P. tricornutum histidine auxotroph strain without the need for antibiotics.
Plasmid stability analyses performed on spike protein expression cultures produced seemingly
conflicting results. While rearrangements were observed in a large proportion of the plasmids recovered from these cultures, the RBD coding region was present and unmutated in a majority of
transformed cells. These results suggest that the rearrangements were random, likely occurring
during conjugation, and not due to active selection against overexpression of the RBD domain.
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Regardless, this result highlights the need for thorough analysis of plasmid stability in P. tricornutum protein overexpression strains, and identification/isolation of transformants with unmutated
plasmids for downstream protein expression.
Mass spectrometry analysis of proteins isolated from expression culture media revealed that
while full-length spike proteins were being expressed and secreted, they were ultimately being
degraded. This is likely occurring via proteolysis, as several peptides derived from predicted proteases were also identified by the mass spectrometry analysis. The cultures that were harvested
for mass spectrometry analysis were in late-log/stationary phase and might have been expressing
proteases as a scavenging mechanism in response to nutrient starvation. Analysis of secreted proteins in cultures in earlier growth stages is needed to investigate this possibility. If proteases are
determined to be an issue in all growth stages it may require the genetic knockout of these secreted proteases in order for stable expression and high yield of the full-length spike protein to be
achieved.
In this study, we have engineered strains of P. tricornutum able to express and secrete SARSCoV-2 spike proteins, and express SARS-CoV-2 spike receptor-binding domain proteins that mimic
commercially available mammalian-produced receptor-binding domain proteins in regards to antiRBD antibody affinity. This system will potentially allow for cost-effective large-scale production
of viral antigens to facilitate widespread serological testing in the fight against the current SARSCoV-2 pandemic. This system can also be rapidly repurposed to address future pandemics and
produce other high-value bioproducts.
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Chapter 5
Discussion
The model marine diatom P. tricornutum is a promising species for biosynthesis of high-value
products including biofuels, omega-3 fatty acids, and biopharmaceuticals. As P. tricornutum is
photoautotrophic and has a relatively fast growth rate, it is able to be grown inexpensively at large
scales. It is a prolific oil producer, being able to accumulate up to 60% dry-cell weight in lipids,
making it an attractive species for biofuel production (1), and due to its high ratios of polyunsaturated fatty acids (PUFAs), it is being explored for omega-3 fatty acid production as well (2).
Additionally, previous studies suggest P. tricornutum is capable of producing proteins with modifications that mimic those made in mammalian cells (3, 4), making it attractive for protein biopharmaceutical production. However, converting P. tricornutum into an ideal organism for biofuel,
food, and pharmaceutical production requires further genetic and biotechnological development of
this species.
Compared to more well-studied microalgae such as C. reinhardtii, P. tricornutum is relatively
undeveloped as a bioproduction strain. As a result, it has limited genetic tools available for genome
editing and synthetic pathway development. Consequently, this thesis focused on the biotechnological development of P. tricornutum to facilitate engineering of this species for industrial production and synthetic biology applications. We accomplished this by generating novel plasmid-based
expression tools, a gene-editing system (5), and valuable strains for P. tricornutum (6). We demonstrated the utility of these tools and strains by engineering P. tricornutum to produce SARS-CoV-2
antigens to aid in the fight against the current global pandemic.
To improve P. tricornutum’s ability to express foreign genes, we identified new endogenous
genetic regulatory elements that could drive expression of exogenous genes. These elements suc-
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cessfully drove expression of antibiotic resistance markers and reporter genes, and were used to
design and assemble a plasmid-based multi-gene biosynthesis pathway that was stably maintained
in P. tricornutum for 160 generations. While we examined pathway stability, expression of the
biosynthetic pathway was not investigated by us, but was to be performed by our collaborators
(5). Examining expression of complex synthetic pathways would aid in understanding how artificial multi-gene pathways driven by endogenous promoters behave in this organism. Additionally,
growth rates and viability of P. tricornutum strains harbouring a desired biosynthetic pathway
should be examined to ensure that the pathway is not toxic or a significant metabolic burden, before moving to industrial scales. Further characterization of expression levels of these promoters
during various growth stages and under different growth conditions should also be performed to
better determine how they behave. This will be critical to understand for the successful design and
implementation of future biosynthetic pathways.
To enable precise genome modifications we designed a stably replicating plasmid-based Cas9
gene-editing system for P. tricornutum. This system was used to successfully knock out the P. tricornutum urease gene and we demonstrated that edited strains could be easily cured of the Cas9
expression plasmid by culturing in the absence of antibiotic selection. Previous Cas9 editing systems relied on genomic integration of the expression construct (7–9), causing prolonged exposure
to the nuclease and potentially increasing the risk of off-target cleavage effects. We predict the
ability to cure our Cas9 editing system likely decreases the risk of off-target cleavage. A recent
study has shown that replicating plasmid-based Cas9 editing systems did not produce mutations at
predicted off-target sites (10), supporting our prediction.
Transformation and maintenance of episomal expression constructs in P. tricornutum is currently achieved using antibiotics that are prohibitively expensive for growing cultures large enough
for industrial-scale chemical or protein production (11). To address this, we created auxotrophic
P. tricornutum mutants using our Cas9 gene-editing system by knocking out key enzymes in the
uracil and histidine biosynthesis pathways. We demonstrated that intact, plasmid-encoded versions
of these genes could complement the auxotrophic phenotypes and be used as selective markers for
transformation and maintenance of plasmids in these strains. Although these selection systems
function robustly, further biological characterization of the auxotrophic strains and how their complementation markers function to maintain large biosynthetic pathways should be performed to
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properly evaluate their utility as production strains. Generation of additional auxotrophic strains
may also be beneficial, as different auxotrophs may grow more robustly when complemented, or
be more suitable to certain biosynthesis applications than those described here.
We observed large deletions generated by Cas9 editing when creating the knockout strains
described in chapters 2 and 3. These observations add to a body of evidence that Cas9 editing promotes large deletions which largely go unobserved due to the nature of the screens for Cas9 editing
that are commonly used (7, 12, 13). For example, the Surveyor and T7EI assays are commonly
used screens for editing which use endonucleases that cleave at mismatched DNA bases in DNA
heteroduplexes (14). The substrate DNA for these assays are double-stranded DNA molecules
generated by PCR amplifying a ∼500 bp region centered around the Cas9 target site from edited
and untreated cells, which are then hybridized together. Thus, the assays are only able to examine
repair outcomes localized around the editing site. The long-range PCR and Nanopore long-read
sequencing methods employed to screen for Cas9 editing events in this study were shown to be
good alternatives to the traditional screening methods (15), and can be applied to identify large
deletions generated by Cas9 editing in other biological systems. Our results are further supported
by a recent study which used both long-range PCR and PacBio long-read sequencing to detect
large deletions generated by Cas9 in mammalian cells (16). The large deletions detected here
suggest that Cas9 editing with a single sgRNA in P. tricornutum could achieve the same result as
paired Cas9 nickases that are designed to introduce large deletions (17), and may be an alternative
to recently developed methods to multiplex sgRNAs on Cas9-editing plasmids for P. tricornutum
(18).
To demonstrate the utility of the tools and strains described in chapters 2 and 3, we engineered a
P. tricornutum strain that expresses the SARS-CoV-2 full-length spike and spike receptor-binding
domain (RBD) antigens. These strains were designed to secrete antigens into the media, and
while mass spectrometry confirmed full-length spike protein presence in culture supernatants, it appeared to be heavily degraded. The presence of proteases detected in culture supernatants suggests
successful purification of secreted spike proteins may require creating secreted-protease-deficient
P. tricornutum strains. We observed that the RBD antigen was robustly expressed intracellularly
and could be purified by nickel-affinity chromatography. P. tricornutum-produced RBD proteins
were also recognized by anti-RBD antibodies developed against an RBD antigen produced in hu-
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man cells. This suggests they may be serologically-reactive, a requirement for use in serological
tests. Further analysis of the RBD expression strains is required to determine if the antigen is being
secreted and whether secreted RBD protein is recognized by antibodies produced in humans in response to SARS-CoV-2 infection. The RBD domain possesses two sites which undergo N-linked
glycosylation in human cells (19). These may be differentially modified in P. tricornutum with unknown effects on antibody affinity, although previous studies suggest P. tricornutum may perform
glycosylation similarly to mammalian systems (3, 4, 20, 21). Currently, SARS-CoV-2 antigens are
being produced in mammalian and insect cell culture systems which are prohibitively expensive
to scale for large-scale antigen production. P. tricornutum cultures are much cheaper to maintain
and can easily be grown in industrial scales at a substantially lower cost than would be required
for mammalian or insect cultures. If this system proves to produce serologically-reactive SARSCoV-2 proteins, it will be an efficient and cost-effective method to produce antigens for serological
tests. This system can also be rapidly adapted to address future pandemics and could be used to
produce functional human therapeutics.
The tools and strains described here have many benefits for the future of this field. Only a
small number of secretion signal peptides have been applied for transgenic protein production
in P. tricornutum (4, 22), and to date no study has been published comparing the efficiency of
secretion signal peptides for promoting the secretion of transgenic proteins from P. tricornutum into
the growth media. The replicating-plasmids and tools developed here will enable rapid screening,
not only of signal peptides, but of many genetic elements to further characterize the biology of this
organism and expand its utility as a biosynthesis platform.
Efficient production of exogenous proteins in P. tricornutum may be hampered by a number of
endogenous proteins produced by this species. For example, P. tricornutum abundantly secretes a
number of proteins into the growth media (22), and produces proteases that may target transgenic
proteins and reduce product yields (23, 24). The tools developed here will allow for knockout of
these endogenous proteins and proteases to create strains that would enhance stability and simplify
the downstream purification of secreted transgenic proteins.
The auxotrophs and complementation systems developed here eliminate the need for expensive antibiotics typically used for selection of transgenic P. tricornutum strains. Utilizing these
auxotrophic strains for large-scale production would lower the input costs of protein and chemical
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biosynthesis in this species, and open up a wide range of production applications to P. tricornutum
that were previously not economically viable. Although P. tricornutum has Generally Recognized
As Safe (GRAS) status, it is a photoautotroph which makes biocontainment an issue for certain laboratory and industrial applications of this species. We have shown that the auxotrophs described
here do not survive in the absence of supplementation with uracil or histidine. Performing research
in these auxotrophic backgrounds would allow for biocontainment of any transgenic P. tricornutum
strains created. This will potentially enable research on hazardous chemical and protein products
to be performed in P. tricornutum that would previously have not been possible.
This study is the first report of i) an episomal Cas9 gene-editing system for P. tricornutum,
and ii) the selection and maintenance of episomal vectors in auxotrophic P. tricornutum strains
using plasmid-encoded complementation markers. These genetic tools and strains will enable
more rapid and more advanced engineering of P. tricornutum for protein and chemical biosynthesis
applications, and will further the study of diatom biology.
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B.1
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Figure B.1: Flow chart of two-plasmid propagation experimental design.

134

B.2

Supplemental Tables

Table B.1: Assaying promoters and terminators in P. tricornutum. Values listed for each replicate represent total
exconjugants (calculated by counting surviving colonies after plating 5% of total scraped cells and multiplying by 20.

Promoter
Terminator
EF1α
40SRPS8
H4-1B
γ-Tubulin
RBCMT
FcpB
FcpC
FcpD
EF1α Term
40SRPS8 Term
H4-1B Term
γ-Tubulin Term
RBCMT Term
FcpB Term
FcpC Term
FcpD Term
FcpF (+ve)
Mock conj. (-)

Pt colonies per conjugation
Rep. 1 Rep. 2 Rep. 3 Average
2000
2880
4000
180
2500
1560
440
4100
3000
3320
3000
1640
3060
3300
3100
2760
1980
0

1760
3100
3020
120
1720
1620
320
3680
2420
2840
2360
1640
3020
3140
2420
2180
2160
0

2020
3360
3600
120
1400
1820
320
3220
2720
2180
2740
1280
2840
2240
2460
2780
1840
0

1927
3113
3540
140
1873
1667
360
3667
2713
2780
2700
1520
2973
2893
2660
2573
1993
0

Standard Error of
the Mean
84
139
284
20
327
79
40
254
167
330
186
120
68
330
220
197
92
0
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Table B.2: Two-plasmid propagation in P. tricornutum. Plasmids p0521s and pPtGE31 were sequentially conjugated into P. tricornutum

P. tricornutum strain

Pt + p0521s clone 1
Pt + p0521s clone 2
Pt + p0521s clone 3
Pt + p0521s clone 4
Pt + p0521s clone 5
Pt + p0521s clone 1, pPtGE31
clone 1 (c1.1)
Pt + p0521s clone 1, pPtGE31
clone 2 (c1.2)
Pt + p0521s clone 1, pPtGE31
clone 3 (c1.3)
Pt + p0521s clone 1, pPtGE31
clone 4 (c1.4)
Pt + p0521s clone 1, pPtGE31
clone 5 (c1.5)
Pt + p0521s clone 4, pPtGE31
clone 1 (c4.1)
Pt + p0521s clone 4, pPtGE31
clone 2 (c4.2)
Pt + p0521s clone 4, pPtGE31
clone 3 (c4.3)
Pt + p0521s clone 4, pPtGE31
clone 4 (c4.4)
Pt + p0521s clone 4, pPtGE31
clone 5 (c4.5)

Plasmid rescue
(Number of E. coli
colonies obtained)

Number of E. coli colonies
from which correct
plasmids were isolated
based on I-CeuI digest
and multiplex PCR screen

Ratio of p0521s to pPtGE31
isolated from P.
tricornutum clone

113
0
0
149
84

3/3
0
0
3/3
2/3

Not applicable
Not applicable
Not applicable
Not applicable
Not applicable

44

20/20

14:6

55

Not determined

Not determined

29

Not determined

Not determined

29

Not determined

Not determined

47

Not determined

Not determined

72

20/20

15:5

68

Not determined

Not determined

48

Not determined

Not determined

128

Not determined

Not determined

155

Not determined

Not determined

Table B.3: Vanillin biosynthesis plasmid assembly, propagation and recovery.
Four E. coli colonies with correctly assembled pathway plasmid
were identified.
Each correct plasmid was conjugated to P. tricornutum, and for
each two colonies were isolated for further analysis
After 40 days of propagation, DNA was extracted from P.
tricornutum cells and transformed into E. coli. Number of E. coli
colonies obtained are listed.
Number of correct colonies as confirmed by MPX PCR and
diagnostic digest over the number of colonies tested.
After an additional 80 days (total 120) of propagation DNA was
extracted again from the same P. tricornutum cultures and
transformed into E. coli. Number of E. coli colonies obtained are
listed.
Number of correct colonies as confirmed by MPX PCR and
diagnostic digest over the number of colonies tested.

V1

V7

V3

V4

c1

c2

c1

c2

c1

c2

c1

c2

1

3

3

1

0

3

3

0

*1/1

0/3

0/3

0/1

0

*3/3

0/3

0

700

not
tested

33

0

0

44

not
tested

0

0/3

0

0

*3/3

*3/3

0
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Table B.4: Vanillin biosynthesis construct (p0521s-V) sequence analysis. Constructs were fully sequenced after
initial assembly (V1.0 and V3.0) and after 40 days (V1.1 and V3.1) and 120 days (V1.4 and V3.4) of serial passage in
P. tricornutum.
Ref
Pos

Ref
base

V10

V11

V14

V30

V31

V34

Type

Description

Feature affected

Effect

Backbone

Unknown

FcpF Promoter

Unknown

phenylalanine
ammonia lyase
(PAL)

Silent
mutation
(R127)

trans-cinnamate 4hydroxylase (C4H)

Frameshift

H4-1B Terminator

Unknown

H4-1B Terminator

Unknown

H4-1B Terminator

Unknown

H4-1B Terminator

Unknown

H4-1B Terminator

Unknown

H4-1B Terminator

Unknown

H4-1B Terminator

Unknown

H4-1B Terminator

Unknown

H4-1B Terminator

Unknown

H4-1B Terminator

Unknown

40SRPS8 Terminator

Unknown

URA3 region
(downstream of
URA3 ORF)

Unknown

4-hydroxycinnamoyl
CoA ligase (4CL)

Frameshift

EF1α Terminator

Unknown

FcpD Promoter

Unknown

vanillin synthase
(VAN)

A355T

6165
[+1]

-

172
bp

-

-

-

-

-

Indel

V10 has a 172 bp insertion after position 6165. The area
consists of repeats of ”TCTGGGCCCACTGTTCCACTT
GTATCGTCGGTCTGATAATCAG” and the 172 bp insertion
corresponds to 4 additional repeats of this sequence.
Therefore, it is likely a sequencing contig assembly error.
Sequence coverage for V10 in this area is low but high in the
adjacent regions. Sequence coverage in this area for V11 and
V14 is high.

9713
9714
9715
9716

G
A
C
A

G
A
C
A

-

-

G
A
C
A

G
A
C
A

G
A
C
A

Indel
Indel
Indel
Indel

V11 and V14 have a 4 bp deletion of positions 9713-9716.
Sequence coverage at these positions is high for all
assemblies.

11929

G

G

G

G

A

A

A

SNP

15326

A

-

A

-

A

A

A

Indel

15327

A

-

A

-

A

A

A

Indel

15372

A

A

A

A

C

C

C

SNP

15377

T

T

T

T

C

C

C

SNP

15464

T

T

T

T

C

C

C

SNP

15514
[+1]

-

-

-

-

G

G

G

Indel

15518

A

A

A

A

-

-

-

Indel

15519

A

A

A

A

G

G

G

SNP

15535

T

T

T

T

G

G

G

SNP

15540

G

G

G

G

T

T

T

SNP

15681

G

G

G

G

A

A

A

SNP

15880

A

A

A

A

C

C

C

SNP

20222
[+1]

-

-

-

-

A

A

A

Indel

22507

C

C

-

-

C

C

C

Indel

22508

C

C

-

-

C

C

C

Indel

25525
[+1]

-

-

-

-

-

G

G

Indel

26903
[+1]

-

-

-

-

T

T

T

Indel

27500

G

A

A

A

G

G

G

SNP

29768

G

G

G

G

G

A

A

SNP

V30, V31, and V34 have a G to A transition at position
11929. This results in a silent mutation at R127 in the
phenylalanine ammonia lyase (PAL) enzyme in the
metabolic pathway. Sequence coverage at this position is
high for all assemblies.
V10 and V14 have a 2 bp deletion of positions 15326-15327.
This causes a frameshift in the coding region of the trans
cinnamate 4-hydroxylase (C4H) enzyme (505 a.a) of the
metabolic pathway resulting in a normal protein from
residues 1-503, followed by 14 new residues and a stop
codon. Sequencing coverage for V10 and V14 is very high
in this area. However, sequence coverage for V11 is 0 at
these positions and very poor in the surrounding area.
Therefore, it is likely that V11 also contains the deletion.
V30, V31, and V34 have an A to C transversion at position
15372. Sequence coverage at this position is high for all
assemblies.
V30, V31, and V34 have a T to C transition at position
15377. Sequence coverage at this position is high for all
assemblies.
V30, V31, and V34 have a T to C transition at position
15464. Sequence coverage at this position is high for all
assemblies.
V30, V31, and V34 have a 1 bp G insertion after position
15514. Sequence coverage at this position is high for all
assemblies.
V30, V31, and V34 have a 1 bp deletion of position 15518.
Sequence coverage at this position is high for all assemblies.
V30, V31, and V34 have an A to G transition at position
15519. Sequence coverage at this position is high for all
assemblies.
V30, V31, and V34 have a T to G transversion at position
15535. Sequence coverage at this position is high for all
assemblies.
V30, V31, and V34 have a G to T transversion at position
15540. Sequence coverage at this position is high for all
assemblies.
V30, V31, and V34 have a G to A transition at position
15681. Sequence coverage at this position is high for all
assemblies.
V30, V31, and V34 have an A to C transversion at position
15880. Sequence coverage at this position is high for all
assemblies.
V30, V31, and V34 have a 1 bp A insertion after position
20222. Sequence coverage at this position is high for all
assemblies.
V11 and V14 have a 2 bp deletion of positions 22507-22508.
Sequence coverage at these positions is high for all
assemblies.
V31 and V34 have a 1 bp G insertion after position 25525.
This causes a frameshift in position 812 of the coding region
of the 4-hydroxycinnamoyl-CoA ligase (4CL) enzyme (566
a.a) in the metabolic pathway resulting in a normal protein
from residues 1-271, followed by 14 residue substitutions
and a premature stop codon which removes the last 281
residues. Sequence coverage is very high in this region and
there is no ambiguity.
V30, V31, and V34 have a 1 bp T insertion after position
26903. Sequence coverage at this position is high for all
assemblies.
V10, V11, and V14 have an G to A transition at position
27500. Sequence coverage at these positions is high for all
assemblies.
V31 and V34 have a G to A transition at position 29768. This
results in a A355T mutation in the vanillin synthase (VAN)
enzyme (356 a.a) of the metabolic pathway. Sequence
coverage at this position is high for all assemblies.
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29805
[+1]
30051
[+1]

-

-

-

-

-

T

T

Indel

-

-

-

-

-

C

C

Indel

30052

G

G

G

G

G

C

C

SNP

30055

C

C

C

C

C

-

-

Indel

30056

A

A

A

A

A

T

T

SNP

33150
[+1]

-

-

A

A

-

-

-

Indel

33175
[+1]

-

-

-

-

-

A

A

Indel

V31 and V34 have a 1 bp T insertion after position 29805.
Sequence coverage at this position is high for all assemblies.
V31 and V34 have a 1 bp C insertion after position 30051.
Sequence coverage at this position is high for all assemblies.
V31 and V34 have a G to C transversion at position 30052.
Sequence coverage at this position is high for all assemblies.
V31 and V34 have a 1 bp deletion at position 30055.
Sequence coverage at this position is high for all assemblies.
V31 and V34 have an A to T transversion at position 30056.
Sequence coverage at this position is high for all assemblies.
V11 and V14 have a 1 bp A insertion after position 33150.
Sequence coverage at this position is high for all assemblies.
V31 and V34 have a 1 bp A insertion after position
33175.Sequence coverage at this position is high for all
assemblies.

FcpD Terminator

Unknown

FcpD Terminator

Unknown

FcpD Terminator

Unknown

FcpD Terminator

Unknown

FcpD Terminator

Unknown

Backbone

Unknown

Backbone

Unknown

Table B.5: List of oligonucleotides used in this study.
Name

Sequence (50 to 30 )

Description

DE2675
DE2676
DE2677
DE2678
DE2681
DE2682
DE2683
DE2684
DE2687
DE2688
DE2689
DE2690
DE2691
DE2692
DE2693

AAATTAACCCTCACTAAAGGGAACAAAAGCTGGTACCTAACGAAACGAATAGAAGCTCCC
GTGAGCACCGGAACGGCACTGGTCAACTTGGCCATGATTACGTGATATTATACGATACAA
GAAATTAACCCTCACTAAAGGGAACAAAAGCTGGTACCTAACCCTGCGATAGACCTTTTC
GGTGAGCACCGGAACGGCACTGGTCAACTTGGCCATGGTATTCTATTCTCTGATTCCTTC
CGAAATTAACCCTCACTAAAGGGAACAAAAGCTGGTACCTAACGTCGGTCTCTTTCCCGG
CGCGGTGAGCACCGGAACGGCACTGGTCAACTTGGCCATGTTGGCTGTTGTTTGTTTTCG
TAACCCTCACTAAAGGGAACAAAAGCTGGTACCTAATTCGTTGATATTTTTATTCAAATG
GCGCGGTGAGCACCGGAACGGCACTGGTCAACTTGGCCATATTGCAAGTAGAAGCGCAGC
ATTAACCCTCACTAAAGGGAACAAAAGCTGGTACCTAAACACGGAGGATCTATCTACAGC
GTGAGCACCGGAACGGCACTGGTCAACTTGGCCATGGTAGGATCACGAAGAGATACTTTG
ATTAACCCTCACTAAAGGGAACAAAAGCTGGTACCTAAGAAACATACCTTCAGCGTCGTC
CGCGCGGTGAGCACCGGAACGGCACTGGTCAACTTGGCCATCTTGACTTCTGGCAACCGC
AATTAACCCTCACTAAAGGGAACAAAAGCTGGTACCTAAGAGCACAAGAGGTGACAAAAG
GTGAGCACCGGAACGGCACTGGTCAACTTGGCCATTTTGTCGAAATGTATATATGTGTTG
TTAACCCTCACTAAAGGGAACAAAAGCTGGTACCTAAACTAGCTTGATTGGGATATCTCG
CGGCAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGAATGCGGGAGTGGACCGCGACG
ATCCGTCCG
TATTAAAAAATTTAAATTATAATTATTTTTATAGCACGTGAAGCAGTCGAAAATTCTTACCCAA
ACTTAG
CGGCAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGAAGATAAGAATATCTCATTGTGA
ACATCTAA
TATTAAAAAATTTAAATTATAATTATTTTTATAGCACGTGGGGGTGGATAAAGAAGAAAGGGG
TAGGGGT
CGGCAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGAGCTTGCGCTTGATCCTCGACTTT
GTTGCTC
TATTAAAAAATTTAAATTATAATTATTTTTATAGCACGTGAGCCGATTAGCAACAGAGAATGAA
GCCAAC
CGGCAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGAAGCAAACTCATTATGATGCATG
GGAGTGCG
TATTAAAAAATTTAAATTATAATTATTTTTATAGCACGTGAATGGCGATGACTTACGAGGAGG
GCGACCA
CGGCAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGAAAATACAAATTCATGTACCTAA
ACGATAGT
TATTAAAAAATTTAAATTATAATTATTTTTATAGCACGTGGGCACTACCGGTACGCCCAACACG
ATCCAA
CGGCAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGATTTACTTGCTGGGTAGGCCGTTT
CTGGAAT
TATTAAAAAATTTAAATTATAATTATTTTTATAGCACGTGCACCTTTGGCAATTCGAATTTGTTT
GATAG
CGGCAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGATTTTGTTACATTTACTGACTTCA
AGGAGTC
TATTAAAAAATTTAAATTATAATTATTTTTATAGCACGTGATTGCAGCTTGTTGCAGAAGGATG
TAGGCTC
CGGCAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGATTTTGTTACATTTACTGACTTCA
AGGAGTC
TATTAAAAAATTTAAATTATAATTATTTTTATAGCACGTGGACGTTTTCACTCTCGAGCACAGGT
TTTTT
GACGACTTCGCCGGTGTGGTCCGGGACGACGTGACCCTGTTCATCAGCGCGGTCCAGGAGTAC
GTACGCGTAACATATTG
TACAGCTCGTCCAGGCCGCGCACCCACACCCAGGCCAGGGTGTTGTCCGGCACCACCTGGCTG
ATTGTGGAATCAAAGAA
ACTTCGCCGGTGTGGTCCGGGACGACGTGACCCTGTTCATCAGCGCGGTCCAGGAGTACGTTT
TGTTGTGGTCTATTGAC
CTCGTCCAGGCCGCGCACCCACACCCAGGCCAGGGTGTTGTCCGGCACCACCTGGCTTCAAGA
TGACAAAAAGCGTCAGA
ACTTCGCCGGTGTGGTCCGGGACGACGTGACCCTGTTCATCAGCGCGGTCCAGGAGTAAGAA
TACTCATTCTTCGTCAAT
CTCGTCCAGGCCGCGCACCCACACCCAGGCCAGGGTGTTGTCCGGCACCACCTGGCTATTAAA
GGAGAAAAAGAATCAAC
ACTTCGCCGGTGTGGTCCGGGACGACGTGACCCTGTTCATCAGCGCGGTCCAGGAGTAAGACT
CTGCAGGCTCCACGTGA
CTCGTCCAGGCCGCGCACCCACACCCAGGCCAGGGTGTTGTCCGGCACCACCTGGCTAACAAG
GATCAACAACAGGGAAG
AATCGAAAAATTAACCAAGTCGACGGTATCGATAATATTCTAGCTGAGGGTACCCATGGGTAC
GTACGCGTAACATATTG
ACTCGACCGCTCCGGCGACGTCGCGCGCGGTGAGCACCGGAACGGCACTGGTCAACTTGGCT
GATTGTGGAATCAAAGAA

Forward EF1α Promoter with pPtPuc3 homology
Reverse EF1α Promoter with Sh ble homology
Forward 40SRPS8 Promoter with PtPuc3 homology
Reverse 40SRPS8 Promoter with Sh ble homology
Forward H4-1B Promoter with PtPuc3 homology
Reverse H4-1B Promoter with Sh ble homology
Forward γ-Tubulin Promoter with PtPuc3 homology
Reverse γ-Tubulin Promoter with Sh ble homology
Forward RBCMT Promoter with PtPuc3 homology
Reverse RBCMT Promoter with Sh ble homology
Forward FcpB Promoter with PtPuc3 homology
Reverse FcpB Promoter with Sh ble homology
Forward FcpC Promoter with PtPuc3 homology
Reverse FcpC Promoter with Sh ble homology (for FcpD also)
Forward FcpD Promoter with PtPuc3 homology

D9 F
D9 R
D18 F
D18 R
D14 Falt
D14 Ralt
D13 F
D13 R
D16 F
D16 R
D10 F
D10 R
D11 F
D11 R
D12 F
D12 R
DE2580
DE2581
DE2534
DE2535
DE2536
DE2537
DE2538
DE2539
DE2582
DE2583

Forward EF1α Terminator with Sh ble homology
Reverse EF1α Terminator with pPtPuc3 homology
Forward 40SRPS Terminator with Sh ble homology
Reverse 40RPS Terminator with pPtPuc3 homology
Forward H4-1B Terminator with Sh ble homology
Reverse H4-1B Terminator with pPtPuc3 homology
Forward γ-Tubulin Terminator with Sh ble homology
Reverse γ-Tubulin Terminator with pPtPuc3 homology
Forward RBCMT Terminator with Sh ble homology
Reverse RBCMT Terminator with pPtPuc3 homology
Forward FcpB Terminator with Sh ble homology
Reverse FcpB Terminator with pPtPuc3 homology
Forward FcpC Terminator with Sh ble homology
Reverse FcpC Terminator with pPtPuc3 homology
Forward FcpD Terminator with Sh ble homology
Reverse FcpD Terminator with pPtPuc3 homology
Forward FBAC2-1 intron with Sh ble homology (SexAI)
Reverse FBAC2-1 intron with Sh ble homology (SexAI)
Forward EIF6-1 intron with Sh ble homology (SexAI)
Reverse EIF6-1 intron with Sh ble homology (SexAI)
Forward RPS4-1 intron with Sh ble homology (SexAI)
Reverse RPS4-1 intron with Sh ble homology (SexAI)
Forward TUFA-1 intron with Sh ble homology (SexAI)
Reverse TUFA-1 intron with Sh ble homology (SexAI)
Forward FBAC2-1 intron with Sh ble homology (MscI)
Reverse FBAC2-1 intron with Sh ble homology (MscI)
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DE3214
DE3215
DE3216
DE3217
DE2614
DE2615
DE3526
DE3527
DE3528

GAAAAATTAACCAAGTCGACGGTATCGATAATATTCTAGCTGAGGGTACCCATGGGTACGTTT
TGTTGTGGTCTATTGAC
ACCGCTCCGGCGACGTCGCGCGCGGTGAGCACCGGAACGGCACTGGTCAACTTGGCTTCAAG
ATGACAAAAAGCGTCAGA
GAAAAATTAACCAAGTCGACGGTATCGATAATATTCTAGCTGAGGGTACCCATGGGTAAGAAT
ACTCATTCTTCGTCAAT
ACCGCTCCGGCGACGTCGCGCGCGGTGAGCACCGGAACGGCACTGGTCAACTTGGCTATTAA
AGGAGAAAAAGAATCAAC
GAAAAATTAACCAAGTCGACGGTATCGATAATATTCTAGCTGAGGGTACCCATGGGTAAGACT
CTGCAGGCTCCACGTGA
ACCGCTCCGGCGACGTCGCGCGCGGTGAGCACCGGAACGGCACTGGTCAACTTGGCTAACAA
GGATCAACAACAGGGAAG
GTTTCACAGTCAGGAATAACACTAGCTCGTCTTCACGTAACTATAACGGTCCTAACGTCGGTCT
CTTTCCCGGGAAACGG
AACTAGTGGTGGTGGTGGTGGTGCACAGCCTAGGCACTCGTGGTGGTGGTGGTGGTGCATGT
TGGCTGTTGTTTGTTTTC
CTCTCGGCTACAACCGACAAAAGTCTTTACAGTCAATACCGAAAACAAACAACAGCCAACATGC
ACCACCACCACCACCA
TGTATATAATCGTTCCAAGGTTTTAAAGACGAGCAACAAAGTCGAGGATCAAGCGCAAGCTTA
ACAGTTCCTTGGTTTCA
CAATTCAGCTTGCACATCCTTAACCACTCCATAATCGTTATGAAACCAAGGAACTGTTAAGCTTG
CGCTTGATCCTCGAC
ATACTTCTCACCCCTTTGTTTTCTTGGACTGCGTGAGTTTGGAAAAGGTCTATCGCAGGGAGCC
GATTAGCAACAGAGAA
TCACTACATATAGATCCTTCACGGAGAAAAGTTGGCTTCATTCTCTGTTGCTAATCGGCTCCCTG
CGATAGACCTTTTCC
GTTCAGCGGGTCGCTCTCCACGATGGCGCCGTTGCCCGCGTGGTGGTGGTGGTGGTGCATGG
TATTCTATTCTCTGATTC
TCGTCGTCGCAATTGTCGTTGCGTTGATCTTGCACCGAAGGAATCAGAGAATAGAATACCATG
CACCACCACCACCACCA
CTGTAAACAAAGAATAAAATTGGTAAATCATTAGATGTTCACAATGAGATATTCTTATCTTTAC
ATATCGTAAGGCACGC
GCGGTTGCAACGCCTCGGTTGCCTTCGGATCTGTACAAACGCGTGCCTTACGATATGTAAAGA
TAAGAATATCTCATTGT
ATCCTTGAAGCTGTCCCTGATGGTCGTCATCTACCTGCCTGGACAGCATGGCCTGCAACGGGG
GTGGATAAAGAAGAAAG
CCCTGAGCCATCCTCCCCACTCAGGAGATGACCCCTACCCCTTTCTTCTTTATCCACCCCCGTTGC
AGGCCATGCTGTCC
CCGAAACCACCATGAACCTCCCAAACAACACCCGACCTCGGGGAGCTTCTATTCGTTTCGCGAT
GAAACGAGAGAGGATG
GTAACCGGGCATGTTCATCATCAGTAACCCGTATCGTGAGCATCCTCTCTCGTTTCATCGCGAA
ACGAATAGAAGCTCCC
AGTGATTGGTGTCTCGGTGGCAGGCCGGACCATGGTGGAATCTCTGATGTTAATTTTCATGATT
ACGTGATATTATACGA
TAGTAGAGAAACTTCCATCGGATCGTATCATAATATTGTATCGTATAATATCACGTAATCATGA
AAATTAACATCAGAGA
GCCCCTGTGATAGCACCTAGTATTGTTTTCCGGACGGATCGTCGCGGTCCACTCCCGCATTCAT
AGTCTTGAAGAAACAG
AAGATATTGAGAAAGGAACTAAAGAGAATTCTTACAAACTCTGTTTCTTCAAGACTATGAATGC
GGGAGTGGACCGCGAC
AAGTACCCTAAAAGACATAGCACGCGACAAGCACGAGCGAGATATCCCAATCAAGCTAGTAA
GCAGTCGAAAATTCTTAC
AGTTTAAAGTAGGTGTATCTACAAACGGTCCTAAGTTTGGGTAAGAATTTTCGACTGCTTACTA
GCTTGATTGGGATATC
CTCCTCGTCCACGTCCTTGGATCCATTTTGCTGCTGTTGGTGCTCCACCCATGTAGCCATTTTGT
CGAAATGTATATATG
AGTCCTCCCTCATAATCTCTGTTAGAGTTTACCAACAACACATATATACATTTCGACAAAATGGC
TACATGGGTGGAGCA
TCCTGGAAACGACGGCAGTATCGATTCCTCGACTCCTTGAAGTCAGTAAATGTAACAAAACTA
GTGGTGGTGGTGGTGGT
ACATGCACCACCACCACCACCACGAGTGCctaGGCTGTGCACCACCACCACCACCACTAGTTTTG
TTACATTTACTGACT
ATCGCTATAATGACCCCGAAGCAGGGTTATGCAGCGGAAGATCTATATTACCCTGTTATGACGT
TTTCACTCTCGAGCAC
CAAGTTGACCAGTGCCGTTC
GGACACGACCTCCGACCAC
ACTGGATGGGTCCTTCACC
CAGGGCATGCTCATGTAGAG
AGGCAAAGCGTGGTGTTCTTA
TCTGGGGAGCCTCAGTCAATA
tcgaGGTATCGTTAAGGCCGATGT
aaacACATCGGCCTTAACGATACC
tcgaTGGTATCGTTAAGGCCGATG

DE3529

aaacCATCGGCCTTAACGATACCA

DE3530

tcgaATGACGTACGCACGCCCCTT

DE3531
DE3532
DE3533
DE3713
DE3712
DE3714
DE3715
MPX 1F
MPX 1R
MPX 2F
MPX 2R
MPX 3F
MPX 3R
MPX 4F
MPX 4R

aaacAAGGGGCGTGCGTACGTCAT
tcgaCCGGAAATGATCGTCAAGGG
aaacCCCTTGACGATCATTTCCGG
CAGTGCCCCCTCCAAACAT
CAAGGCGTTGTCCTTCGAC
TAGTCAAGCCATGGGCCG
CGTTCCAGACCATGTCTTTCTT
TCGTAGCGCTGTGAAGGTTA
GAATCGCTGTTGGTTGCAG
GCAGTTGCTGCCAATCACTA
GTGCCCCTAGCTTCTTCACA
AGGGACTAAACCGGAGGAGA
TCAATCTCGTGCTCATATTCAA
GCTCTGGACCGATGAGTTG
CACTAGGGGTATGGAATCTGG

DE2540
DE2541
DE2542
DE2543
DE2544
DE2545
D49 F
D49-R
D67 F
D67 R
D68 F
D68 R
D69 F
D69 R
D70 F
D70 R
D71 F
D71 R
D72 F
D72 R
D73 F
D73 R
D74 F
D74 R
D75 F
D75 R
D76 F
D76 R
D77 F
D77 R
D50 F
D50-R

Forward EIF6-1 intron with Sh ble homology (MscI)
Reverse EIF6-1 intron with Sh ble homology (MscI)
Forward RPS4-1 intron with Sh ble homology (MscI)
Reverse RPS4-1 intron with Sh ble homology (MscI)
Forward TUFA-1 intron with Sh ble homology (MscI)
Reverse TUFA-1 intron with Sh ble homology (MscI)
Forward H4-1B Promoter with p0521s homology
Reverse H4-1B Promoter with PAL homology
Forward PAL-2A-C4H with H4-1B Promoter homology
Reverse PAL-2A-C4H with H4-1B Terminator homology
Forward H4-1B Terminator with PAL-2A-C4H homology
Reverse H4-1B Terminator with 40SRPS8 Promoter homology
Forward 40SRPS8 Promoter with H4-1B Terminator homology
Reverse 40SRPS8 Promoter with TAL-2A-C3H homology
Forward TAL-2A-C3H with 40SRPS8 Promoter homology
Reverse TAL-2A-C3H with 40SRPS8 Terminator homology
Forward 40SRPS8 Terminator with TAL-2A-C3H homology
Reverse 40SRPS8 Terminator with URA3 homology
Forward URA3 with 40SRPS8 Terminator homology
Reverse URA3 with EF1α Promoter homology
Forward EF1α Promoter with URA3 homology
Reverse EF1α Promoter with HCT-2A-4CL homology
Forward HCT-2A-4CL with EF1α Promoter homology
Reverse HCT-2A-4CL with EF1α Terminator homology
Forward EF1α Terminator with HCT-2A-4CL homology
Reverse EF1α Terminator with FcpD Promoter homology
Forward FcpD Promoter with EF1α Terminator homology
Reverse FcpD Promoter with COMT-2A-VAN homology
Forward COMT-2A-VAN with FcpD Promoter homology
Reverse COMT-2A-VAN with FcpD Terminator homology
Forward FcpD Terminator with COMT-2A-VAN homology
Reverse FcpD Terminator with p0521s homology
Forward Sh ble qPCR and MPX PCR screening primer
Reverse Sh ble qPCR and MPX PCR screening primer
Forward nat qPCR and MPX PCR screening primer
Reverse nat qPCR and MPX PCR screening primer
Forward Actin16 qPCR and MPX screening primer
Reverse Actin16 qPCR and MPX screening primer
Top strand urease sgRNA#1
Bottom strand urease sgRNA#1
Top strand urease sgRNA#2
Bottom strand urease sgRNA#2 and reverse urease sgRNA#3
target site primer
Top strand urease sgRNA#3 and forward urease sgRNA#1 and
sgRNA#2 target site primer
Bottom strand urease sgRNA#3
Top strand urease sgRNA#4
Bottom strand urease sgRNA#4
Reverse urease sgRNA#1 and sgRNA#2 target site primer
Forward urease sgRNA#3 target site primer
Forward urease sgRNA#4 target site primer
Reverse urease sgRNA#4 target site primer
Forward Vanillin pathway MPX PCR screening primer 1
Reverse Vanillin pathway MPX PCR screening primer 1
Forward Vanillin pathway MPX PCR screening primer 2
Reverse Vanillin pathway MPX PCR screening primer 2
Forward Vanillin pathway MPX PCR screening primer 3
Reverse Vanillin pathway MPX PCR screening primer 3
Forward Vanillin pathway MPX PCR screening primer 4
Reverse Vanillin pathway MPX PCR screening primer 4
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MPX 5F
MPX 5R
MPX 6F
MPX 6R

GATGCGAGAGCAAATGTCAA
GCGAATCGTTTTGTGTCAGA
TCGGTTGACATCTGATTGGA
CCACCATTTGTCACTGCATC

Forward Vanillin pathway MPX PCR screening primer 5
Reverse Vanillin pathway MPX PCR screening primer 5
Forward Vanillin pathway MPX PCR screening primer 6
Reverse Vanillin pathway MPX PCR screening primer 6

Table B.6: List of plasmids used in this study.
Plasmid

Description

Reference or source

p0521s
pPtPuc3
pPtGE1
pPtGE2
pPtGE3
pPtGE4
pPtGE5
pPtGE6
pPtGE7
pPtGE8
pPtGE9
pPtGE10
pPtGE11
pPtGE12
pPtGE13
pPtGE14
pPtGE15
pPtGE16
pPtGE17
pPtGE18
pPtGE19
pPtGE20
pPtGE21
pPtGE22
pPtGE23
pPtGE24
pPtGE25
pPtGE26
pPtGE27
pPtGE28
pPtGE29
pPtGE30
pPtGE31

P. tricornutum expression vector, ZeoR
P. tricornutum expression vector, ZeoR
p0521s with FBAC2 intron 1 in Sh ble MscI site
p0521s with TUFA intron 1 in Sh ble MscI site
p0521s with EIF6 intron 1 in Sh ble MscI site
p0521s with RPS4 intron 1 in Sh ble MscI site
p0521s with FBAC2 intron 1 in Sh ble SexAI site
p0521s with TUFA intron 1 in Sh ble SexAI site
p0521s with EIF6 intron 1 in Sh ble SexAI site
p0521s with RPS4 intron 1 in Sh ble SexAI site
p0521s with mutated RPS4 intron 1 in Sh ble MscI site
pPtPuc3 with EF1α Promoter driving Sh ble
pPtPuc3 with 40SRPS8 Promoter driving Sh ble
pPtPuc3 with H4-1B Promoter driving Sh ble
pPtPuc3 with γ-Tubulin Promoter driving Sh ble
pPtPuc3 with RBCMT Promoter driving Sh ble
pPtPuc3 with FcpB Promoter driving Sh ble
pPtPuc3 with FcpC Promoter driving Sh ble
pPtPuc3 with FcpD Promoter driving Sh ble
pPtPuc3 with EF1α Promoter and Terminator driving Sh ble
pPtPuc3 with 40SRPS8 Promoter and Terminator driving Sh ble
pPtPuc3 with H4-1B Promoter and Terminator driving Sh ble
pPtPuc3 with γ-Tubulin Promoter and Terminator driving Sh ble
pPtPuc3 with RBCMT Promoter and Terminator driving Sh ble
pPtPuc3 with FcpB Promoter and Terminator driving Sh ble
pPtPuc3 with FcpC Promoter and Terminator driving Sh ble
pPtPuc3 with FcpD Promoter and Terminator driving Sh ble
pPtPuc3 with H4-1B Promoter and FcpA Terminator driving nat
pPtPuc3 with FcpD Promoter and FcpA Terminator driving nat
pPtPuc3 with H4-1B Promoter and FcpA Terminator driving cat
pPtPuc3 with FcpD Promoter and FcpA Terminator driving cat
P. tricornutum expression vector, FcpD promoter and FcpA terminator driving Sh ble
P. tricornutum expression vector, FcpD promoter and FcpA terminator driving nat
P. tricornutum expression vector, FcpD promoter and FcpA terminator driving Sh ble and nat linked
by a T2A self cleaving peptide linker
P. tricornutum expression vector, FcpD promoter and FcpA terminator driving GFP and mCherry
linked by a T2A self cleaving peptide linker
P. tricornutum expression vector, 40SRPS8 promoter and terminator driving Sh ble, FcpB promoter
and FcpA terminator driving Cas9
P. tricornutum expression vector, 40SRPS8 promoter and terminator driving Sh ble, FcpB promoter
and FcpA terminator driving TevCas9
P. tricornutum vanillin biosynthesis pathway plasmid

Karas, et al., 2015
Karas, et al., 2015
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

pPtGE32
pPtGE33
PPtGE34
pPtGE35
p0521s-V

This study
This study
This study
This study
This study
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Table B.7: List of genetic parts.
Name

FBAC2-1 Intron

TUFA-1 Intron

EIF6-1 Intron

RPS4-1 Intron

pEF1α

p40SRPS8

pH4-1B

pγ-Tubulin

Sequence
GTACGTACGCGTAACATATTGTAGCCAATTTGGTGTCGACGGCATGGTCTCGCAGG
GAACGATAGAAAAACGTTGACACCTAGAAACGGGGGCTCTGGCACGGCAGCTCTC
CACGGATTCTCTCGCAGTATTACACGGGCTATGCAGTGGACAGGGATACCAAACG
TATGTTGGTGTCTTAATGTAAACTTTGCCCGTAAATTCCGTCCATATCGATCGAATC
CTTACCGTCAAGGGAGACCTCCAGTTCCCATGGTCGAGGGGCTTTCGTGGACCATC
CCGCCGCAAGATCCATCCGCTGGTGTGACGTCGAGCAGCGCCGAACGGTGTCAGT
GACGTGGCATCCCTCCCCCATCCACAGCAAACACGAGTAGTTTTGGTCGCGTTTAT
ACCGCGCTCCAAACCCCAGAATTGGCCGTCGCGGTTTTCCGTACCGTTGGTCTCAC
ACTGGTCCCGCGTTTTTTCTTTGATTCCACAATCAG
GTAAGACTCTGCAGGCTCCACGTGAACGAGTACCTCGAACGGTATGGTACCGTCA
CAATACACGGTTTCTGCCCTTGTTAGCTCACACGTTTGCTGTCCTTTCTACTCGTTC
TTCCCTGTTGTTGATCCTTGTTAG
GTACGTTTTGTTGTGGTCTATTGACAACTGTAGAGTGCGTGAAGCATTTACATCTT
GAAATGGTACATCTGACGCTTTTTGTCATCTTGAAG
GTAAGAATACTCATTCTTCGTCAATGAGATTGTTGAGTCTCTGATAGGAACCGAAA
ATGTAGGAAGGAAGCGCTGGCAACTTTCTGATGAAAGATGTTTCTGATGAAAGAC
GTTTGCCGTTGACAAACATCCGTCCCACGAAAGTAGTGTCGGGAAACGTTGGCTC
ACTCGGTTGATTCTTTTTCTCCTTTAATAG
CGAAACGAATAGAAGCTCCCCGAGGTCGGGTGTTGTTTGGGAGGTTCATGGTGGT
TTCGGTGTCGCTTGCTCGCTCGCTCGTTCGCAGTGACAGACAGTTCGTGAGACACG
AGAACCGTTGGCGTCCGAGTTCGGGTGCCGCATTTCGTCGTCTCCACGATTCAATT
CTTGCCCATCAGACGAGTCCCGAATTCCGTGACTCTGGATGCGATTTACTTTCTAA
CTGTAAGCGAAACTCAACGATTCCGTACGTTGTTTTCTATTTTACAGTGAGTCTTCG
ATACCACCGTACAACCATCGTTCGTGTACCGTCTGGTAGTCCCACGTGTCGACAAC
GTGTGGCTCTGGACCGATGAGTTGTTTGCCGTTCGGAAACGAGCAGTACCAAGGA
ATTCACAGAAACACAGCCCATGTAACACAACGACCGCGAATCGTTTCGGTGCTCT
CGCTTCGCGTACGGGCGGGCGGTCCTCCCGAGCAGCGAGAGGAGTCCGCAGCGTC
ATAGTTGCAATCCGGGCCCCCCTCGCGTTGTTCACTCTCTCGTCTAGTAGAGAAAC
TTCCATCGGATCGTATCATAATATTGTATCGTATAATATCACGTAATC
CCCTGCGATAGACCTTTTCCAAACTCACGCAGTCCAAGAAAACAAAGGGGTGAGA
AGTATACGCACCTTTCGGTTTCGGCATAATTCTTAAACTCTTGTGGTCACTTTCTTG
TGAAGAAGCTAGGGGCACTCGTTTTCCCTCAGAGCCTGCAAACACAAAATTCCTG
CAGTCAATTGTCCCAACACTCGGCAAACCGTATGCGCAAGCAACGATGCGCAGAA
GGCCGTGGATGGATGGCGACTCGCGATATGGCTTCTTGGGTCGCCAGTGTGGTAC
GTCCGGCGTATGTCAATACGCGAATTCGGACGACTGGCATCTCTAGGAGGAGGAT
TCCTTCTTTTATGACATGTTTATTTTATATACATTGATGCTTTCCGACAGTCGGAAG
TAATAAATGAATTTATTTCAAGACTACCTATACTCCTTTGACTTGTTCGACTAATCT
TACCGCTTACTAAAATCTCGAAATCACGCTTGACCTCTCGCACGCAAATTTTTGCT
GCTGGACGCTACGCACTCGGCCCAATTCTTCTCGGTCCTCGTCGTCGCAATTGTCG
TTGCGTTGATCTTGCACCGAAGGAATCAGAGAATAGAATACC
CGTCGGTCTCTTTCCCGGGAAACGGGTACACTCCTCCGCGCCAACAACATATTACT
ACTACTACCAAGAACGTCCACGGCCTTGTCGTGCGTTACGCTCTCCCAACGCGTGC
GGGGTAAATTACGTCTCGGTTTGCTAAGTAGCGCACAGCTAAATAGATGACCGTT
ATTGTATTTAAGATCATTCAATATTGATTGCATTGTACTTTGCGTCAAACTGAAATT
CCCTCGTACTAACGGTTAACCCGTCAACCCTAAGCGTTCGCCCAAAGTAGTCAACC
GGGACACGCGAACCGACATTGGGCAGATCTTTCACAGACAGAAAACCATTTCCAA
TCCAAATAAGCATGACTATTACACACCCATTCGTAGCGCGAGGACAAACTGATAG
CTCCAACAAAATGCGCCAACATCGTACATTGTAAGAAGCTTACGGAACACTATGT
ATGTAGAACCATACGAACAGCAACTAGTACTGGCCATCGAGCAGCGGTGACTCCC
GGCTTTCGTAGCGCTGTGAAGGTTACACTCTCACAATTCGCTCTCGGCTACAACCG
ACAAAAGTCTTACTCACAGTCAATACCGAAAACAAACAACAGCCAAC
TTCGTTGATATTTTTATTCAAATGTATCGGGAGGAGTAGAGGTTGATTAACTGTAA
ACAATTTCCTATTTACTGTTAAGGACCAGCTGCTGCAGTAGGTATGGCCTATCCAC
TAAACGCACTCACGGAACGCCTCGCGAAATTTACCCACGGCCAACTTACATTACC
GCCTTTTGTGAATTGGAAACGCCGCATGATTCTCAAATGCGCAGAATTTCAAACGG
TAGCTTGCGGTGGAGACTCGCTCATTGACAGTGAAACTACCTTGTGTCCTCGGATT
TTCAGATATACCTATACAGTTCATGGCAAAATTTCGTTCATGAACGCACGTGATCC
ATTGCTCGCGATTCCCGTTTTTGATTGTGAACGCGGGATTACATGCGTGCGGTGAC
GGTAGTCCAGACACAGATATTTGCAATACCGGGCCCTTTTCACTACAGACCCTGTA
GGGGTATGTTGACGAGAATGAACTCGCAGACTGCCAAAATCGCTTTGGCTGATCC
CAAGTTTTGGCACTCCATCGTAATTTGTCATATTCCATACGGTAGCTTCGACTGAA
TCCAGACAAACAATTTAGTCCAGCTGCGCTTCTACTTGCAAT

Description

Fructose-1,6-bisphosphate
aldolase intron 1
[20:568575-569056]

Elongation Factor Tu intron 1
[21:403882-404017]
Eukaryotic Translation
Initiation Factor 6 intron 1
[1:704734-704825]
40S Ribosomal Protein S4
intron 1
[1:607235-607430]

Elongation Factor-1 alpha
Promoter

40S ribosomal protein S8
Terminator

Histone H4 Promoter

Tubulin gamma chain
Promoter
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pRBCMT

pFcpB

pFcpC

pFcpD

tEF1α

t40SRPS8

tH4-1B

ACACGGAGGATCTATCTACAGCAGCGATGAGGGCGCCCGAGAAAGAAAGAACGA
TTGCCGTACTATTCTCTTTGACCTTTGGGCGCTCGCTCGTATCTTTGAAGCGACTGT
TGGGGTCTCAGGGTCCAAAAAACAGAAACTGGATTGACAGTGTGTCTGGACCTTG
TCGAACCTTACAGTTACATTACAGTTAATTGTCACTGTAAATAGTCTATCGCTGGA
TTACGTCATCGCGTGACTGGGTGGGAATCCTTCTTGTTGACAGTGAATCTACGGTA
TACTATTCCTTGGGCGCTTGTACTTGTGTCTCGAGATTGCCGACAGTGACGTCAAT
TCGGCACCCACACCTTCCACCCGCCGAACCAAAATCAACAACACGAAGCACACGA
CCGACCGACTGTACACGTGAAGGAGCAAACCATCGAACGAAAGGAGCCTTCCACG
GACACAACCCGAAAGCTCGACACCCTTCACCCACGCAAAGTATCTCTTCGTGATCC
TACC
GAAACATACCTTCAGCGTCGTCTTCACTGTCACAGTCAACTGACAGTAATCTTTGG
CCCGTAGAGGTTCGAAATTCAATCTATTAAATACAGCAGGATAAGACACAAGAGC
GACATCCTGACATCAACTCCGTGAACAGCAAATCCTGGTTGAACACGTATCCTTTT
GGGGGCCTCCAGCTACGACGCTCGCCCCAGCTGGGGCTTCCTTACTATACACAGCG
CATATTTCGCGGTTGCCAGAAGTCAAG
GAGCACAAGAGGTGACAAAAGCCACCGGCTGGATCGCACTTCTCGGAATTTCCCC
CCTACTATCAAACAAATTCGAATTGCCAAAGGTGAAGgGACTAACTGTAAATCCTg
aTCAATCAAGGTCTCAATCAAGTACAATGGGCTACAATGATATTTAGATGGGAACA
CAATGAAACaAATTGAAACTTCTACTGACAGGAGCGCAATTGACTTGTGTAGCTTT
TCATGAGCACTTGATTGCTACCaATTGTGAACGGGATGGGGAAAGACTCGAAAAG
GTGCATGCTTCCGATAATCTACTATATTTTCTAGAATCAAATAATATTTAAATGAA
TGAGGTCCTCAGCGTACGTTAAGCCTACTTATTTAGAACGAGAAGTCAGACCGAG
GGGTACTAAAATTCTAAGGGTTGAGAGGTATCTTGATTCCGGGTCTATGGAAGCCC
ATCCTTGTTGAAGCTTGAACACGATCCTTGTGAAAGGCCGACGTTGCGCGAAAAA
ACAGCCTGCCGATTTCTTTCCTTCTTTCTCGTCTCAACCTATATACTTTCATAATCTC
TGTTAgAGTTTACCAACAACACATATATACATTTCGACAAA
ACTAGCTTGATTGGGATATCTCGCTCATGTTTGTCGCGTGCTATGTCTTTTTAGGTA
CTTTGAACCTACGTTCGTACTTGTATAATATGATCATCGTATTATCGTTTTTCATCC
GTCCAGCGCAAAATGCATTAGCAGCTAGTCCTAGCGTGCGGAGCTACCTGgACAG
GTGCATGACGGATGCGTGTCCTTCAGTGAcTTTCTAATTAACAGTAACTTCTTTACT
TATGTTTCAGTTTGTAAGAAGCGGGATTCGCTCGTCGGTTGACATCTGATTGGACT
GCGTCGGCACaTGAAAACTACATTGTGAAATCTGCTAAAACTCCGGGTATCTCTGA
CACAAAACGATTCGgCtTCgCAATTTCAACATTACGGTCAAGGCTAACGTATCTTTC
TCGGTCAACTTCAGATTAtGCCGAtTAAATTGTCGTAGCTTTCAAGGCGTTTTGAGT
ACTGCGGCAGTTGTTGAACCTGCAAGGAGAAGATCTCGACAACAGAATAaAGCGA
AAAATGGGTCTCATGCACTAACACTCAGgCCTCCCTCATAATCTCTGTTtGAGTTTA
CCAACAACACATATATACATTTCGACAAA
ATGCGGGAGTGGACCGCGACGATCCGtCCgGaAAAcAATACTAGGTGCTATCACAG
GGGCGCGTTTTGGAGAGACGTTCTGCGGAAACACGAATTTAGAATACGTAACTAA
CATATAAACTGGATAGCCCTCGCATCGGAACTTAGAATGTTCGCCTCAATTTTTAG
TTTAGCGTGGAGCAGAGATACCTTTCCATTTGGCAAAATCTACCTTTCGTGAGGGA
CATCTTGAGAAATAAGCGGACTTGTAGACTAGGACCGTGGTAACCTCCTCTCAATC
TACCAATGTTGTCTGATTTCCGAGCCGCGCGGCTGAAAATCGTCTAGCACTTGGAT
GCGAGAGCAAATGTCAAGTCCTGCTCTGTCCTGTTGGACGCTTTCCTCTCACCGCG
AGAGGGCTTTCACTCGCGAAACACGTATTTCATATTCAAACTCTATGAAGTTTAAA
GTAGATGTATCTACAAACGGTCCTAAGTTTGGGTAAGAATTTTCGACTGCAT
AGATAAGAATATCTCATTGTGAACATCTATGATTTACCAATTTTATTCTTTGTTTAC
AGTTAGACGCCAGTAATTGTGCTGTTTCTCTCAAGTCTGTGTCAATACAAACTACG
AAACTTGGCAATTTTTCTCTTGAATATGAGCACGAGATTGAAACGCACAAAGGAA
ATTAGTTTCCATCCTTTGACAAAGTTTGTTGCTGTTTAGAGAACAGATGTCAAAAT
TAACGTGCCATGGAATTGAACCATGGTGCGCTATCCCCAAATCACGTCGTTTGACC
TCGTCACATTTAAGGTATATCAAGCATATTCACTTATATCTTGACATCCTCCCTGCT
TGATATTCCTTTGCCCTTGAGCCATCTTCCCCACACGCTGGAGATGACCCCTGCCC
CTCCTTTCTTTATCCACCCGAGTAAGGTGTCGACAAGTCACTTTGCCCCTGAGCCA
TCCTCCCCACTCAGGAGATGACCCCTACCCCTTTCTTCTTTATCCACCCC
GCTTGCGCTTGATCCTCGACTTTGTTGCTCGTCTTTAAAACCTTGGAACGATTATAT
ACAATCACCAACTCAAAAACCGGATTTTCTAAAATCCACCCAAACAACCAAAGAA
AATACTTCTCATTGCATTTATGAATCACAGCAGACCTGCGTCCTTTTAAAACTTAG
ATCCTGTTTTCTTATAAAAAACAGATCAAATTTTCTGGGAGTTCATTGACTCTGCC
AGTCAGAATCAATCCTGCAGTAATTCTTTATTTACAGGTGAAAGTAAAAGAGAAT
CCCAATTTTTTGCTTGTACATTAAGGTCCTCCTTACATTACAGCTAATTTCAAAATA
AGATGAAGTTGGATTCGTGTCCTTTCATGGTGATGTGATATTCTGCACTATACCAA
ACACCGTGAAATGTCAGCTAGAGCTTGTCATGAGGCAGTTGCTGCCAATCACTAC
ATATAGATCCTTCACGGAGAAAAGTTGGCTTCATTCTCTGTTGCTAATCGGCT

Ribulose-1,5-bisphosphate
carboxylase/oxygenase small
subunit N-methyltransferase I
Promoter

Fucoxanthin-chlorophyll a/c
binding protein B Promoter

Fucoxanthin-chlorophyll a/c
binding protein C Promoter

Fucoxanthin-chlorophyll a/c
binding protein D Promoter

Elongation Factor-1 alpha
Terminator

40S ribosomal protein S8
Terminator

Histone H4 Terminator
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tγ-Tubulin

tRBCMT

tFcpB

tFcpC

tFcpD

AGCAAACTCATTATGATGCATGGGAGTGCGACCGAGTTTCGAACGATGCTAACGA
ACATTATTAGTGGAAGGCAGTCATTGTTGTATGCGTCAAAGTATATAATCAGACGG
ACAGTAGTTCATTTTAAACTTTTGTTCGGAAAGCGTTGATCATTCATCGGGGAATC
GCGCTAACGAGCAGTAATTGGAGTTGTAACTGCAGGCTCAACGCGTTTCTGGCTCC
CGTGGGTTACCATAATGCTAACTATCATTCTTTATTTGCAGTATCACCAGTCCAAG
AATTATTCGTGGTCATTTCTGATGCTACTGTGGAGAAGTGAGAGTAATTTCGCCGA
CTTTGAAGTGAAGACGCGTCTCCGAACGTAGATTGTTGGTATTGTACCATTGAAGG
AGAGTTTTTGAACTCAGGTTGTTGATCGTAATGTCCGCGACATCCTGGCGCACTAC
ACGCCAATGACCATAACATGTCTTGGTCGCCCTCCTCGTAAGTCATCGCCATT
AAATACAAATTCATGTACCTAAACGATAGTATGGATGATGGGAGTAATTGCACTA
TAATTGTAGAACCTTGTAAGAGGAAAAAATGATCTTACTGTGTTATTTCCTCTTGA
AAGAATCTATGGATAAAATAAGAGAGGACGCTAGGTGGTAACATTCCGGCAAAAC
ACTGGCGCCTAAATTTTTGCCGGAATCGTCAATTGCAACGGTTGTACCGGTGCTTT
GTTTTAGTGTTTCGCCTTGCTACCCTTCAGGAACCGGTAACGAACACCTCCGCCAC
CCCGGACCCGCTCTGTTTTAGTTTGAATGGACTTGCGCAAAGAATCCTTATCATTC
GCCTGTGACCGGGTTCCTTCCTTGGCCAAATTTGCCAGAAAGGTTTCCCGATCAAT
GCTAGGGGTGCTTCCGCCTCCACTTGCCGTGGGAGTGTTCCCACCGCTACTTGCCG
TTGGAGTGCTATCACTATCGGAGCCTTGGATCGTGTTGGGCGTACCGGTAGTGCC
TTTACTTGCTGGGTAGGCCGTTTCTGGAATAACATATTAGATTCTAACTGGTTCGA
AGCATTGCGTTGCTGTAACATTCCCGTTCACAAAAATACAGAACAGTCTAGAAGTT
CGCGACGACATAATTTTTCTCTTTAGGAGGCCGGGGTTGTAATTGTTCTAGGGCTG
TTCCAATAGAGAAGATAAGATGATCAAACATACCAGCCGCGCTTGATTGGACGGA
GTACGTTTGCATCAGCTATTTTTCAAAAGCGCTGCACGACGCACACTCTATGAACA
CTTCAAGACTCTCAACGCAAGTGACAACCATCCTCTCCAAAAGGCTATCTTTCGGG
GCACCTGTAATATAAAAAAGCATGGCAGTGCATTCCATGCAAAAAATGTCTAATC
TGGTTGGGTTTTAAAGTCCGTATCGAGCACAGAGGTGACAAAAGCCACCGGCTGG
ATCGCACTTCTCGGAATTTCCCCCCTACTATCAAACAAATTCGAATTGCCAAAGGT
G
TTTTGTTACATTGACTTCAAGGAGTCGAGGAATCGATACTGCCGTCGTTTCCAGGA
TCCGAGGTTTCTATAGACTCTCTATAGACTCTGTTAACCTAATAGAATCAGACATA
CCTCTCCTGCTATTTTGTTTTTATGAATTTGGCTTTTGCCTCTCTAGTCAGATTTGAA
TGTTATTTTCCGCCAGGTGTGTTAGTCGGGCTCTCGTTTGAGTTACAAGAGGGATT
GAGTGGCGAGGATTCACTCTAATGTAAATATGACTGTGAACAAAACTTTAAAATT
ACTACGCATCTTCTTTGACTGTCAGATATTCGTCGGTGACAGCAGTCAATGCCTGC
AAATTGTCCTCCTGGGTCGCAATTTGGTTTTGGATTGACCTGGTATGCATTATGAA
GAAAAAAATTCGTTATTAGCCAACTGCCTAGCGTGCACATTGCATGGTTAGACCTC
CTTGACGACTGTGAGCCTACATCCTTCTGCAACAAGCTGCAAT
TTTTGTTACATTTACTGACTTCAAGGAGTCGAGGAATCGATACTGCCGTCGTTTCC
AGGATCCGAGGTTTCATAAACTCTGTTAACGTTATAGAAACAGACTTACCTCTCCT
ACGCCATTCACGTAATATTCGCAATATGCTATTCTTCCTCTGAAGACCAGGTTTAT
GTGCTGCCTGAAACTATTTCAATAAGTCAGCTGCACTTGCACAGGGTTTCACAAGG
AAAGCGTGTCTTTTTTTCCAACGTAGGCGTCGCTTTCGTCTGACTCTTACTCTTACA
TTCACAGCCAATACTTACAATTAGTAAAAAACCTGTGCTCGAGAGTGAAAACGTC

Tubulin gamma chain
Terminator

Ribulose-1,5-bisphosphate
carboxylase/oxygenase small
subunit N-methyltransferase I
Terminator

Fucoxanthin-chlorophyll a/c
binding protein B Terminator

Fucoxanthin-chlorophyll a/c
binding protein C Terminator

Fucoxanthin-chlorophyll a/c
binding protein D Terminator
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PAL

ATGCACCACCACCACCACCACGAGTGCGAGAACGGCCGCGGCGTTGCTGCAACCA
ACAGCGATTCCCTGTGCATGGCGACGCCCCGCGCCGACCCGCTTAACTGGGGCAA
GGCGGCGGAGGAGCTGATGGGCAGCCACCTGGACGAGGTCAAGCGGATGGTGGC
CGAGTACCGCCAACCCTTGGTGAAGATCGAGGGCGCCAGCCTCAGCATCGCGCAG
GTGGCCGCCGTGGCCACCGGCGCTGGCGAGGCCCGGGTCGAGCTGGACGAGTCTG
CCCGTAGCCGGGTCAAGGCAAGCAGCGACTGGGTCATGACCAGCATGATGAACGG
CACCGACAGCTACGGCGTCACCACCGGCTTCGGCGCCACGTCGCACAGGAGGACC
AAGGAGGGCGGCGCGCTCCAGAGGGAGCTCATCAGGTTCCTCAACGCCGGCGCCT
TCGGCACCGGCGCGGACGGCCACGTCCTGCCGGCCGAGACGACGCGCGCGGCCAT
GCTCGTCCGCATCAACACCCTCCTCCAGGGGTACTCTGGCATCCGCTTCGAGATCC
TCGAGGCGATCGTCAAGCTGCTCAACGCCAACGTCACGCCGTGCCTGCCGCTCCGC
GGCACGGTAACCGCGTCCGGCGACCTCGTGCCGCTCTCCTACATTGCGGGCCTCGT
CACCGGGCGTGAGAACTCTGTTGCGGTTGCCCCAGACGGCAGCAAGGTCAACGCC
GCCGAGGCATTCAAGATTGCCGGAATCCAGGGCGGCTTCTTCGAGCTGCAGCCCA
AGGAGGGTCTTGCGATGGTGAACGGCACGGCCGTGGGCTCTGGCCTTGCCTCCAC
TGTGCTCTTCGAGGCTAATATCCTTGCCATCCTCGCCGAGGTCCTGTCTGCCGTGTT
CTGCGAGGTCATGAACGGCAAGCCGGAGTACACTGACCACCTGACCCACAAGCTC
AAGCACCACCCGGGACAGATCGAGGCTGCTGCCATCATGGAGCACATCTTGGAGG
GCAGCTCCTACATGAAGCTTGCCAAGAAGCTCGGCGAGCTCGATCCCTTGATGAA
GCCCAAGCAGGACCGGTACGCGCTCCGCACGTCGCCGCAGTGGCTTGGCCCCCAG
ATTGAGGTTATCCGCGCCGCCACCAAGTCCATTGAGCGCGAGATCAACTCCGTCA
ACGACAACCCGCTCATCGATGTCGCCCGAAGCAAGGCTCTTCACGGTGGCAACTT
CCAGGGCACGCCCATCGGGGTGTCCATGGACAACACCCGTCTCGCCATCGCAGCC
ATCGGCAAGCTCATGTTTGCGCAGTTCTCTGAGCTCGTCAACGACTACTACAACAA
CGGCTTGCCCTCCAACCTGTCCGGTGGGCGCAACCCCAGCTTGGACTACGGCTTTA
AGGGTGCCGAGATCGCCATGGCGTCCTACTGCTCCGAGCTGCAGTTCCTGGGGAA
CCCGGTCACCAACCACGTGCAGAGCGCGGAGCAGCACAACCAGGACGTCAACTCA
CTGGGACTCATCTCCTCCAGGAAGACTGCTGAGGCCATCGAGATCCTAAAGCTCAT
GTCCTCGACGTTCCTGATCGCCCTGTGCCAGGCCGTGGACCTGCGCCACATCGAGG
AGAACGTCAAGAGCGCTGTCAAGAGCTGCGTGATGACGGTGGCGAAGAAGACCCT
GAGCACCAACTCCACCGGTGGTCTCCACGTCGCCCGCTTCTGCGAGAAGGACCTG
CTCCAGGAGATCGAGCGCGAGGCGGTGTTCGCGTATGCCGACGACCCCTGCAGCG
CTAACTACCCGCTGATGAAGAAGCTTCGCAACGTGCTCGTGGAGCGCGCCCTCGC
CAACGGCGCTGCCGAGTTCAACGCGGAGACATCCGTGTTCGCCAAGGTCGCCCAG
TTCGAGGAGGACCTGCGCGCGGCGCTGCCAAAGGCGGTGGAGGCTGCACGGGCG
GCTGTCGAGAACGGCACGGCAGGGATACCGAACAGAATCGCCGAGTGCCGCTCCT
ACCCGCTCTACCGCTTCGTGCGCGAGGAGCTCGGAGCCGTGTACCTCACCGGCGA
GAAGACGCGCTCTCCCGGCGAGGAGCTGAACAAGGTGCTCGTTGCCATCAACCAG
GGCAAGCACATCGACCCGTTGCTCGAGTGCCTCAAGGAGTGGAACGGCGAGCCAC
TGCCCATCTGCTAA
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ATGGACCTCCTCTTGCTGGAGAAGTCTCTAATCGCCGTCTTCGTGGCGGTGATTCT
CGCCACGGTGATTTCAAAGCTCCGCGGCAAGAAATTGAAGCTACCTCCAGGTCCT
ATACCAATTCCGATCTTCGGAAACTGGCTTCAAGTAGGAGATGACCTCAACCACC
GTAATCTCGTCGATTACGCTAAGAAATTCGGCGATCTCTTCCTCCTCCGTATGGGT
CAGCGTAACCTAGTCGTCGTCTCTTCACCGGATCTAACCAAGGAAGTGCTCCACAC
ACAAGGCGTTGAGTTTGGATCTAGAACGAGAAACGTCGTGTTCGACATTTTCACCG
GGAAAGGTCAAGATATGGTGTTCACTGTTTACGGCGAGCATTGGAGGAAGATGAG
AAGAATCATGACGGTTCCTTTCTTCACCAACAAAGTTGTTCAACAGAATCGTGAAG
GTTGGGAGTTTGAAGCAGCTAGTGTTGTTGAAGATGTTAAGAAGAATCCAGATTCT
GCTACGAAAGGAATCGTGTTGAGGAAACGTTTGCAATTGATGATGTATAACAATA
TGTTCCGTATCATGTTCGATAGAAGATTTGAGAGTGAGGATAGTCCTCTTTTCCTT
AGGCTTAAGGCTTTGAATGGTGAGAGAAGTCGATTAGCTCAGAGCTTTGAGTATA
ACTATGGAGATTTCATTCCTATCCTTAGACCATTCCTCAGAGGCTATTTGAAGATTT
GTCAAGATGTGAAAGATCGAAGAATCGCTCTTTTCAAGAAGTACTTTGTTGATGAG
AGGAAGCAAATTGCGAGTTCTAAGCCTACAGGTAGTGAAGGATTGAAATGTGCCA
TTGATCACATCCTTGAAGCTGAGCAGAAGGGAGAAATCAACGAGGACAATGTTCT
TTACATCGTCGAGAACATCAATGTCGCCGCGATTGAGACAACATTGTGGTCTATCG
AGTGGGGAATTGCAGAGCTAGTGAACCATCCTGAAATCCAGAGTAAGCTAAGGAA
CGAACTCGACACGGTTCTTGGACCGGGTGTGCAAGTCACCGAGCCTGATCTTCACA
AACTTCCATACCTTCAAGCTGTGGTTAAGGAGACTCTTCGTCTGAGAATGGCGATT
CCTCTCCTCGTGCCTCACATGAACCTCCATGATGCGAAGCTCGCTGGCTACGATAT
CCCAGCAGAAAGCAAAATCCTTGTTAATGCTTGGTGGCTAGCAAACAACCCCAAC
AGCTGGAAGAAGCCTGAAGAGTTTAGACCAGAGAGGTTCTTTGAAGAAGAATCGC
ACGTGGAAGCTAACGGAAATGACTTCAGGTATGTGCCGTTTGGTGTTGGACGTAG
AAGCTGTCCCGGGATTATATTGGCATTACCTATTTTGGGGATCACCATTGGTAGGA
TGGTCCAGAACTTCGAGCTTCTTCCTCCTCCAGGACAGTCTAAAGTGGATACTAGT
GAGAAAGGTGGACAATTCAGCTTGCACATCCTTAACCACTCCATAATCGTTATGAA
ACCAAGGAACTGTTAA
ATGCACCACCACCACCACCACGCGGGCAACGGCGCCATCGTGGAGAGCGACCCGC
TGAACTGGGGCGCGGCGGCGGCGGAGCTGGCCGGGAGCCACCTGGACGAGGTGA
AGCGCATGGTGGCGCAGGCCCGGCAGCCCGTGGTCAAGATCGAGGGCTCCACCCT
CCGCGTCGGCCAGGTGGCCGCCGTCGCCTCCGCCAAGGACGCGTCCGGCGTCGCC
GTCGAGCTCGACGAGGAGGCCCGCCCCCGCGTCAAGGCCAGCAGCGAGTGGATCC
TCGACTGCATCGCCCACGGCGGCGACATCTACGGCGTCACCACCGGCTTCGGCGG
CACCTCCCACCGCCGCACCAAGGACGGGCCCGCGCTCCAGGTCGAGCTGCTCAGG
CATCTCAACGCCGGAATCTTCGGCACCGGCAGCGACGGGCACACGCTGCCGTCGG
AGGTCACCCGCGCGGCGATGCTGGTGCGCATCAACACCCTCCTCCAGGGCTACTCC
GGCATCCGCTTCGAGATCCTCGAGGCCATCACGAAGCTGCTCAACACCGGTGTCA
GCCCCTGCCTGCCGCTCCGGGGCACCATCACCGCGTCGGGCGACCTGGTCCCGCTC
TCCTACATCGCCGGCCTCATCACGGGCCGCCCCAACGCGCAGGCCGTCACCGTCG
ACGGAAGGAAGGTGGACGCCGCCGAGGCGTTCAAGATCGCCGGCATCGAGGGCG
GCTTCTTCAAGCTCAACCCCAAGGAGGGCCTCGCCATCGTCAACGGCACGTCCGTG
GGCTCCGCGCTCGCGGCCACCGTGATGTACGACGCCAACGTCCTGGCCGTCCTGTC
GGAGGTCCTGTCCGCCGTCTTCTGCGAGGTCATGAACGGCAAGCCCGAGTACACG
GACCACCTGACCCACAAGCTGAAGCACCACCCGGGGTCCATCGAGGCCGCGGCCA
TCATGGAGCACATCCTGGATGGCAGCTCCTTCATGAAGCAGGCCAAGAAGGTGAA
CGAGCTGGACCCGCTGCTGAAGCCCAAGCAGGACAGGTACGCGCTCCGCACGTCG
CCGCAGTGGCTGGGCCCCCAGATCGAGGTCATCCGCGCCGCCACCAAGTCCATCG
AGCGCGAGGTCAACTCCGTGAACGACAACCCGGTCATCGACGTCCACCGCGGCAA
GGCGCTGCACGGCGGCAACTTCCAGGGCACCCCCATCGGCGTGTCCATGGACAAC
GCCCGCCTCGCCATCGCCAACATCGGCAAGCTCATGTTCGCGCAGTTCTCCGAGCT
CGTCAACGAGTTCTACAACAACGGGCTCACCTCCAACCTGGCCGGCAGCCGCAAC
CCCAGCCTGGACTACGGCTTCAAGGGCACCGAGATCGCCATGGCCTCCTACTGCTC
CGAGCTCCAGTACCTGGGCAACCCCATCACCAACCACGTGCAGAGCGCGGACGAG
CACAACCAGGACGTGAACTCCCTGGGCCTCGTCTCGGCCAGGAAGACCGCCGAGG
CGATCGACATCCTGAAGCTCATGTCGTCCACCTACATCGTGGCGCTGTGCCAGGCC
GTGGACCTGCGCCACCTCGAGGAGAACATCAAGGCGTCGGTGAAGAACACCGTGA
CCCAGGTGGCCAAGAAGGTGCTGACCATGAACCCCTCGGGCGAGCTCTCCAGCGC
CCGCTTCAGCGAGAAGGAGCTGATCAGCGCCATCGACCGCGAGGCCGTGTTCACG
TACGCGGAGGACGCGGCCAGCGCCAGCCTGCCGCTGATGCAGAAGCTGCGCGCCG
TGCTGGTGGACCACGCCCTCAGCAGCGGCGAGCGCGGAGCGGGAGCCCTCCGTGT
TCTCCAAGATCACCAGGTTCGAGGAGGAGCTCCGCGCGGTGCTGCCCCAGGAGGT
GGAGGCCGCCCGCGTGGCGTCGCCGAGGGCACCGCCCCCGTGGCGAACCGGATCG
CGGACAGCCGGTCGTTCCCGCTGTACCGCTTCGTGCGCGAGGAGCTCGGCTGCGTG
TTCCTGACCGGCGAGAGGCTCAAGTCCCCCGGCGAGGAGTGCAACAAGGTGTTCG
TCGGCATCAGCCAGGGCAAGCTCGTGGACCCCATGCTCGAGTGCCTCAAGGAGTG
GGACGGCAAGCCGCTGCCCATCAACATCAAGTAA
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ATGTCGTGGTTTCTAATAGCGGTGGCGACAATCGCCGCCGTCGTATCCTACAAGCT
AATCCAACGGCTAAGATACAAGTTCCCACCAGGCCCAAGCCCCAAGCCGATCGTC
GGTAACCTCTACGACATAAAACCGGTCCGGTTCAGATGTTACTACGAGTGGGCTC
AATCTTATGGACCAATCATATCGGTCTGGATCGGTTCAATTCTAAACGTGGTCGTA
TCTAGCGCCGAGCTAGCAAAAGAAGTTCTGAAAGAACACGACCAGAAACTCGCCG
ACCGGCACCGGAACAGATCGACGGAAGCATTTAGCCGCAACGGTCAGGATCTTAT
ATGGGCCGATTATGGGCCTCATTACGTGAAGGTGAGAAAAGTTTGCACGCTTGAG
CTCTTCACACCGAAACGACTCGAGTCTCTCAGACCTATCCGTGAAGATGAAGTCAC
CGCCATGGTTGAATCCGTCTTCAGAGACTGTAACCTTCCTGAAAACAGAGCAAAA
GGTTTACAACTGAGGAAGTACTTAGGAGCGGTTGCGTTCAACAACATAACGCGGC
TAGCCTTTGGGAAGCGTTTTATGAACGCTGAAGGTGTTGTGGACGAGCAAGGGCT
TGAGTTCAAGGCCATAGTATCCAACGGTCTGAAGCTAGGTGCTTCACTGTCAATAG
CTGAACACATCCCGTGGCTCAGGTGGATGTTTCCGGCTGATGAGAAGGCGTTTGCT
GAGCACGGGGCTCGTCGTGACCGCCTCACTCGAGCTATCATGGAGGAGCATACTT
TGGCCCGTCAAAAGTCTAGTGGAGCGAAACAGCATTTCGTTGATGCGTTGCTAAC
GTTGAAGGATCAGTATGATCTTAGTGAGGATACTATCATTGGTCTTCTATGGGATA
TGATCACGGCAGGGATGGACACGACAGCGATAACAGCGGAATGGGCGATGGCGG
AAATGATCAAGAATCCAAGAGTGCAACAAAAAGTGCAAGAAGAGTTCGACAGAG
TGGTTGGACTTGACCGGATCTTAACCGAGGCAGATTTCTCCCGCTTACCTTACTTG
CAATGCGTGGTGAAAGAGTCATTCAGGCTGCATCCTCCAACGCCTCTAATGCTACC
TCACCGAAGCAACGCAGATGTCAAGATCGGAGGCTATGATATTCCCAAAGGATCA
AACGTTCATGTGAATGTGTGGGCTGTGGCTAGAGACCCGGCTGTATGGAAAAATC
CATTTGAGTTTAGACCAGAGAGATTCTTGGAAGAAGATGTTGACATGAAGGGTCA
TGATTTTAGGCTGCTTCCGTTTGGAGCTGGAAGACGGGTTTGTCCCGGTGCACAAC
TTGGTATCAATTTGGTAACTTCGATGATGAGTCATTTGCTTCACCATTTTGTTTGGA
CACCTCCTCAAGGGACTAAACCGGAGGAGATTGACATGTCTGAAAACCCTGGACT
CGTTACTTACATGCGTACCCCTGTGCAAGCGGTTGCAACGCCTCGGTTGCCTTCGG
ATCTGTACAAACGCGTGCCTTACGATATGTAA
ATGAAAATTAACATCAGAGATTCCACCATGGTCCGGCCTGCCACCGAGACACCAA
TCACTAATCTTTGGAACTCCAACGTCGACCTTGTCATCCCCAGATTCCATACCCCT
AGTGTCTACTTCTACAGACCCACCGGCGCTTCCAATTTCTTTGACCCTCAGGTCAT
GAAGGAAGCTCTTTCCAAAGCCCTTGTCCCTTTTTACCCTATGGCTGGTCGCTTGA
AGAGAGACGATGATGGTCGTATTGAGATCGATTGTAACGGTGCTGGTGTTCTCTTC
GTTGTGGCTGATACTCCTTCTGTTATCGATGATTTTGGTGATTTTGCTCCTACCCTT
AATCTCCGTCAGCTTATTCCCGAAGTTGATCACTCCGCTGGCATTCACTCTTTCCCG
CTTCTCGTTTTGCAGGTGACTTTCTTTAAATGTGGGGGAGCTTCACTTGGGGTTGG
GATGCAACATCACGCGGCAGATGGTTTCTCTGGTCTTCATTTTATCAACACATGGT
CTGATATGGCTCGTGGTCTTGACCTAACCATTCCACCTTTCATTGATCGAACACTCC
TCCGAGCTAGGGACCCGCCACAGCCTGCTTTTCATCATGTTGAATATCAGCCTGCA
CCAAGTATGAAGATACCTCTTGATCCGTCTAAATCAGGACCTGAGAATACCACTGT
CTCTATATTCAAATTAACACGAGACCAGCTTGTTGCTCTTAAGGCGAAATCCAAGG
AGGATGGGAACACTGTCAGCTACAGCTCATACGAGATGTTGGCAGGGCATGTGTG
GAGATCAGTGGGAAAGGCGCGAGGGCTTCCAAACGACCAAGAGACGAAACTGTA
CATTGCAACTGATGGAAGGTCTAGACTACGTCCGCAGCTGCCTCCTGGTTACTTTG
GGAATGTGATATTCACTGCAACACCATTGGCTGTTGCAGGGGATTTGTTATCTAAG
CCAACATGGTATGCTGCAGGACAGATTCATGATTTCTTGGTTCGTATGGATGATAA
CTATCTGAGGTCAGCTCTTGACTACCTGGAGATGCAGCCTGATCTGTCAGCCCTTG
TCCGCGGTGCACATACCTACAAGTGCCCAAATTTGGGAATCACAAGCTGGGTTAG
ATTACCTATTTATGATGCAGACTTTGGTTGGGGTCGTCCTATCTTTATGGGACCTGG
TGGAATTCCATACGAGGGTTTGTCTTTTGTGCTACCAAGTCCTACTAATGATGGCA
GCTTATCCGTTGCCATTGCCCTCCAATCTGAACACATGAAACTGTTTGAGAAGTTT
TTGTTTGAGATATAA
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ATGGCGGCGACACATCTTCACATACCGCCAAATCCTAAAACCCAAACGTCTCACC
AAAACCCTCCCTTTTGGTTCTCTTCTAAAACAGGAATCTACACCAGCAAATTCCCT
TCCCTACACCTCCCCGTCGACCCAAATCTCGACGCCGTCTCCGCTCTTTTCTCACAC
AAACACCACGGCGATACAGCGCTCATCGATTCCTTAACCGGGTTCTCAATATCTCA
CACTGAGCTACAGATTATGGTTCAATCAATGGCGGCTGGGACCTATCACGTTTTAG
GTGTTCGTCAAGGTGACGTTGTATCACTCGTCTTGCCTAATTCCGTCTATTTTCCGA
TGATTTTCCTCTCTTTGATCTCGCTTGGTGCTATTGTTACTACCATGAATCCTTCGA
GTAGTTTAGGAGAGATTAAGAAGCAAGTTAGTGAGTGTAGTGTTGGATTAGCTTTT
ACTTCTACTGAAAACGTTGAGAAGCTGAGTTCTTTGGGGGTTAGTGTGATTAGTGT
ATCTGAAAGTTACGATTTTGATTCGATTCGTATCGAAAACCCGAAGTTTTACTCCA
TTATGAAAGAAAGTTTTGGGTTTGTACCAAAACCGTTGATTAAGCAAGACGATGT
AGCTGCAATTATGTATTCATCTGGAACAACTGGAGCTAGTAAAGGAGTTTTGTTAA
CTCATAGGAATTTGATAGCATCAATGGAGCTTTTTGTGAGGTTTGAAGCTTCTCAG
TACGAATATCCGGGATCGAGTAATGTTTATCTAGCAGCTTTGCCTTTGTGCCATAT
CTACGGGTTATCACTCTTTGTGATGGGATTGTTGTCTCTGGGATCAACTATTGTTGT
TATGAAGAGGTTTGATGCTTCTGATGTTGTTAATGTAATTGAAAGGTTTAAGATCA
CTCATTTCCCGGTTGTTCCACCTATGTTGATGGCATTGACAAAGAAGGCAAAAGGA
GTTTGTGGTGAAGTGTTTAAAAGTTTGAAGCAAGTTTCTTCTGGAGCAGCTCCTTT
GAGTAGGAAGTTCATTGAAGATTTCCTTCAGACTCTTCCTCATGTCGATTTGATTC
AGGGATATGGAATGACTGAATCAACTGCAGTTGGAACACGGGGCTTCAACTCGGA
AAAGCTTAGTAGGTATTCTTCTGTGGGACTACTGGCTCCTAATATGCAAGCCAAGG
TAGTAGATTGGAGCTCTGGTTCTTTCCTTCCACCAGGAAACCGAGGAGAGCTCTGG
ATACAAGGTCCCGGTGTCATGAAAGGATACTTGAATAACCCAAAAGCAACTCAGA
TGAGTATAGTTGAAGATAGTTGGCTACGTACTGGGGATATTGCTTATTTTGATGAA
GATGGTTACTTGTTTATTGTTGACCGTATTAAGGAGATTATAAAGTACAAAGGCTT
TCAGATCGCTCCAGCAGATTTGGAGGCTGTTCTTGTTTCACATCCCTTGATTATCGA
CGCTGCAGTAACAGCTGCCCCAAATGAAGAATGTGGAGAGATTCCGGTAGCATTC
GTTGTCCGGAGACAAGAAACAACACTTTCAGAAGAAGATGTAATAAGCTATGTAG
CTTCTCAGGTTGCACCCTACAGGAAGGTGAGGAAAGTGGTGATGGTCAACTCTAT
ACCAAAATCTCCAACTGGGAAGATATTGAGAAAGGAACTAAAGAGAATTCTTACA
AACTCTGTTTCTTCAAGACTATGA
ATGGCTACATGGGTGGAGCACCAACAGCAGCAAAATGGATCCAAGGACGTGGAC
GAGGAGGCGTGCATGTACGCCATGCAGTTGTCGAGCATGGTCGTCCTCCCGATGA
CGCTTAGGGTAGCCGTCGAGCTCGGCATACTCGAACAAATCCAGGCCGGGGGCCC
AGATTCGTACCTTACTGCCGAGGATTTGGCGGCGAGGCTCGGCAACTCCAACCCCT
TAGCTCCGGTCATGATCGAGCGGATCCTGCGCCTGCTCACCAGCTACTCCATCCTT
AACTTCACCGACACCGTCGACGGGGAGGGTAGGACCGTCCGGAGCTACGGCGCGG
CGCATGTCTGCAAGTACCTGACTCCCAACCAGGACGGCGTCTCCATGGCGCCTCTC
GTCCTCATGAACACGGATAAGGTCCTTATGGAGAGCTGGTACCACATGAAGGATG
CAGTGACAAATGGTGGAATACCATTCAATCTAGCATATGGGATGACAGCTTTTGA
GTATCATGGGAAAGATCTAAGGTTTAATAAGGTGTTCAACGAGGGCATGAAGAAC
AACTCGATCATTATAACGAAGAAGATTTTAGAGAGATACAAAAGGTTTGAAGATG
TCAATGTTTTAATTGATGTTGGTGGTGGAATTGGTGGAACTATCAGTATGATTACT
GCAAAGTATCCACATATACATGGGATTAATTTTGACCTTCCTCATGTTGTTTCTGA
AGCTCCACCTTTCCAAGGGGTAGAACATGTCGGTGGAAACATGTTTGAAAGTGTC
CCCATTGGTGATGCAATCTTCATAAAGTGGATTCTTCATGATTGGAGTGATGAGCA
TTGTTTGAAGCTCCTAAGAAATTGTGCAAAATCTTTACCTGACAAAGGAAAAGTCA
TAGTTGTGGAATGCATTCTTCCCGATGCACCTTTGGTGACGCCAGAGGCTGAAGGT
GTCTTTCATTTGGACATGATAATGTTGGCTCACAATCCTGGGGGAAAGGAGAGAA
CAAAGAAAGAGTTTAAAGAATTGGCTATGCTATCTGGTTTCTCTAATTTCAAGGCA
CTTTTTAGTTATGCTAATGTTTGGGTCATGGAATTCAACAAATAA
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ATGGCAGCTAAGCTCCTCTTCTTCCTACTCTTCCTGGTCTCCGCCCTCTCCGTCGCG
CTCGCCGGTTTCGAAGAAGACAATCCAATCCGGTCCGTTACACAAAGGCCTGACT
CGATTGAGCCTGCCATCCTCGGCGTCCTTGGCAGTTGCCGCCACGCCTTCCACTTC
GCACGGTTCGCCCGCAGGTACGGGAAGAGCTACGGATCGGAGGAGGAGATCAAG
AAGAGGTTCGGGATCTTCGTGGAGAATCTAGCGTTTATCCGGTCCACTAATCGGAA
GGATCTGTCGTATACCCTAGGAATCAACCAATTCGCCGACCTGACCTGGGAGGAA
TTCCGGACCAATCGCCTTGGTGCGGCGCAGAACTGCTCGGCGACTGCGCATGGAA
ACCACCGGTTTGTCGATGGCGTGCTTCCTGTAACGAGGGATTGGAGGGAGCAAGG
GATAGTGAGCCCTGTAAAGGACCAAGGAAGCTGTGGATCTTGCTGGACTTTCAGT
ACTACTGGAGCACTAGAGGCTGCATATACACAGCTAACTGGAAAGAGCACATCAT
TATCTGAACAGCAACTTGTGGACTGTGCCTCAGCATTCAATAACTTTGGATGCAAT
GGAGGTTTGCCTTCCCAAGCCTTTGAATACGTTAAGTACAATGGAGGCATCGACAC
AGAACAGACTTATCCATACCTTGGTGTCAATGGTATCTGCAACTTCAAGCAGGAG
AATGTTGGTGTCAAGGTCATTGATTCGATAAACATCACCCTGGGTGCTGAGGATGA
GTTGAAGCATGCAGTGGGCTTGGTGCGTCCAGTTAGCGTTGCATTTGAGGTTGTGA
AAGGTTTCAATCTGTACAAGAAAGGTGTATACAGCAGTGACACCTGTGGAAGAGA
TCCAATGGATGTGAACCACGCAGTTCTTGCCGTCGGTTATGGAGTCGAGGACGGG
ATTCCTTATTGGCTCATCAAGAACTCATGGGGTACAAATTGGGGTGACAATGGCTA
CTTTAAGATGGAACTCGGCAAGAACATGTGTGGTGTTGCAACTTGCGCATCTTATC
CCATTGTGGCTGTGCACCACCACCACCACCACTAG

Vanillin synthase from Vanilla
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Table C.1: Wild-type P. tricornutum UMPS sequence analysis. Base positions are numbered relative to the first
base of the start codon in the genomic PtUMPS sequence. SNPs highlighted in red were not present in the reference
genome. SNPs located in intronic sequences were not included in this table.

Base
Position
102
127
237
246
519
542
591
599
938
1003
1048
1930

Reference Allele 1 Allele 2 Allele 1 Allele 2
Genome
Base
Base
Residue Residue
A/G
A
G
A34
A34
G/A
G
A
E43
K43
T/C
T
C
D79
D79
G/A
G
A
M82
I82
G
G
A
V147
I147
G/T
G
T
L154
L154
C/A
C
A
R171
S171
T/C
T
C
N173
N173
G/A
G
A
M286
I286
A/T
A
T
Q308
L308
C/T
C
T
T323
I323
T/A
T
A
I510
I510
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Table C.2: Wild-type P. tricornutum PRA-PH/CH sequence analysis. Base positions are relative to the first base
of the start codon in the genomic PtPRA-PH/CH sequence. SNPs highlighted in red were not present in the reference
genome.

Base
Position
113
203
268
270
318
319
354
406
423
623
732
817
825
892
978
1205
1306
1323
1350

Reference Allele 1 Allele 2 Allele 1 Allele 2
Genome
Base
Base
Residue Residue
T/A
T
A
F38
Y38
A/C
A
C
Q68
P68
C/T
C
T
L90
F90
C/T
C
T
L90
F90
T/C
T
C
V106
V106
T/C
T
C
L107
L107
C/T
C
T
C118
C118
A/G
A
G
T136
A136
T/G
T
G
F141
L141
A/T
A
T
Q208
L208
G/A
G
A
R244
R244
A/G
A
G
T273
A273
C/T
C
T
V275
V275
C/T
C
T
L298
L298
T/G
T
G
L326
L326
A/G
A
G
E402
G402
G/A
G
A
V436
I436
C/T
C
T
A441
A441
G/A
G
A
R450
R450

Table C.3: Growth rates of WT and UMPS complement strains in minimal L1 media. Generation times represent
the mean value ± standard deviation for three replicates.

P. tricornutum strain
generation time (hours)
WT
29.8±2.6
∆UMPS2 + pPtUMPSA1
27.9±2.8
∆UMPS2 + pPtUMPSA2
24.8±1.5
∆UMPS2 + pPtUMPScA1
28.5±0.9
∆UMPS2 + pPtUMPScA2
23.4±0.8
∆UMPS1 + pPtUMPSA1
26.5±2.7
∆UMPS1 + pPtUMPSA2
29.8±0.7
∆UMPS1 + pPtUMPScA1
26.5±4.0
∆UMPS1 + pPtUMPScA2
30.7±1.2
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Table C.4: List of P. tricornutum auxotroph genotypes.
Strain Name
∆UMPS1
∆UMPS2
∆UMPS3
∆PRAPHCH1

Genotype
PtUMPSg.[1637 1654del];[1050 1661del]
PtUMPSg.[1636 1652del];[1636 2415delinsT]
PtUMPSg.[309 310insA];[309 310insA]
PtPRA-PH/CHg.[924 934del];[924 929del]

Description
P. tricornutum uracil auxotroph strain 1
P. tricornutum uracil auxotroph strain 2
P. tricornutum uracil auxotroph strain 3
P. tricornutum histidine auxotroph strain 1

Table C.5: List of plasmids used in this study.
Plasmid

Description

Reference or Source

pPtGE31
P. tricornutum expression vector
Slattery, et al., 2018
pPtGE34
P. tricornutum expression vector, 40SRPS8 promoter and terminator driving Sh ble, FcpB promoter and FcpA terminator driving Cas9
Slattery, et al., 2018
pPtGE35
P. tricornutum expression vector, 40SRPS8 promoter and terminator driving Sh ble, FcpB promoter and FcpA terminator driving TevCas9 Slattery, et al., 2018
pPtUMPSA1
pPtGE31 encoding PtUMPS allele 1 driven by the PtUMPS promoter and terminator
This study
pPtUMPSA2
pPtGE31 encoding PtUMPS allele 2 driven by the PtUMPS promoter and terminator
This study
pPtUMPScA1 pPtGE31 encoding PtUMPS allele 1 cDNA driven by the PtUMPS promoter and terminator
This study
pPtUMPScA2 pPtGE31 encoding PtUMPS allele 2 cDNA driven by the PtUMPS promoter and terminator
This study
pPtPRAPHCH pPtGE31 encoding PtPRA-PH/CH allele 1 driven by the PtPRA-PH/CH promoter and terminator
This study
pTA-Mob
Mobilization helper plasmid required for conjugation
Strand, et al., 2014
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Table C.6: List of oligonucleotides used in this study.
Name
DE3644
DE3645
DE3646
DE3647
DE3648
DE3649
DE4236
DE4237
DE4162
DE4163
DE4164
DE4165
DE4166
DE4167
DE3650
DE3651

Sequence (5’ to 3’) (Priming sequence for PCR)
tcgaATTAAGTATCGAAACGAATA
aaacTATTCGTTTCGATACTTAAT
tcgaTAAATTGGTCGGGACTTCGT
aaacACGAAGTCCCGACCAATTTA
tcgaCGACCAACGTTTTGCAAA
aaacTTTGCAAAACGTTGGTCG
tcgagATTTTGTTGGATGTCAAGCG
aaacCGCTTGACATCCAACAAAATc
tcgagCTACTACAGCCGTTCCCGGAA
aaacTTCCGGGAACGGCTGTAGTAGc
tcgagTCGCGAAAGTCAGCGGCCCC
aaacGGGGCCGCTGACTTTCGCGAc
tcgagGGCTCGACAAAGACTGTGAC
aaacGTCACAGTCTTTGTCGAGCCc
tcgaGGACTCGGACAACCCCGATT
aaacAATCGGGGTTGTCCGAGTCC

DE3728

GGCCTGGCAGCTTTATCAGTAG

DE3726
DE3727

GGTCAACACCAATTCGCTG
GAAGACTGACAATTGACACGACC

DE3724

GACGAAGTGTCTACTCACAGACAGC

DE3725

TCCCATCAGTGGTGAAAGCG

DE4176
DE4177
DE4174
DE4175
DE4178
DE4179

ACGCCGCCATGGTTGGTC
CTCGTCTTGAAACAGACGTTTCGTG
CCGAGTGATACTGTTCGCTTCG
GGAGTCCACTCGCGAGAC
GACCGCCTCGCAACTCGG
CCACGTGTGCCTTCGTATCG
AGCAGGGTTATGCAGCGGAAGATCTATATTAC
CCTGTTATAAAGGCGGCGAATACTTCAT
TGCAGTCACTCCGCTTTGGTTTCGTAACTATA
ACGGTCTCGATGACTGACAAAGGTATTC
TGCAGTCACTCCGCTTTGGTTTCGTAACTAT
AACGGTCCTCGCGTTTTACGCGCCGTC
AGCAGGGTTATGCAGCGGAAGATCTATATT
ACCCTGTTATGCCCGCCTGATGCGTCG
TCCTTTTCCAGTGCTTCGAT
TACCTGCTGCATCAGCTTTG
TGGGTGTTGTGCTCTGCTAC
TCTCCAAAGCCCAATTTTTG
ACTCAGCGTCACCTCCACTT
GAATGCACCGATCACAACTG
TCGAGGGAAGAGGCTAGACA
TTCCGTTGCATTGATGTTGT

DE4553
DE4552
DE4622
DE4623
DE5178
DE5179
DE5180
DE5181
DE5182
DE5183
DE5184
DE5185

Description
Top strand sgRNA.UMPS.1944 for PtUMPS
Bottom strand sgRNA.UMPS.1944 for PtUMPS
Top strand sgRNA.UMPS.1646 for PtUMPS
Bottom strand sgRNA.UMPS.1646 for PtUMPS
Top strand sgRNA.UMPS.157 for PtUMPS
Bottom strand sgRNA.UMPS.157 for PtUMPS
Top strand sgRNA.UMPS.311 for PtUMPS
Bottom strand sgRNA.UMPS.311 for PtUMPS
Top strand sgRNA.PRAPHCH.929 for PtPRA-PH/CH
Bottom strand sgRNA.PRAPHCH.929 for PtPRA-PH/CH
Top strand sgRNA.PRAPHCH.120 for PtPRA-PH/CH
Bottom strand sgRNA.PRAPHCH.120 for PtPRA-PH/CH
Top strand sgRNA.PRAPHCH.1000 for PtPRA-PH/CH
Bottom strand sgRNA.PRAPHCH.1000 for PtPRA-PH/CH
Top strand sgRNA.IGPSPRAI.244 for PtI3GPS-PRAI
Bottom strand sgRNA.IGPSPRAI.244 for PtI3GPS-PRAI
Rev screening primer for sgRNA.UMPS.1944 site
(pair with DE3646)
Fwd screening primer for sgRNA.UMPS.1646 site
Rev screening primer for sgRNA.UMPS.1646 site
Fwd screening primer for sgRNA.UMPS.157
and sgRNA.UMPS.311 sites
Rev screening primer for sgRNA.UMPS.157
and sgRNA.UMPS.311 sites
Fwd sgRNA.PRAPHCH.929 screening primer
Rev sgRNA.PRAPHCH.929 screening primer
Fwd sgRNA.PRAPHCH.120 screening primer
Rev sgRNA.PRAPHCH.120 screening primer
Fwd sgRNA.PRAPHCH.1000 screening primer
Rev sgRNA.PRAPHCH.1000 screening primer
Fwd PtUMPS promoter with pPtGE31
homology
Rev PtUMPS terminator with pPtGE31
homology
Fwd PtPRA-PH/CH promoter with pPtGE31
homology
Rev PtPRA-PH/CH terminator with pPtGE31
homology
Fwd primer to amplify ∼6kb around sgRNA.IGPSPRAI.244 site
Rev primer to amplify ∼6kb around sgRNA.IGPSPRAI.244 site
Fwd primer to amplify ∼6kb around sgRNA.UMPS.1944 site
Rev primer to amplify ∼6kb around sgRNA.UMPS.1944 site
Fwd primer to amplify ∼6kb around sgRNA.UMPS.311 site
Rev primer to amplify ∼6kb around sgRNA.UMPS.311 site
Fwd primer to amplify ∼6kb around PtUrease sgRNA.UREASE.1187 site
Rev primer to amplify ∼6kb around PtUrease sgRNA.UREASE.1187 site
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Appendix D
Supplemental information for Chapter 4
D.1

Supplemental Tables

Table D.1: List of plasmids used in this study.
Plasmid
pPtGE31
pPtPRAPHCH
pDMI-2 PtRBD c14
pDMI-2 PtRBD c14
pDMI-2 PtSpike c1
pDMI-2 PtSpike c2

Description

Reference or Source

P. tricornutum expression vector (also called pDMI-2)
Slattery et al., 2018
pPtGE31 encoding PtPRA-PH/CH allele 1 driven by the PtPRA-PH/CH promoter and terminator
Slattery et al., 2020
pPtGE31 encoding P. tricornutum codon-optimized RBD driven by HASP1 promoter version 1
This study
pPtGE31 encoding P. tricornutum codon-optimized RBD driven by HASP1 promoter version 2
This study
pPtGE31 encoding P. tricornutum codon-optimized full-length Spike driven by HASP1 promoter version 1 This study
pPtGE31 encoding P. tricornutum codon-optimized full-length Spike driven by HASP1 promoter version 2 This study
pPtGE31 encoding P. tricornutum codon-optimized full-length Spike (K986P and V987P)
pDMI-2 PtSpike2P c1
This study
driven by HASP1 promoter version 1
pPtGE31 encoding P. tricornutum codon-optimized full-length Spike (K986P and V987P)
pDMI-2 PtSpike2P c2
This study
driven by HASP1 promoter version 2
pDMI-2 HsRBD
pPtGE31 encoding human codon-optimized RBD driven by 40SRPS8 promoter
This study
pDMI-2 HsSpike
pPtGE31 encoding human codon-optimized full-length Spike driven by 40SRPS8 promoter
This study
pPtGE31 encoding human codon-optimized full-length Spike (K986P and V987P)
pDMI-2 HsSpike2P
This study
driven by 40SRPS8 promoter
pTA-Mob
Mobilization helper plasmid required for conjugation
Strand et al., 2014
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Table D.2: List of oligonucleotides used in this study.
Name

Sequence (5’ to 3’) (Priming sequence for PCR)

DE3197 ATCTTCCGCTGCATAACCC
ATGGATATACCGAAAAAATCGCTATAATGACCCCGAAGCA
DE3627
GGGTTATGCAGCGGAAGATGGGGTGGATAAAGAAGAAAGG
DE4130 CCCTGCGATAGACCTTTTCC
DE3061 GGTATTCTATTCTCTGATTC
DE5239 ATGAATCTTCGTTGTATCCTTCCG
TGGTAAATCATAGATGTTCACAATGAGATA
DE5240
TTCTTATCTTCAATGGTGATGGTGATGGTG
TTTCCCAGCTACTCGACGCATCAGGCGGG
DE5241
CGGATTGATAGTGAAAACCTTATTCATTGTC
DE5242 AGCCCCAGCCGAGAAG
AAAAATTTAATTTTCATTAGTTGCAGTCAC
DE5243
TCCGCTTTGGTTTCTCGCGTTTTACGCGCC
ACCGGCTTAAGCTCTGACAATGAATAAGG
DE5244
TTTTCACTATCAATCCGCCCGCCTGATGCGT
DE5245 AGATAAGAATATCTCATTGTGAACA
AGTTCGTGGGCCAAGAAACTGACGGCGCG
DE5246
TAAAACGCGAGAAACCAAAGCGGAGTGACTG
GCGTTGATCTTGCACCGAAGGAATCAGAG
DE5247
AATAGAATACCATGTTCGTGTTTCTGGTGCT
TAAATCATAGATGTTCACAATGAGATATTCT
DE5248
TATCTTTATCAATGGTGATGGTGATGGTG
AATCATAGATGTTCACAATGAGATATTCTTA
DE5249
TCTTCATTAGTGATGATGATGATGATGTC
TTGTTTTCTTGGACTGCGTGAGTTTGGAAA
DE5250
AGGTCTATCGCAGGGGCCCGCCTGATGCGT
DE5251 GCGGGATCTGCCTCAGG
DE5252 CCTGTACCGGCTGTTCCG
DE5253 GCCAGCCAGAGCATCATTG
DE5254 ATGTGCTGTACGAGAACCAG
DE5255 AGATTCTGTCCGACGAAGCG
DE5256 CTCCAAACACACTCCGATTAAC
DE5257 CTTGGATTCGAAAGTTGGAGG
DE5258 CCAGACTCAAACGAATTCGC
DE5259 GGCCTACCGTTTCAACGG
DE5260 ACCGTGTACGATCCGCTG
DE5323 ACGGAGTAATCGGCGACGC
DE5326 GAGTTGTACAGCACGGAGTAGTCG

Description
Fwd pDMI-2 vector
Rev 40SRPS8 terminator with pDMI-2 vector homology
Fwd 40SRPS8 Promoter
Rev 40SRPS8 Promoter
Fwd PtSpike/RBD (universal)
Rev PtSpike/RBD (universal) with 40SRPS8 terminator homology
Fwd HASP1 promoter and signal peptide with HIS4 cassette homology
Rev HASP1 promoter and signal peptide
Fwd HIS4 cassette with pDMI-2 vector homology
Rev HIS4 cassette with HASP1 promoter homology
Fwd 40SRPS8 terminator
Rev pDMI-2 vector with HIS4 cassette homology
Fwd HsSpike/RBD (universal) with 40SRPS8 promoter homology
Rev HsRBD with 40SRPS8 terminator homology
Rev HsSpike with pDMI-2 vector homology
Rev HIS4 cassette with 40SRPS8 promoter homology
Fwd HsSpike sequencing primer 1
Fwd HsSpike sequencing primer 2
Fwd HsSpike sequencing primer 3
Fwd HsSpike sequencing primer 4
Fwd PtSpike/RBD sequencing primer 1
Fwd PtSpike sequencing primer 2
Fwd PtSpike sequencing primer 3
Fwd PtSpike sequencing primer 4
Fwd PtSpike sequencing primer 5
Fwd PtSpike sequencing primer 6
Rev PtRBD screening primer
Rev HsRBD screening primer

154

Curriculum Vitae
SAMUEL S. SLATTERY
======================

Education:
PhD Candidate, Biochemistry, 2014-current
Western University, London, Ontario
Bachelor of Science, Honors Specialization in Genetics and Biochemistry, 2010-2014
Western University, London, Ontario
Publications:
Slattery, S.S., Cholod, J., Stuckless, E., Wang, H., Olteanu, D., Rizvi, I., Karas, B.J., Edgell, D.R.
(2020). Examining the Effects of a Ku70 Knockout on DNA Damage Repair in Phaeodactylum
tricornutum. (In Preparation).
Slattery, S.S., Wang, H., Giguere, D.J., Kocsis, C., Urquhart, B.L., Karas, B.J., Edgell, D.R.
(2020). Plasmid-Based Complementation of Large Deletions in Phaeodactylum tricornutum
Biosynthetic Genes Generated by Cas9 Editing. Scientific Reports. 10: 1-12.
https://doi.org/10.1038/s41598-020-70769-6
Wang, H., Slattery, S.S., Karas, B.J., Edgell, D.R. (2018). Delivery of the Cas9 or TevCas9
System into Phaeodactylum tricornutum via Conjugation of Plasmids from a Bacterial Donor.
Bio-protocol 8(16): e2974.
http://dx.doi.org/10.21769/BioProtoc.2974
Slattery, S.S., Diamond, A., Wang, H., Therrien, J.A., Lant, J.T., Jazey, T., Lee, K., Klassen,
Z., Desgagne-Penix, I., Karas, B.J., Edgell, D.R. (2018). An Expanded Plasmid-Based Genetic Toolbox Enables Cas9 Genome Editing and Stable Maintenance of Synthetic Pathways
in Phaeodactylum tricornutum. ACS Synthetic Biology. 7(2): 328-338.
http://dx.doi.org/10.1021/acssynbio.7b00191

155
Presentations:
An Expanded Plasmid-Based Genetic Toolbox Enables Cas9 Genome Editing and Stable Maintenance of Synthetic Pathways in Phaeodactylum tricornutum. Annual Conference of the Canadian Society of Microbiology (CSM), Sherbrooke, Quebec. June, 2019 (abstract/poster)
An Expanded Plasmid-Based Genetic Toolbox Enables Cas9 Genome Editing and Stable Maintenance of Synthetic Pathways in Phaeodactylum tricornutum. Synthetic Biology Symposium
4.0 Conference, Waterloo, Ontario. May, 2019 (abstract/poster)
An Expanded Plasmid-Based Genetic Toolbox Enables Cas9 Genome Editing and Stable Maintenance of Synthetic Pathways in Phaeodactylum tricornutum. Synthetic Biology: Engineering
Evolution, and Design (SEED) Conference, Scottsdale, Arizona. June, 2018 (abstract/poster)
An Expanded Plasmid-Based Genetic Toolbox Enables Cas9 Genome Editing and Stable Maintenance of Synthetic Pathways in Phaeodactylum tricornutum. Synthetic Biology Symposium
3.0 Conference, London, Ontario. May, 2018 (abstract/poster)
Plasmid-based tools for generating designer Phaeodactylum tricornutum strains. Synthetic Biology
Symposium 2.0 Conference, London, Ontario. May, 2017 (abstract/poster)
Plasmid-based tools for developing designer Phaeodactylum tricornutum strains. London Health
Research Day, London, Ontario. March, 2017 (invited speaker)
Awards and Honors:

Award

Value (CDN)

Level

MITACS Accelerate
Internship
Ontario Graduate
Scholarship
Synthetic Biology Symposium
Top Poster
Synthetic Biology Symposium
2nd Place Poster
Synthetic Biology Symposium
Top Poster
Departmental Symposium
Top Oral Presentation
Western Graduate Research
Scholarship
Dean’s Honour List

$10,000

National

$15,000
$200
$200
$250
$50
(tuition)
-

Location of
Tenure

Western
University
Provincial
Western
University
Provincial
Western
University
Provincial
Western
University
Provincial
Western
University
Institutional Western
University
Institutional Western
University
Institutional Western
University

Period Held
2020/05-2020/09
2018/05-2019/05
2019
2018
2017
2017
2014/09-2019/09
2012/09-2014/05

156
Experience:
Laboratory
Research Assistant, Western University, Department of Biochemistry 2014/05 - 2014/09 (Dr.
Edgell)
Teaching Assistantships
Biochemistry 3381A, Western University 2018
Biochemistry 3380G, Western University 2018
Biochemistry 3380G, Western University 2017
Biochemistry 2280A, Western University 2017
Biochemistry 2280A, Western University 2016
Biochemistry 2280A, Western University 2016 Summer
Biochemistry 2280A, Western University 2015

